Sentence,class,file
"In our case, the patient had been taking methimazole for  This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/08/a6/jpis-45-76.PMC4415005.pdf
ORCID Eun-Cheol Kim http://orcid.org/0000-0002-8445-2594 Joon Bong Park http://orcid.org/0000-0003-4959-8587 Ji-Youn Hong http://orcid.org/0000-0003-1040-7077 Kyung Lhi Kang http://orcid.org/0000-0002-0511-5742REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/08/a6/jpis-45-76.PMC4415005.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/fb/main.PMC4415116.pdf
1936-5233/15http://dx.doi.org/10.1016/j.tranon.2015.02.003,OADS,/arxiv_data1/oa_pdf/d9/fb/main.PMC4415116.pdf
1476-5586/15 http://dx.doi.org/10.1016/j.neo.2015.02.005,OADS,/arxiv_data1/oa_pdf/82/cb/main.PMC4415117.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
1936-5233/15http://dx.doi.org/10.1016/j.tranon.2015.01.003,OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
The total microarray raw and normalized data of this study are public available at the Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo/) with acces- sion number GSE56303.,OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
http://dx.doi.org/10.1016/S0140-6736(01)05965-7 .,OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
"CA Cancer J Clin 61,6 9 –90.http://dx.doi.org/10.3322/caac.20107 .",OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
http://dx.doi.org/10.1016/j.ijrobp.2004.12.037 .,OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
http://dx.doi.org/10.1016/S0140-6736(03)13778-6 .,OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
V. 1.2009. http://www.nccn.org ; 2009.,Non-OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
http://dx.doi.org/10.1056/NEJMoa021967 .,Non-OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
http://dx.doi.org/10.1200/JCO.2005.05.0229 .,OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
http://dx.doi.org/10.1038/35000501 .,Non-OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
http://dx.doi.org/10.1111/his.12058 .,Non-OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
"Eur J Cancer 45, 228 –247.http://dx.doi.org/10.1016/j.ejca.2008.10.026 .",OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
http://dx.doi.org/10.1128/JCM.,Non-OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
http://dx.doi.org/10.1093/bioinformatics/btq410 .,OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
http://dx.doi.org/10.1186/gb-2004-5-10-r80 .,Non-OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
http://dx.doi.org/10.1038/415530a .,Non-OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
http://dx.doi.org/10.1038/ng1502 .,Non-OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
http://dx.doi.org/10.1038/sj.neo.7900251 .,Non-OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
http://dx.doi.org/10.1186/1471-2407-9-365 .,Non-OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
http://dx.doi.org/10.1002/cncr.25870 .,Non-OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
http://dx.doi.org/10.1007/s00432-012-1317-9 .,Non-OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
http://dx.doi.org/10.1158/1078-0432.CCR-06-0357 .84 Transcript Profiling Fernandez-Retana et al.,OADS,/arxiv_data1/oa_pdf/89/91/main.PMC4415118.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/dc/main.PMC4415120.pdf
1476-5586/15http://dx.doi.org/10.1016/j.neo.2015.03.003,OADS,/arxiv_data1/oa_pdf/e6/dc/main.PMC4415120.pdf
1476-5586/15 http://dx.doi.org/10.1016/j.neo.2015.02.006,OADS,/arxiv_data1/oa_pdf/46/58/main.PMC4415121.pdf
"These strategies have led to the classification of more than 200 CT antigens (CT antigendatabase, http://www.cta.lncc.br ), with new CT antigens continuing to be discovered [2].",Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
1936-5233/15http://dx.doi.org/10.1016/j.tranon.2015.02.001,OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
"Using the University of California Santa Cruz Genome Browser and the CT antigen database ( http://www.cta.lncc.br ), we generated a scaled diagram demonstrating the location of the major CT antigen gene families on the X chromosome (bottom).",OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
"MiR-888expression data were also obtained for a panel of cancers using the University of Iowa Institute for Clinical and Translation Science Compass website ( https://research.icts.uiowa.edu/compass/ , accessed 28 February 2014).",OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
"There are more than200 CT antigens currently classified in the CT antigen database(http://www.cta.lncc.br ), many of which have yet to be investigated for their immunogenic potential [3].",Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1038/nrc1669 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
"Cancer Immunity CT Gene, Database; 2013 [ http://www.cta.lncc.br ].",OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/ 10.1038/nature03440 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1093/mol- bev/msp284 [msp284; pii].,OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1016/j.cell.2007.04.040 [S0092-8674(07)00604-6; pii].,OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/ 10.3892/or.2011.1372 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/ 10.4161/cc.26984 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
"J Genet Genomics 41,3 5 –42.http://dx.doi.org/10.1016/j.jgg.2013.12.002 .",OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1016/j.jsgi.2004.04.003 .,OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/ 10.1016/j.tem.2011.01.005 .,OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1016/j.ygyno.2007.03.042 .,OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1038/mt.2011.219 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
"Gynecol Oncol 106,5 2 –64.http://dx.doi.org/10.1016/j.ygyno.2007.02.033 .",OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/ 10.1016/j.ygyno.2012.06.017 .,OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/ 10.1016/j.neuroscience.2012.08.009 .,OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/ 10.1111/j.1467-9868.2010.00749.x .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1097/AOG.0b013e318176157c .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1097/AOG.0b013e3182605bf1 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/ 10.5858/arpa.2012-0445-OA .,OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1095/biolreprod.106.051870 .,OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1038/ng.2705 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1038/nrg2948 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1371/journal.pone.0034996 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1007/s00414-012-0811-6 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1002/jcb.23165 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1007/s10815-011-9590-0 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1371/journal.pone.0017876 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1038/modpathol.3800232 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1002/ijc.10585 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1093/bioinformatics/bts623 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1074/jbc.M111.301275 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1002/ijc.26177 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
"Mol Cell Biochem 355,1 7 –25.http://dx.doi.org/10.1007/s11010-011-0834-1 .",OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-09-2206 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1095/biolreprod.105.040014 .,OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1038/nsmb.2115 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1016/j.cell.2007.09.020 .,OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1038/nature03076 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
"Nature 455, 64–71.http://dx.doi.org/10.1038/nature07242 .",Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/ 10.1210/jc.2004-0793 .,Non-OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
http://dx.doi.org/10.1016/j.fertnstert.2012.11.054 .96 miR-888: A Novel Cancer-Testis Antigen Hovey et al.,OADS,/arxiv_data1/oa_pdf/00/44/main.PMC4415123.pdf
[9]  ATC codes and DDD values can be found in the official  website of  WHO collaborating center for drug utilization  study (http://www.whocc.no/atc_ddd_index/).,OADS,/arxiv_data1/oa_pdf/19/0d/JFCM-22-101.PMC4415124.pdf
Available  from: http://www.pusdalisbang.jabarprov.go.id/pusdalisbang/ berkas/jabardalamangka/524277_penduduk.pdf.,Non-OADS,/arxiv_data1/oa_pdf/19/0d/JFCM-22-101.PMC4415124.pdf
Available from: http://www.scfhs.org.sa.,Non-OADS,/arxiv_data1/oa_pdf/26/6e/JFCM-22-106.PMC4415125.pdf
Available from: http://www.cdsi.gov.sa/ index.php?option = com_contentandview = articleandid = 88.,OADS,/arxiv_data1/oa_pdf/26/6e/JFCM-22-106.PMC4415125.pdf
Available from:  http://www.who.int/whr/2006/whr06%5Fen.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a5/dd/JFCM-22-111.PMC4415126.pdf
Available from: http://www.thehindu.com/todays‑paper/ tp‑national/severe‑shortfall‑of‑doctors‑in‑odisha/article5932784.,Non-OADS,/arxiv_data1/oa_pdf/a5/dd/JFCM-22-111.PMC4415126.pdf
Available from: http://www.icrier.org/pdf/WP__89.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a5/dd/JFCM-22-111.PMC4415126.pdf
Available from: http://www.phfi.org/images/ pdf/hrh_policy_note_4.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a5/dd/JFCM-22-111.PMC4415126.pdf
Available  from: http://www.hrhresourcecenter.org/node/3326.,Non-OADS,/arxiv_data1/oa_pdf/a5/dd/JFCM-22-111.PMC4415126.pdf
Available  from: http://www.icrier.org/pdf/wp__89.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a5/dd/JFCM-22-111.PMC4415126.pdf
Soc Pet Eng 2007;  https://www.onepetro.org/conference‑ paper/SPE‑108467‑MS.,Non-OADS,/arxiv_data1/oa_pdf/07/af/JFCM-22-73.PMC4415130.pdf
Available from: http://www.who.int/ violence_injury_prevention/violence/activities/adverse_childhood_ experiences/en/.,Non-OADS,/arxiv_data1/oa_pdf/34/64/JFCM-22-78.PMC4415131.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/34/64/JFCM-22-78.PMC4415131.pdf
Available from: http://www.cdc.gov/ violenceprevention/acestudy/pdf/haqmweb.pdf.,Non-OADS,/arxiv_data1/oa_pdf/34/64/JFCM-22-78.PMC4415131.pdf
Available  from: http://www.cdc.gov/violenceprevention/acestudy/prevalence.,Non-OADS,/arxiv_data1/oa_pdf/34/64/JFCM-22-78.PMC4415131.pdf
Available from: http://www.euro.who.,Non-OADS,/arxiv_data1/oa_pdf/34/64/JFCM-22-78.PMC4415131.pdf
Available from: http://www.ojp.,Non-OADS,/arxiv_data1/oa_pdf/34/64/JFCM-22-78.PMC4415131.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/34/64/JFCM-22-78.PMC4415131.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/34/64/JFCM-22-78.PMC4415131.pdf
1476-5586/15http://dx.doi.org/10.1016/j.neo.2015.03.002,OADS,/arxiv_data1/oa_pdf/bf/16/main.PMC4415136.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/f9/main.PMC4415137.pdf
1936-5233/15http://dx.doi.org/10.1016/j.tranon.2015.02.002,OADS,/arxiv_data1/oa_pdf/81/f9/main.PMC4415137.pdf
1936-523/15http://dx.doi.org/10.1016/j.tranon.2015.02.004,OADS,/arxiv_data1/oa_pdf/95/83/main.PMC4415139.pdf
1476-5586/15 http://dx.doi.org/10.1016/j.neo.2015.02.004,OADS,/arxiv_data1/oa_pdf/2f/56/main.PMC4415140.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/e7/main.PMC4415141.pdf
1476-5586/15http://dx.doi.org/10.1016/j.neo.2015.03.004,OADS,/arxiv_data1/oa_pdf/59/e7/main.PMC4415141.pdf
"In addition, single cancer –type assessments were performed to identify private candidate copy number drivers.Candidate driver gene fusions were identified from the MitelmanDatabase of Chromosome Aberrations and Gene Fusions in Cancer(http://cgap.nci.nih.gov/Chromosomes/Mitelman) as well as fromanalyzing 6438 primary tumor sample RNA-seq profiles contained within Oncomine.",OADS,/arxiv_data1/oa_pdf/59/e7/main.PMC4415141.pdf
1936-5233/15http://dx.doi.org/10.1016/j.tranon.2015.03.003,OADS,/arxiv_data1/oa_pdf/8b/9c/main.PMC4415142.pdf
[21] http://www.scanco.ch/en/support/faq-general.html .,Non-OADS,/arxiv_data1/oa_pdf/8b/9c/main.PMC4415142.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/d0/main.PMC4415144.pdf
1936-5233/15 http://dx.doi.org/10.1016/j.tranon.2015.03.001,Non-OADS,/arxiv_data1/oa_pdf/56/d0/main.PMC4415144.pdf
"Statistical analyses were performed using SAS version 9.3 (SAS Institute, Cary, NC) and R 2.13.2(Vienna, Austria; http://www.R-project.org/ ).",OADS,/arxiv_data1/oa_pdf/56/d0/main.PMC4415144.pdf
"http://dx.doi.org/10.5415/apallergy.2015.5.2.103 Asia Pac Allergy 2015;5:103-113 http://apallergy.orgBronchial asthma and hypovitaminosis D in Saudi  children  Huria M Aldubi1, Eman M Alissa1,*, Hayat Z Kamfar2, Osama Gaber1, and Zuhair M Marzouki1 Departments of 1Clinical Biochemistry and 2Paediatrics, Faculty of Medicine, King AbdulAziz University, Jeddah 21483, Saudi Arabia Background:  Asthma, a common lung disease in children, is caused by excessive immune responses to environmental antigens.",Non-OADS,/arxiv_data1/oa_pdf/19/17/apa-5-103.PMC4415176.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/17/apa-5-103.PMC4415176.pdf
"Aldubi HM, et al.Asia Pacific allergy104 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.103INTRODUCTION Bronchial asthma is the most common chronic condition in  children and adolescents worldwide, affecting around 300 million  patients, and the prevalence is continuing to rise [1].",Non-OADS,/arxiv_data1/oa_pdf/19/17/apa-5-103.PMC4415176.pdf
"Asthma and vitamin D105 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.103American Thoracic Society standards [15], by recording changes  in the peak expiratory flow (PEF), and C -ACT score.",Non-OADS,/arxiv_data1/oa_pdf/19/17/apa-5-103.PMC4415176.pdf
"Aldubi HM, et al.Asia Pacific allergy106 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.103to vitamin D status.",OADS,/arxiv_data1/oa_pdf/19/17/apa-5-103.PMC4415176.pdf
"Asthma and vitamin D107 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.103noted between serum 25-hydroxyvitamin D levels and TNF-α  levels ( r = –0.450, p < 0.0001).",Non-OADS,/arxiv_data1/oa_pdf/19/17/apa-5-103.PMC4415176.pdf
"Aldubi HM, et al.Asia Pacific allergy108 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.103independent determinant of circulating vitamin D levels (β =  – 0.",Non-OADS,/arxiv_data1/oa_pdf/19/17/apa-5-103.PMC4415176.pdf
"Asthma and vitamin D109 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.103and poor asthma control [22, 29, 30].",Non-OADS,/arxiv_data1/oa_pdf/19/17/apa-5-103.PMC4415176.pdf
"Aldubi HM, et al.Asia Pacific allergy110 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.103predictor of circulating vitamin D levels in our study (β = 0.575,  p < 0.0001, 95% CI, 1.290–1.991).",Non-OADS,/arxiv_data1/oa_pdf/19/17/apa-5-103.PMC4415176.pdf
"Asthma and vitamin D111 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.103deficiency causes increase in the expression of TNF-α, thereby  increasing inflammation and decreases the expression of vitamin D receptors (VDRs) [6].",Non-OADS,/arxiv_data1/oa_pdf/19/17/apa-5-103.PMC4415176.pdf
"Aldubi HM, et al.Asia Pacific allergy112 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.103Pharmacol 2008;155:84-92.",OADS,/arxiv_data1/oa_pdf/19/17/apa-5-103.PMC4415176.pdf
"Asthma and vitamin D113 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.103Adikibi T, Pridgeon C, Dallman M, Loke TK, Robinson DS, Barrat FJ,  O’Garra A, Lavender P , Lee TH, Corrigan C, Hawrylowicz CM.",Non-OADS,/arxiv_data1/oa_pdf/19/17/apa-5-103.PMC4415176.pdf
"Hypothesis & Experience  Original Article Asia Pacific allergypISSN 2233-8276 · e ISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2015.5.2.114 Asia Pac Allergy 2015;5:114-122Reduced IRF7 response to rhinovirus unrelated  with DNA methylation in peripheral mononuclear  cells of adult asthmatics Sae-Hoon Kim1,2,3, Kyung-Hwan Lim1,2, Han-Ki Park1,2, Suh-Young Lee1,2,3, Soon-Hee Kim4, Hye-Ryun Kang1,2,    Heung-Woo Park1,2, Yoon-Seok Chang1,2,3, and Sang-Heon Cho1,2,* 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-899, Korea 2Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul 110-899, Korea 3Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 463-707, Korea 4Biomedical Research Institute, Seoul National University Bundang Hospital, Seongnam 463-707, Korea Background:  Human rhinoviruses are the major cause of asthma exacerbation in both children and adults.",Non-OADS,/arxiv_data1/oa_pdf/8d/7f/apa-5-114.PMC4415177.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/7f/apa-5-114.PMC4415177.pdf
"http://apallergy.org Received:  January 3, 2015 Accepted:  April 12, 2015",Non-OADS,/arxiv_data1/oa_pdf/8d/7f/apa-5-114.PMC4415177.pdf
Reduced IRF7 response to rhinovirus in asthmatics115 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.114 INTRODUCTION Asthma is a chronic inflammatory disease with great socioeco - nomic burden [1].,Non-OADS,/arxiv_data1/oa_pdf/8d/7f/apa-5-114.PMC4415177.pdf
"Asia Pacific allergy116 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.114Grand Island, NY, USA) supplemented with 10% fetal bovine se - rum (Sigma-Aldrich Co.) and infected with a major group rhino - virus, rhinovirus-16 (multiplicity of infection, 1).",Non-OADS,/arxiv_data1/oa_pdf/8d/7f/apa-5-114.PMC4415177.pdf
Reduced IRF7 response to rhinovirus in asthmatics117 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.114 16.3 ± 5.3 and mean predicted % of FEV1 was 82.8% ± 19.7% at  the time of enrollment.,Non-OADS,/arxiv_data1/oa_pdf/8d/7f/apa-5-114.PMC4415177.pdf
"Asia Pacific allergy118 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.114tion compared to media only-treated controls, but there was no  significance difference between normal control and asthmatics (Fig.",Non-OADS,/arxiv_data1/oa_pdf/8d/7f/apa-5-114.PMC4415177.pdf
Reduced IRF7 response to rhinovirus in asthmatics119 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.114sion of IRF7 in the response to rhinovirus in the asthmatic PBMCs.,Non-OADS,/arxiv_data1/oa_pdf/8d/7f/apa-5-114.PMC4415177.pdf
Asia Pacific allergy120 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.114production and secretion.,Non-OADS,/arxiv_data1/oa_pdf/8d/7f/apa-5-114.PMC4415177.pdf
"Reduced IRF7 response to rhinovirus in asthmatics121 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.114In conclusion, the mRNA expression of type I IFN, IFN-α, and  IFN-β in response to rhinovirus was impaired in the PBMCs of  asthmatics.",Non-OADS,/arxiv_data1/oa_pdf/8d/7f/apa-5-114.PMC4415177.pdf
Asia Pacific allergy122 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.114entiated human airway epithelium to infection by rhinovirus.,Non-OADS,/arxiv_data1/oa_pdf/8d/7f/apa-5-114.PMC4415177.pdf
"Educational & Teaching Material  Case report http://dx.doi.org/10.5415/apallergy.2015.5.2.123 Asia Pac Allergy 2015;5:123-127Eosinophilic myocarditis: case series and    literature review Kyoung-Hee Sohn1,2,3, Woo-Jung Song2,3, Byung-Keun Kim1,2,3, Min-Koo Kang2,3, Suh-Young Lee1,2,3, Jung-Won Suh1,2,   Yeonyee E Yoon1,2, Sae-Hoon Kim1,2,3, Tae-Jin Youn1,2, Sang-Heon Cho2,3, and Yoon-Seok Chang1,2,3,* 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 463-707, Korea 2Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea 3Seoul National University Medical r esearch Center, Seoul National University College of Medicine, Seoul 110-799, Korea Eosinophilic myocarditis is a condition resulting from various eosinophilic diseases, including helminth infection, drug  hypersensitivity, systemic vasculitis or idiopathic hypereosinophilic syndromes.",Non-OADS,/arxiv_data1/oa_pdf/f1/cc/apa-5-123.PMC4415178.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/cc/apa-5-123.PMC4415178.pdf
"http://apallergy.orgINTRODUCTION Eosinophilic myocarditis is a condition resulting from various  eosinophilic diseases, including helminth infection, drug hyper - sensitivity, systemic vasculitis or idiopathic hypereosinophilic syndromes (HES).",Non-OADS,/arxiv_data1/oa_pdf/f1/cc/apa-5-123.PMC4415178.pdf
"Sohn KH, et al.Asia Pacific allergy124 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.127regions, reflecting the under-recognition of the disease among  clinicians.",Non-OADS,/arxiv_data1/oa_pdf/f1/cc/apa-5-123.PMC4415178.pdf
Eosinophilic myocarditis125 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.127revealed concentric left ventricular hypertrophy (LVH) with  preserved LV systolic function but whole apex akinesia and  pericardial effusion.,Non-OADS,/arxiv_data1/oa_pdf/f1/cc/apa-5-123.PMC4415178.pdf
"Sohn KH, et al.Asia Pacific allergy126 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.127tive (1.975; cutoff, 0.999).",OADS,/arxiv_data1/oa_pdf/f1/cc/apa-5-123.PMC4415178.pdf
Eosinophilic myocarditis127 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.1272006;22:1233-7.,Non-OADS,/arxiv_data1/oa_pdf/f1/cc/apa-5-123.PMC4415178.pdf
Available from: http://www.j-circ.or.jp/ guideline/pdf/JCS2009_izumi_h.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f1/cc/apa-5-123.PMC4415178.pdf
"Case ReportAsia Pacific allergypISSN 2233-8276 · e ISSN 2233-8268http://dx.doi.org/10.5415/apallergy.2015.5.2.128 Asia Pac Allergy 2015;5:128-131 Anaphylaxis due to ruptured pulmonary hydatid   cyst in a 13 -year-old boy Ahmet Özdemir1,*, Şefika Elmas Bozdemir2, Demet Akbiyik2, Ghania Daar3, Sabriye Korkut1, Levent Korkmaz1,    and Osman Baştuğ1  1Department of Pediatrics, Erciyes University Medical Faculty, 38039 Kayseri, Turkey 2Department of Pediatrics, Kayseri Teaching and Research Hospital, 38170 Kayseri, Turkey 3Department of Pediatrics, Yozgat Bozok University Faculty of Medicine, 66200 Yozgat, Turkey Hydatid cyst, a common disease in the world, is usually transmitted to humans through dog feces.",Non-OADS,/arxiv_data1/oa_pdf/19/d8/apa-5-128.PMC4415179.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/d8/apa-5-128.PMC4415179.pdf
"http://apallergy.orgINTRODUCTION Hydatid cyst, an infection of echinococcus granulosus, is  commonly encountered in our country.",Non-OADS,/arxiv_data1/oa_pdf/19/d8/apa-5-128.PMC4415179.pdf
"Ruptured pulmonary hydatid cyst129  apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.128 of the time, but rarely the bone, muscle, brain, kidney, and spleen  are affected.",Non-OADS,/arxiv_data1/oa_pdf/19/d8/apa-5-128.PMC4415179.pdf
" Özdemi A, et al.130 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.128 Asia Pacific allergyrespectively.",Non-OADS,/arxiv_data1/oa_pdf/19/d8/apa-5-128.PMC4415179.pdf
Ruptured pulmonary hydatid cyst131 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.128and IFAT for echinococcus were recorded as 1/64 and 1/1000  respectively.,Non-OADS,/arxiv_data1/oa_pdf/19/d8/apa-5-128.PMC4415179.pdf
EditorialAsia Pacific allergypISSN 2233-8276 · e ISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2015.5.2.57 Asia Pac Allergy 2015;5:57-58 Copyright © 2015.,Non-OADS,/arxiv_data1/oa_pdf/c7/83/apa-5-57.PMC4415180.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/83/apa-5-57.PMC4415180.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/c7/83/apa-5-57.PMC4415180.pdf
apallergy.org  Katelaris CHAsia Pacific allergy http://dx.doi.org/10.5415/apallergy.2015.5.2.5758   vitamin D. This edition’s featured review article is a thorough discussion  by Dao et al.,Non-OADS,/arxiv_data1/oa_pdf/c7/83/apa-5-57.PMC4415180.pdf
"http://dx.doi.org/10.5415/apallergy.2015.5.2.59 Asia Pac Allergy 2015;5:59-67 http://apallergy.orgRecent advances of pharmacogenomics in severe  cutaneous adverse reactions: immune and    nonimmune mechanisms Ro-Lan Dao1,2, Shih-Chi Su1,2, and Wen-Hung Chung1,2,*  1Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospitals, Taipei, Linkou, and Keelung,  Taiwan 2College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan  Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms  (DRESS) are severe cutaneous adverse reactions (SCAR) which are majorly caused by drugs.",Non-OADS,/arxiv_data1/oa_pdf/68/71/apa-5-59.PMC4415181.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Severe cutaneous adverse reactions (SCAR), including  Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis  (TEN), and drug reaction with eosinophilia and systemic symp - toms (DRESS) are known to have potential lethality and lifelong sequelae.",Non-OADS,/arxiv_data1/oa_pdf/68/71/apa-5-59.PMC4415181.pdf
"Dao RL, et al.Asia Pacific allergy60 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.59severe interface vacuolization are significant in DRESS cases [9].",Non-OADS,/arxiv_data1/oa_pdf/68/71/apa-5-59.PMC4415181.pdf
"Immune and nonimmune mechanisms61 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.59Indian [52], and Malaysian [53], HLA-B*15:1 1 and CBZ-SJS/TEN in  Japanese [54], Korean [55], and Han Chinese [56, 57], HLA-B*59:01 and CBZ-SJS/TEN in Japanese [58], HLA-A*31:01 and CBZ-SJS/TEN/ drug-induced hypersensitivity syndrome in Japanese [59, 60], and  CBZ-maculopapular exanthema (MPE)/DRESS in Han Chinese [61, 62], European [62, 63], HLA-B*13:01 and dapsone induced hyper - sensitivty in Han Chinese [64], HLA-B*15:02 and lamotrigine-SJS/TEN in Han Chinese [65, 66], HLA-B*15:02 and phenytoin (PHT)- SJS/TEN in Thai [51], HLA-B*59:01 and methazolamide-SJS/TEN  in Korean and Japanese [67], HLA-DRB1*01:01 and nevirapine hypersensitivity in Australian [68] and French [69], HLA-B*14:02 (or HLA-B*14:02-Cw*08:02 haplotype)-nevirapine hypersensitiv - ity in Sardinian [70], HLA-B*35:05 and nevirapine-MPE/DRESS in Thai [71], HLA-Cw*08:01 or 08:02 and navirapine hypersensitivity  in Sardinian [70] and Japanese [72], HLA-B*73 and oxicam-SJS/ TEN [48], HLA-A2 and B12 and oxicam-TEN [41], HLA-A29, B12, and DR7 and oxicam-TEN sulfonamide-TEN [41], HLA-B*15:02 and oxcarbazepine-SJS/TEN [66].",Non-OADS,/arxiv_data1/oa_pdf/68/71/apa-5-59.PMC4415181.pdf
"Dao RL, et al.Asia Pacific allergy62 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.59PHARMACOGENOMICS IN NONIMMUNE  MEDIATED MECHANISMS Though the HLA predisposition plays a critical role in drug- induced SCAR, other factors like individual differences in drug  clearance or metabolism may also contribute to SCAR develop - ment, recovery or prognosis.",Non-OADS,/arxiv_data1/oa_pdf/68/71/apa-5-59.PMC4415181.pdf
Immune and nonimmune mechanisms63 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.59phisms were found to be associated with SJS/TEN susceptibility  [81] (Table 1).,OADS,/arxiv_data1/oa_pdf/68/71/apa-5-59.PMC4415181.pdf
"Dao RL, et al.Asia Pacific allergy64 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.59EurosCAR-study.",OADS,/arxiv_data1/oa_pdf/68/71/apa-5-59.PMC4415181.pdf
Immune and nonimmune mechanisms65 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.5939.,Non-OADS,/arxiv_data1/oa_pdf/68/71/apa-5-59.PMC4415181.pdf
"Dao RL, et al.Asia Pacific allergy66 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.59J Dermatol s ci 2014;73:101-9.",OADS,/arxiv_data1/oa_pdf/68/71/apa-5-59.PMC4415181.pdf
Immune and nonimmune mechanisms67 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.5977.,Non-OADS,/arxiv_data1/oa_pdf/68/71/apa-5-59.PMC4415181.pdf
http://dx.doi.org/10.1136/annrheumdis-2014-205577.,Non-OADS,/arxiv_data1/oa_pdf/68/71/apa-5-59.PMC4415181.pdf
"Original ArticleAsia Pacific allergypISSN 2233-8276 · e ISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2015.5.2.68 Asia Pac Allergy 2015;5:68-77 HLA-B*1502 and carbamazepine-induced severe  cutaneous adverse drug reactions in Vietnamese Dinh Van Nguyen 1,2,3,*,†, Hieu Chi Chu2,†, Doan Van Nguyen1,2, Minh Hong Phan4, Timothy Craig5, Karl Baumgart6,   and Sheryl van Nunen3 1Department of Allergy and Clinical Immunology, Hanoi Medical University, Hanoi 10000, Vietnam 2Center of Allergology and Clinical Immunology, Bach Mai Hospital, Hanoi 844, Vietnam 3Department of Allergy and Clinical Immunology, Royal North Shore Hospital and Sydney Medical School-Northern, The University of Sydney,  Sydney, NSW 2065, Australia 4Outpatients Department, Bach Mai Hospital, Hanoi 844, Vietnam 5Section of Allergy, Asthma and Immunology, Penn State University, Hershey, PA 17033, USA 6Sonic Clinical Institute, Macquarie Park, Sydney, NSW 2113, Australia Background:  In Vietnam, we observed a high incidence of carbamazepine (CBZ)-induced severe cutaneous adverse drug  reactions (SCARs)–Stevens-Johnson  syndrome (SJS)/toxic epidermal necrolysis (TEN), and drug-induced hypersensitivity rash with  eosinophilia and systemic symptoms (DRESS).",Non-OADS,/arxiv_data1/oa_pdf/2f/50/apa-5-68.PMC4415182.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/50/apa-5-68.PMC4415182.pdf
"http://apallergy.orgReceived: March 6, 2015Accepted: April 1, 2015",Non-OADS,/arxiv_data1/oa_pdf/2f/50/apa-5-68.PMC4415182.pdf
" HLA-B*1502 and CBZ in Vietnamese 69 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.68 INTRODUCTION The use of carbamazepine (CBZ), a common medication em - ployed for seizure prophylaxis and multiple other neurologically  based disorders, has been confirmed to be associated with se - vere cutaneous adverse drug reactions (SCARs) such as Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), and drug-induced hypersensitivity syndrome with rash, eosinophilia  and systemic symptoms (DRESS).",Non-OADS,/arxiv_data1/oa_pdf/2f/50/apa-5-68.PMC4415182.pdf
"Nguyen DV, et al.Asia Pacific allergy70 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.682.",OADS,/arxiv_data1/oa_pdf/2f/50/apa-5-68.PMC4415182.pdf
" HLA-B*1502 and CBZ in Vietnamese 71 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.68ity 76.0%, positive predictive value 85% and negative predictive  value 82.6% (Tables 3, 4).",OADS,/arxiv_data1/oa_pdf/2f/50/apa-5-68.PMC4415182.pdf
"Nguyen DV, et al.Asia Pacific allergy72 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.68Table 3.",Non-OADS,/arxiv_data1/oa_pdf/2f/50/apa-5-68.PMC4415182.pdf
 HLA-B*1502 and CBZ in Vietnamese 73 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.68 Table 4 .,Non-OADS,/arxiv_data1/oa_pdf/2f/50/apa-5-68.PMC4415182.pdf
"Nguyen DV, et al.Asia Pacific allergy74 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.68previous studies in Asians with different ancestries such as Han  Chinese [3, 4, 6-9], Thais [4, 10, 27], Malays [4, 12], Indians [1 1] and Singaporeans [4, 13].",Non-OADS,/arxiv_data1/oa_pdf/2f/50/apa-5-68.PMC4415182.pdf
" HLA-B*1502 and CBZ in Vietnamese 75 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.68cated that development of a rash was nearly twice as frequent in  females (OR,1.84; 95% CI, 1.32–2.60; p < 0.001).",Non-OADS,/arxiv_data1/oa_pdf/2f/50/apa-5-68.PMC4415182.pdf
"Nguyen DV, et al.Asia Pacific allergy76 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.68REFERENCES 1.",OADS,/arxiv_data1/oa_pdf/2f/50/apa-5-68.PMC4415182.pdf
 HLA-B*1502 and CBZ in Vietnamese 77 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.6822.,Non-OADS,/arxiv_data1/oa_pdf/2f/50/apa-5-68.PMC4415182.pdf
"Original ArticleAsia Pacific allergypISSN 2233-8276 · e ISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2015.5.2.78 Asia Pac Allergy 2015;5:78-83 http://apallergy.orgClinical manifestation and sensitization of allergic  children from Malaysia Aravind Yadav1,2,* and Rakesh Naidu2,3 1Department of Pediatric Pulmonary, University of Texas Health Science Center at Houston, Houston Medical School, Houston, TX 77030,  USA 2Department of Molecular Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia 3School of Medicine and Health Sciences, Monash University Sunway Campus, 46150 Bandar Sunway, Malaysia Background:  An epidemiological rise of allergic diseases in developing countries raises new challenges.",Non-OADS,/arxiv_data1/oa_pdf/6f/f4/apa-5-78.PMC4415183.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/f4/apa-5-78.PMC4415183.pdf
Allergens and children79 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.78 conditions such as allergic rhi  nitis and asthma in school aged  children.,Non-OADS,/arxiv_data1/oa_pdf/6f/f4/apa-5-78.PMC4415183.pdf
"Yadav A and Naidu RAsia Pacific allergy80 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.78<2 years were significantly more likely to be sensitized to egg  white ( p < 0.01), cow’s milk ( p = 0.044), cod fish ( p = 0.035) and  peanut ( p = 0.012), but not to soya ( p = 0.057), wheat ( p = 0.23)  or shrimp ( p = 0.29).",Non-OADS,/arxiv_data1/oa_pdf/6f/f4/apa-5-78.PMC4415183.pdf
"Allergens and children81 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.78year of life primarily featured chronic itchy rash, wheeze and  rhinoconjunctivitis [9], however allergic rhinitis developed after 6 years of age and rarely <2 years of age [10], in concordance to our  observation.",Non-OADS,/arxiv_data1/oa_pdf/6f/f4/apa-5-78.PMC4415183.pdf
"Yadav A and Naidu RAsia Pacific allergy82 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.78of outgrowing peanut sensitization, lending support towards  mounting evidence that peanut allergy in Asia maybe distinct from the West.",Non-OADS,/arxiv_data1/oa_pdf/6f/f4/apa-5-78.PMC4415183.pdf
"Allergens and children83 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.78Iyngkaran N, Gonzalez-Andaya A, Wah LB, Hsieh KH.",Non-OADS,/arxiv_data1/oa_pdf/6f/f4/apa-5-78.PMC4415183.pdf
"Original ArticleAsia Pacific allergypISSN 2233-8276 · e ISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2015.5.2.84 Asia Pac Allergy 2015;5:84-97 http://apallergy.orgEconomic value of atopic dermatitis prevention  via infant formula use in high-risk Malaysian   infants Abhijeet J Bhanegaonkar1, Erica G Horodniceanu1, Amir Hamzah Abdul Latiff2, Sanjay Woodhull3, Phaik Choo Khoo3,  Patrick Detzel4, Xiang Ji1, and Marc F Botteman1,* 1Pharmerit International, Bethesda, MD 20814, USA  2Department of Pediatrics, Pantai Hospital Kuala Lumpur, 59100 Kuala Lumpur, Malaysia 3Department of Pediatrics, Ramsay Sime Darby, Subang Jaya Medical Centre, 47500 Subang Jaya, Malaysia 4Nestlé Research Center, 1000 Lausanne 26, Switzerland Background:  Breastfeeding is best for infants and the World Health Organization recommends exclusive breastfeeding for at least  the first 6 months of life.",Non-OADS,/arxiv_data1/oa_pdf/3d/b4/apa-5-84.PMC4415184.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/b4/apa-5-84.PMC4415184.pdf
"Economic value of PHF-W for AD prevention-Malaysia85 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.84 INTRODUCTION Atopic dermatitis (AD) is one of the most prevalent inflamma - tory skin disorders affecting infants and young children [1, 2].",Non-OADS,/arxiv_data1/oa_pdf/3d/b4/apa-5-84.PMC4415184.pdf
"Bhanegaonkar AJ, et al.Asia Pacific allergy86 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.84approaches were considered upon AD development: formula  switch only, pharmacotherapy only, and combination formula switch and pharmacotherapy.",Non-OADS,/arxiv_data1/oa_pdf/3d/b4/apa-5-84.PMC4415184.pdf
Economic value of PHF-W for AD prevention-Malaysia87 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.84who were initially on PHF-W. A child who responded to phar - macotherapy was assumed to complete the treatment course  and remain on their formula until up to 12 months of age.,Non-OADS,/arxiv_data1/oa_pdf/3d/b4/apa-5-84.PMC4415184.pdf
"Bhanegaonkar AJ, et al.Asia Pacific allergy88 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.84and 0.450 with severe AD episodes based on previously pub - lished data [36, 37].",OADS,/arxiv_data1/oa_pdf/3d/b4/apa-5-84.PMC4415184.pdf
Economic value of PHF-W for AD prevention-Malaysia89 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.84Table 2.,Non-OADS,/arxiv_data1/oa_pdf/3d/b4/apa-5-84.PMC4415184.pdf
"Bhanegaonkar AJ, et al.Asia Pacific allergy90 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.84analyses were conducted to test the impact of changing key  model assumptions either alone or in combination.",OADS,/arxiv_data1/oa_pdf/3d/b4/apa-5-84.PMC4415184.pdf
Economic value of PHF-W for AD prevention-Malaysia91 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.84Table 4.,Non-OADS,/arxiv_data1/oa_pdf/3d/b4/apa-5-84.PMC4415184.pdf
‡Costs obtained from MIMS (http://www.mims.com/Malaysia/home/Index).,Non-OADS,/arxiv_data1/oa_pdf/3d/b4/apa-5-84.PMC4415184.pdf
"ǁCosts associated with time loss estimated using average  hourly wages in Kuala Lumpur (MYR 51.3, http://www.salaryexplorer.com/salary-survey.php?loc=1515&loctype=3, last accessed March 30th 2014), labor force participation (64.40%) (Source: Nestle Malaysia affiliate), and hours spent was obtained from expert panel.",OADS,/arxiv_data1/oa_pdf/3d/b4/apa-5-84.PMC4415184.pdf
"Bhanegaonkar AJ, et al.Asia Pacific allergy92 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.84age.",OADS,/arxiv_data1/oa_pdf/3d/b4/apa-5-84.PMC4415184.pdf
"Economic value of PHF-W for AD prevention-Malaysia93 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.84PHF-W was MYR 1,1 13 (US $352) (95% CI, MYR 317–1,884), irrespec - tive of AD development (Table 5).",OADS,/arxiv_data1/oa_pdf/3d/b4/apa-5-84.PMC4415184.pdf
"Bhanegaonkar AJ, et al.Asia Pacific allergy94 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.84AD (6.88 across all cases, 4.38 visits in mild, 7.02 visits in moder - ate, and 12.26 visits in severe cases) may be conservative when  compared to values for Australia [6] (12.88 visits overall; 7.0 visits  in mild, 13.0 visits in moderate, and 23.2 visits in severe cases) but  very consistent with Thailand [8] (approximately 4.3 to 4.6 visits overall; 4.0 visits in mild, 8.0 visits in moderate, and 12 to 13 visits for severe cases).",Non-OADS,/arxiv_data1/oa_pdf/3d/b4/apa-5-84.PMC4415184.pdf
"Economic value of PHF-W for AD prevention-Malaysia95 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.84firmed by diagnostic testing or suspected by clinical history, shift - ing to a non-CMF is common practice.",Non-OADS,/arxiv_data1/oa_pdf/3d/b4/apa-5-84.PMC4415184.pdf
"Bhanegaonkar AJ, et al.Asia Pacific allergy96 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.84multicountry cross-sectional surveys.",OADS,/arxiv_data1/oa_pdf/3d/b4/apa-5-84.PMC4415184.pdf
Economic value of PHF-W for AD prevention-Malaysia97 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.84tion of allergic disease through nutritional interventions.,Non-OADS,/arxiv_data1/oa_pdf/3d/b4/apa-5-84.PMC4415184.pdf
"Original ArticleAsia Pacific allergypISSN 2233-8276 · e ISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2015.5.2.98 Asia Pac Allergy 2015;5:98-102 http://apallergy.orgThe association of forced expiratory volume in one  second and forced expiratory flow at 50% of the   vital capacity, peak expiratory flow parameters,  and blood eosinophil counts in exercise-induced  bronchospasm in children with mild asthma H. Haluk Akar*, Fulya Tahan, and Hatice Eke  Gungor  Department of Pediatric Allergy, Erciyes University School of Medicine, 38039 Kayseri, Turkey Background:  Exercise-induced bronchoconstriction (EIB), which describes acute airway narrowing that occurs as a result of  exercise, is associated with eosinophilic airway inflammation, bronchial hyperresponsiveness.",Non-OADS,/arxiv_data1/oa_pdf/f7/3e/apa-5-98.PMC4415185.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/3e/apa-5-98.PMC4415185.pdf
"FEV1, and FEF50%, PEF, mild asthma99 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.98 INTRODUCTION Exercise-induced bronchospasm (EIB) describes acute airway  narrowing that occurs as a result of exercise [1].",Non-OADS,/arxiv_data1/oa_pdf/f7/3e/apa-5-98.PMC4415185.pdf
Asia Pacific allergy100 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.98obtained from the children and their parents.,Non-OADS,/arxiv_data1/oa_pdf/f7/3e/apa-5-98.PMC4415185.pdf
"FEV1, and FEF50%, PEF, mild asthma101 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.2.98and maximal FEV1, FEF50%, and PEF changes after the exercise test  (p<0.05; FEV1, r=0.54; FEF50%, r=0.42; PEF, r =0.26) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/f7/3e/apa-5-98.PMC4415185.pdf
"Asia Pacific allergy102 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.2.98According to the presented study, eosinophil may play a major  role in the severity of EIB in mild asthma.",Non-OADS,/arxiv_data1/oa_pdf/f7/3e/apa-5-98.PMC4415185.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/c5/TOORTHJ-9-49.PMC4415200.pdf
"Available from: http://www.cardiothoracicsurgery.org/content/2/1/2 [9] M. J. Thubrikar, S. K. Roskelley, and R. T. Eppink, “Study of stress concentration in the walls of the bovine coronary arterial branch”, J.",Non-OADS,/arxiv_data1/oa_pdf/3d/17/TOBEJ-9-1.PMC4415203.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/-licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/17/TOBEJ-9-1.PMC4415203.pdf
Available from: http://www.dentalcare.com.,Non-OADS,/arxiv_data1/oa_pdf/14/89/JISPCD-5-108.PMC4415328.pdf
"[cited November 15, 2013] Available from http://www.biomedcentral.com/1471- 2393/9/12 12.Kabakyenga JK.,  Östergren PO, Turyakira E, Pettersson KO.",OADS,/arxiv_data1/oa_pdf/64/96/AIPM-12-89.PMC4415391.pdf
"[cited November 23, 2013] Available from http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3231972/ 13.Ezeh, AC.",OADS,/arxiv_data1/oa_pdf/64/96/AIPM-12-89.PMC4415391.pdf
"June 2010 [cited June 29, 2014] Available from http://nigerianstat.gov.ng/pages/download /43.",Non-OADS,/arxiv_data1/oa_pdf/64/96/AIPM-12-89.PMC4415391.pdf
"[cited November 26, 2013] Available from http://www.biomed- central.com/1471-2393/8/9 20.Olugbenga-Bello AI,  Asekun-Olarinmoye EO, Adewole AO et al.",Non-OADS,/arxiv_data1/oa_pdf/64/96/AIPM-12-89.PMC4415391.pdf
"[cited June 29, 2014] Available from http://www.academicjournals.org /article/article/1379689263_Adenike%20et %20al.pdf 21.Varkey LC,  Mishra A, Das A et al.",Non-OADS,/arxiv_data1/oa_pdf/64/96/AIPM-12-89.PMC4415391.pdf
"[cited November 26, 2013]  Available from http://www.measuredhs.com/pubs/pdf/ WP93/WP93.pdf 24.Nour NM.",Non-OADS,/arxiv_data1/oa_pdf/64/96/AIPM-12-89.PMC4415391.pdf
"[cited November 28, 2013] Available from http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC2505173/25.Pembe AB,  Urassa DP, Carlstedt A et al.",OADS,/arxiv_data1/oa_pdf/64/96/AIPM-12-89.PMC4415391.pdf
"[cited November 28, 2013] Available from http://ccforum.com/1471-2393/ 9/12 26.Kadomoto N,  Iwasa H, Takahashi M et al,.",OADS,/arxiv_data1/oa_pdf/64/96/AIPM-12-89.PMC4415391.pdf
"[cited November 30, 2013] Available from http://www.biomedcentral.com/ 1471-2458/11/280 27.Amooti-Kaguna B,  Nuwaha F. Factors influencing choice of delivery sites in Rakai district of Uganda.",Non-OADS,/arxiv_data1/oa_pdf/64/96/AIPM-12-89.PMC4415391.pdf
http://dx.doi.org/ 10.1175/2009MWR2907.1 .,Non-OADS,/arxiv_data1/oa_pdf/5f/dc/nihms661114.PMC4415439.pdf
2012; 50(1):22– 45. http://epubs.siam.org/doi/abs/10.1137/100785958 .,Non-OADS,/arxiv_data1/oa_pdf/5f/dc/nihms661114.PMC4415439.pdf
http://www.sciencedirect.com/science/article/pii/ S0306454912001806 .,Non-OADS,/arxiv_data1/oa_pdf/5f/dc/nihms661114.PMC4415439.pdf
http://epubs.siam.org/doi/abs/ 10.1137/130930406 .,Non-OADS,/arxiv_data1/oa_pdf/5f/dc/nihms661114.PMC4415439.pdf
arXiv: http://dx.doi.org/10.1137/130930406  URL http://dx.doi.org/ 10.1137/130930406 .,OADS,/arxiv_data1/oa_pdf/5f/dc/nihms661114.PMC4415439.pdf
doi: http://dx.doi.org/10.1016/j.ocemod.2014.09.001 .,OADS,/arxiv_data1/oa_pdf/5f/dc/nihms661114.PMC4415439.pdf
version 49 Edition URL http://adcirc.org/documentv49/ ADCIRC_title_page.html 36.,Non-OADS,/arxiv_data1/oa_pdf/5f/dc/nihms661114.PMC4415439.pdf
http://dx.doi.org/10.1175/2009MWR2906.1 .,Non-OADS,/arxiv_data1/oa_pdf/5f/dc/nihms661114.PMC4415439.pdf
URL http://arxiv.org/pdf/1407.3851 .,Non-OADS,/arxiv_data1/oa_pdf/5f/dc/nihms661114.PMC4415439.pdf
URL http://www.csc.noaa.gov/crs/lca/gulfcoast.html 46.,OADS,/arxiv_data1/oa_pdf/5f/dc/nihms661114.PMC4415439.pdf
University of Texas at Austin; http://utchg.github.io/PolyADCIRC/ 2013 .,Non-OADS,/arxiv_data1/oa_pdf/5f/dc/nihms661114.PMC4415439.pdf
URL http://ut-chg.github.io/PolyADCIRC/ 50.,Non-OADS,/arxiv_data1/oa_pdf/5f/dc/nihms661114.PMC4415439.pdf
URL http://ut-chg.github.io/BET/ .,Non-OADS,/arxiv_data1/oa_pdf/5f/dc/nihms661114.PMC4415439.pdf
NOAA C-CAP land coverage ( http://www.csc.noaa.gov/crs/lca/gulfcoast.html )[45].Butler et al.,OADS,/arxiv_data1/oa_pdf/5f/dc/nihms661114.PMC4415439.pdf
The chip data discussed in this publication have been deposited in NCBI’s Gene Expression Omnibus and are accessible through GEO Series accession number GSE62691 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc =GSE62691).,OADS,/arxiv_data1/oa_pdf/81/1f/eji0045-0975.PMC4415462.pdf
Data accessibility Data available from the Dryad Digital Repository: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/84/JPE-52-379.PMC4415554.pdf
Printed in BrazilDOI: http://dx.doi.org/10.1590/S1415-475738138120140275 Send correspondence to Louis Bernard Klaczko.,Non-OADS,/arxiv_data1/oa_pdf/a3/c5/1415-4757-gmb-38-1-55.PMC4415555.pdf
Printed in BrazilDOI: http://dx.doi.org/10.1590/S1415-475738120140087,Non-OADS,/arxiv_data1/oa_pdf/4a/67/1415-4757-gmb-38-1-30.PMC4415556.pdf
"There are, so far, more than 50 different CYP27A1 mutations published (http://www.hgmd.org).",Non-OADS,/arxiv_data1/oa_pdf/4a/67/1415-4757-gmb-38-1-30.PMC4415556.pdf
"The third mutation c.1183C > Tor p.Arg395Cys (patient 1) has accession number: #DB_ID:CYP27A1_00004 (http://www.lovd.nl/3.0/home),is shown in Figure 1A.",Non-OADS,/arxiv_data1/oa_pdf/4a/67/1415-4757-gmb-38-1-30.PMC4415556.pdf
Printed in BrazilDOI: http://dx.doi.org/10.1590/S1415-475738120140022,Non-OADS,/arxiv_data1/oa_pdf/6c/85/1415-4757-gmb-38-1-59.PMC4415557.pdf
"Université de Lausanne, Lausanne,http://www.unil.ch/dee/home/menuinst/soft - wares—dataset/softwares/fstat.html (accessed 11 Jul 2014).",Non-OADS,/arxiv_data1/oa_pdf/6c/85/1415-4757-gmb-38-1-59.PMC4415557.pdf
"University of British Colombia, Vancouver,http://genetics.forestry.ubc.ca/ritland/programs.html (ac - cessed 15 Aug 2006).",Non-OADS,/arxiv_data1/oa_pdf/6c/85/1415-4757-gmb-38-1-59.PMC4415557.pdf
Printed in BrazilDOI: http://dx.doi.org/10.1590/S1415-475738120140146 Send correspondence to María Montenegro.,Non-OADS,/arxiv_data1/oa_pdf/fe/78/1415-4757-gmb-38-1-48.PMC4415558.pdf
"http://www.cnrs-gif.fr/pge/bioinfo/populations/ (May 5,2012).",Non-OADS,/arxiv_data1/oa_pdf/fe/78/1415-4757-gmb-38-1-48.PMC4415558.pdf
"http://pritch.bsd.uchicago.edu/struc - ture.html (May 12, 2012).",Non-OADS,/arxiv_data1/oa_pdf/fe/78/1415-4757-gmb-38-1-48.PMC4415558.pdf
"http://www.stan - ford.edu/group/rosenberglab/distruct.html (May 12, 2012).",Non-OADS,/arxiv_data1/oa_pdf/fe/78/1415-4757-gmb-38-1-48.PMC4415558.pdf
"Core version: vA.1 http://taylor0.biol - ogy.ucla.edu/structureHarvester/ (August 27, 2013).",OADS,/arxiv_data1/oa_pdf/fe/78/1415-4757-gmb-38-1-48.PMC4415558.pdf
"Navíos de la Carrera de Filipinas.http://www.todoababor.es/articulos/nav_carrerafilipinas.htm (August 20, 2013).",Non-OADS,/arxiv_data1/oa_pdf/fe/78/1415-4757-gmb-38-1-48.PMC4415558.pdf
"Revista de la Real Liga Naval Española.http://rlne.info/proaenpdf/proa162pdfs/galeonmanila162.pdf (August 20, 2013).",Non-OADS,/arxiv_data1/oa_pdf/fe/78/1415-4757-gmb-38-1-48.PMC4415558.pdf
Supplementary Material The following online material is available for this article: Figure S1 - Pampa Rocha pigs.Figure S2 - Graphical representation of delta K.This material is available as part of the online article from http://www.scielo.br/gmb.,Non-OADS,/arxiv_data1/oa_pdf/fe/78/1415-4757-gmb-38-1-48.PMC4415558.pdf
Printed in BrazilDOI: http://dx.doi.org/10.1590/S1415-475738120140125 Send correspondence to Regina Célia Mingroni-Netto.,Non-OADS,/arxiv_data1/oa_pdf/a2/39/1415-4757-gmb-38-1-37.PMC4415559.pdf
"Internet Resources 1000 genomes, http://www.1000genomes.org/ (accessed January 15, 2014).",OADS,/arxiv_data1/oa_pdf/a2/39/1415-4757-gmb-38-1-37.PMC4415559.pdf
"ClinVar, http://www.ncbi.nlm.nih.gov/clinvar/intro/ (accessed October 9, 2014).",Non-OADS,/arxiv_data1/oa_pdf/a2/39/1415-4757-gmb-38-1-37.PMC4415559.pdf
"Human Genome Variation Society (HGVS), http://www.hgvs.org/mutnomen (accessed October 15,2013).",Non-OADS,/arxiv_data1/oa_pdf/a2/39/1415-4757-gmb-38-1-37.PMC4415559.pdf
"MutationTaster2, http://www.mutationtaster.org/ (accessed July 01, 2014).",OADS,/arxiv_data1/oa_pdf/a2/39/1415-4757-gmb-38-1-37.PMC4415559.pdf
"NHLBI Exome Sequencing Project (ESP): Exome Variant Server, http://evs.gs.washington.edu/EVS/ (accessed July 01,2014).",OADS,/arxiv_data1/oa_pdf/a2/39/1415-4757-gmb-38-1-37.PMC4415559.pdf
"OMIM: online mendelian inheritance in man, http://www.omim.org/ (accessed January 15, 2014).",Non-OADS,/arxiv_data1/oa_pdf/a2/39/1415-4757-gmb-38-1-37.PMC4415559.pdf
"PolyPhen-2: prediction of functional effects of human nsSNPs, http://genetics.bwh.harvard.edu/pph2/ (accessed December20, 2013).",Non-OADS,/arxiv_data1/oa_pdf/a2/39/1415-4757-gmb-38-1-37.PMC4415559.pdf
"SIFT: sorting Tolerant From Intolerant, http://sift.jcvi.org/ (ac- cessed July 01, 2014).",Non-OADS,/arxiv_data1/oa_pdf/a2/39/1415-4757-gmb-38-1-37.PMC4415559.pdf
"Uniprot: universal protein resource, http://www.uniprot.org/ (ac- cessed December 20, 2013).",OADS,/arxiv_data1/oa_pdf/a2/39/1415-4757-gmb-38-1-37.PMC4415559.pdf
Printed in BrazilDOI: http://dx.doi.org/10.1590/S1415-475738120140162 Send correspondence to Ana Christina Brasileiro-Vidal.,Non-OADS,/arxiv_data1/oa_pdf/09/78/1415-4757-gmb-38-1-93.PMC4415560.pdf
"Jardim Botânico do Rio de Janeiro.http://floradobrasil.jbrj.gov.br/jabot/floradobrasil/FB17581(Accessed on March 20, 2014).",Non-OADS,/arxiv_data1/oa_pdf/09/78/1415-4757-gmb-38-1-93.PMC4415560.pdf
Printed in BrazilDOI: http://dx.doi.org/10.1590/S1415-475738120130336 Correspondence to Jingtao Dou.,Non-OADS,/arxiv_data1/oa_pdf/a6/0a/1415-4757-gmb-38-1-1.PMC4415561.pdf
"These mutations occur in most exons and introns of COL1A1 andCOL1A2 (http://www.le.ac.uk/ge/collagen/; Dalgleish, 1997, 1998).",Non-OADS,/arxiv_data1/oa_pdf/a6/0a/1415-4757-gmb-38-1-1.PMC4415561.pdf
"Importantly, a comparisonwith the compiled list of COL1A1 mutations associated with OI in the osteogenesis imperfecta and Ehlers-Danlossyndrome variant databases (Dalgleish, 1997, 1998 andhttp://www.uniprot.org/uniprot/P02452a) revealed that themutation is novel and had not been previously reported.",Non-OADS,/arxiv_data1/oa_pdf/a6/0a/1415-4757-gmb-38-1-1.PMC4415561.pdf
"Internet Resources Osteogenesis imperfecta and Ehlers-Danlos syndrome variant da - tabases compiled of previously reported OI mutations in COL1A1 and COL1A2, http://www.le.ac.uk/ge/collagen/; last update Mar 13, 2013.",Non-OADS,/arxiv_data1/oa_pdf/a6/0a/1415-4757-gmb-38-1-1.PMC4415561.pdf
"UniProKB database, http://www.uniprot.org/uniprot/P02452.ORF Finder in BLAST software suite, http://www.ncbi.nlm.nih.gov/gorf/.",OADS,/arxiv_data1/oa_pdf/a6/0a/1415-4757-gmb-38-1-1.PMC4415561.pdf
"Supplementary Material The following online material is available for this article:- Table S1 – Clinical, biochemical and inheritance characteristics of OItypes.This material is available as part of the online article fromhttp://www.scielo.br/gmb.",Non-OADS,/arxiv_data1/oa_pdf/a6/0a/1415-4757-gmb-38-1-1.PMC4415561.pdf
Printed in BrazilDOI: http://dx.doi.org/10.1590/S1415-475738138120140192 Send correspondence to Yu-Ming Wei.,Non-OADS,/arxiv_data1/oa_pdf/ba/e9/1415-4757-gmb-38-1-79.PMC4415562.pdf
Supplementary Material The following online material is available for this article:Table S1 - Accession numbers of WOX proteins.This material is available as part of the online article fromhttp://www.scielo.br/gmb.,Non-OADS,/arxiv_data1/oa_pdf/ba/e9/1415-4757-gmb-38-1-79.PMC4415562.pdf
Printed in BrazilDOI: http://dx.doi.org/10.1590/S1415-475738120140147,Non-OADS,/arxiv_data1/oa_pdf/63/92/1415-4757-gmb-38-1-14.PMC4415563.pdf
"Internet Resources Spliceman Web Server, http://fairbrother.biomed.brown.edu/spliceman/index.cgi(April 28, 2014).Mattos et al.",OADS,/arxiv_data1/oa_pdf/63/92/1415-4757-gmb-38-1-14.PMC4415563.pdf
This material is available as part of the online article from http://www.scielo.br/gmb.,Non-OADS,/arxiv_data1/oa_pdf/63/92/1415-4757-gmb-38-1-14.PMC4415563.pdf
Printed in BrazilDOI: http://dx.doi.org/10.1590/S1415-475738120140126 Send correspondence to Juliana Morini Küpper Cardoso Perse - guini.,Non-OADS,/arxiv_data1/oa_pdf/46/7d/1415-4757-gmb-38-1-67.PMC4415564.pdf
"1.0 (d15).http://alleyn.eeb.uconn.edu/gda/2000 (June 30, 2011).Common bean core collection 77",Non-OADS,/arxiv_data1/oa_pdf/46/7d/1415-4757-gmb-38-1-67.PMC4415564.pdf
"Northern Arizona University,http://herb.bio.nau.edul~miller/tfpga.htm (June 30, 2011).",OADS,/arxiv_data1/oa_pdf/46/7d/1415-4757-gmb-38-1-67.PMC4415564.pdf
"R Foundation for Statistical Computing, Vienna, http://www.R-project.org/ (June 30,2011).",Non-OADS,/arxiv_data1/oa_pdf/46/7d/1415-4757-gmb-38-1-67.PMC4415564.pdf
This material is available as part of the online article from http://www.scielo.br/gmb.,Non-OADS,/arxiv_data1/oa_pdf/46/7d/1415-4757-gmb-38-1-67.PMC4415564.pdf
Printed in BrazilDOI: http://dx.doi.org/10.1590/S1415-475738138120140236 Send correspondence to Mariele Porto Carneiro Leão.,Non-OADS,/arxiv_data1/oa_pdf/90/ff/1415-4757-gmb-38-1-86.PMC4415565.pdf
Printed in BrazilDOI: http://dx.doi.org/10.1590/S1415-475738120140137,Non-OADS,/arxiv_data1/oa_pdf/88/7f/1415-4757-gmb-38-1-115.PMC4415566.pdf
Figure S1 - Box plot before and after normalization.This material is available as part of the online version of this article from http://www.scielo.br/gmb.,Non-OADS,/arxiv_data1/oa_pdf/88/7f/1415-4757-gmb-38-1-115.PMC4415566.pdf
Printed in BrazilDOI: http://dx.doi.org/10.1590/S1415-475738120140179 Send correspondence to Mateusz Kurzawski.,Non-OADS,/arxiv_data1/oa_pdf/ae/b1/1415-4757-gmb-38-1-42.PMC4415567.pdf
Printed in BrazilDOI: http://dx.doi.org/10.1590/S1415-475738120140154 Send correspondence to Júlio César Nepomuceno.,Non-OADS,/arxiv_data1/oa_pdf/d4/1c/1415-4757-gmb-38-1-101.PMC4415568.pdf
Printed in BrazilDOI: http://dx.doi.org/10.1590/S1415-475738138120140132 Send correspondence to Kourosh Saberi.,Non-OADS,/arxiv_data1/oa_pdf/0b/3f/1415-4757-gmb-38-1-107.PMC4415569.pdf
Printed in BrazilDOI: http://dx.doi.org/10.1590/S1415-475738120140080,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/1415-4757-gmb-38-1-8.PMC4415570.pdf
"Internet Resources Genepop, http://genepop.curtin.edu.au (accessed on July 14, 2014).",OADS,/arxiv_data1/oa_pdf/9e/ea/1415-4757-gmb-38-1-8.PMC4415570.pdf
Printed in BrazilDOI: http://dx.doi.org/10.1590/S1415-475738120140167,Non-OADS,/arxiv_data1/oa_pdf/8e/a6/1415-4757-gmb-38-1-21.PMC4415571.pdf
"The specific allergic reac - tion to Dermatophagoides pteronyssinus  (D. pteronyssinus ) Molecular Vision  2015; 21:443-450 <http://www.molvis.org/molvis/v 21/443> Received 19 December 2014 | Accepted 23 April 2015 | Published 25 April 2015© 2015 Molecular Vision 443Intracellular IL-4, IL-5, and IFN-γ as the main characteristic of  CD4+CD30+ T cells after allergen stimulation in patients with  vernal keratoconjunctivitis Diana Magaña,1 Gustavo Aguilar,1 Marisela Linares,1 Julio Ayala-Balboa,1 Concepción Santacruz,1 Raúl  Chávez,2 Sergio Estrada-Parra,3 Yonathan Garfias,2 Ricardo Lascurain,2 Maria C. Jiménez-Martínez1,2 1Department of Immunology and Research Unit, Institute of Ophthalmology “Conde de Valenciana Foundation,” México, D.F;  2Immunology Lab, Department of Biochemistry, Faculty of Medicine, National Autonomous University of Mexico, Mexico, D.F;  3Department of Immunology, National School of Biological Sciences, National Polytechnic Institute, Mexico, D.F Background:  Vernal keratoconjunctivitis (VKC) is a severe form of allergic conjunctivitis, in which inflammatory  infiltrates of the conjunctiva are characterized by CD3+ and CD30+ cells.",Non-OADS,/arxiv_data1/oa_pdf/a3/3d/mv-v21-443.PMC4415576.pdf
"Molecular Vision  2015; 21:443-450 <http://www.molvis.org/molvis/v 21/443> © 2015 Molecular Vision  444was confirmed with a skin-prick test positive for D. ptero - nyssinus  (wheal, >3 mm diameter).",Non-OADS,/arxiv_data1/oa_pdf/a3/3d/mv-v21-443.PMC4415576.pdf
Molecular Vision  2015; 21:443-450 <http://www.molvis.org/molvis/v 21/443> © 2015 Molecular Vision  445cells.,Non-OADS,/arxiv_data1/oa_pdf/a3/3d/mv-v21-443.PMC4415576.pdf
Molecular Vision  2015; 21:443-450 <http://www.molvis.org/molvis/v 21/443> © 2015 Molecular Vision  446the D. pteronyssinus  stimulation.,Non-OADS,/arxiv_data1/oa_pdf/a3/3d/mv-v21-443.PMC4415576.pdf
"Molecular Vision  2015; 21:443-450 <http://www.molvis.org/molvis/v 21/443> © 2015 Molecular Vision  447Tc2 cells in corneal damage must be further evaluated, since  CD8+ T cells are involved in the effector phase of allergic  conjunctivitis in the mouse model [ 11].",Non-OADS,/arxiv_data1/oa_pdf/a3/3d/mv-v21-443.PMC4415576.pdf
"Molecular Vision  2015; 21:443-450 <http://www.molvis.org/molvis/v 21/443> © 2015 Molecular Vision  448expression of CD30 on CD4+ T cells [ 5,7].",Non-OADS,/arxiv_data1/oa_pdf/a3/3d/mv-v21-443.PMC4415576.pdf
Molecular Vision  2015; 21:443-450 <http://www.molvis.org/molvis/v 21/443> © 2015 Molecular Vision  449of sCD30 in patients with VKC after Con-A stimulation  compared with the HCs.,Non-OADS,/arxiv_data1/oa_pdf/a3/3d/mv-v21-443.PMC4415576.pdf
Molecular Vision  2015; 21:443-450 <http://www.molvis.org/molvis/v 21/443> © 2015 Molecular Vision  45014.,Non-OADS,/arxiv_data1/oa_pdf/a3/3d/mv-v21-443.PMC4415576.pdf
"One such example is an  increase in the activity of transforming growth factor-beta2 Molecular Vision  2015; 21:451-460 <http://www.molvis.org/molvis/v 21/451> Received 24 October 2014 | Accepted 23 April 2015 | Published 25 April 2015© 2015 Molecular Vision 451Label-free LC–MS/MS quantitative analysis of aqueous humor  from keratoconic and normal eyes Javier Soria,1 Alberto Villarrubia,2 Jesús Merayo-Lloves,3 Félix Elortza,4 Mikel Azkargorta,4 Juan Alvarez de  Toledo,5 Iñaki Rodriguez-Agirretxe,6 Tatiana Suarez,1 Arantxa Acera1 (The first two authors have contributed equally to this work) 1Bioftalmik Applied Research, Bizkaia Science and Technology Park, Derio, Spain; 2Instituto de Oftalmología La Arruzafa,  Córdoba, Spain; 3Instituto Oftalmologico Fernandez Vega and University of Oviedo.",Non-OADS,/arxiv_data1/oa_pdf/8a/e8/mv-v21-451.PMC4415580.pdf
"Molecular Vision  2015; 21:451-460 <http://www.molvis.org/molvis/v 21/451> © 2015 Molecular Vision  452in patients having keratoconus or glaucoma [ 10, 11].",Non-OADS,/arxiv_data1/oa_pdf/8a/e8/mv-v21-451.PMC4415580.pdf
"Molecular Vision  2015; 21:451-460 <http://www.molvis.org/molvis/v 21/451> © 2015 Molecular Vision  453eluted directly into the nanoelectrospray capillary (Proxeon  Biosystems, Odense, Denmark) at 300 nl/min with a 60 min  linear gradient of 3%–50% acetonitrile.",Non-OADS,/arxiv_data1/oa_pdf/8a/e8/mv-v21-451.PMC4415580.pdf
"Molecular Vision  2015; 21:451-460 <http://www.molvis.org/molvis/v 21/451> © 2015 Molecular Vision  454(PTGDS), actin cytoplasmic 2 (ACTG), semaphorin-7A  (SEMA7A), alpha-1-acid glycoprotein 1 (ORM1), latent trans - forming growth factor beta-binding protein 2 (LTBP2), and  Ig kappa chain V-I region EU (IGKC; Figure 1B).",Non-OADS,/arxiv_data1/oa_pdf/8a/e8/mv-v21-451.PMC4415580.pdf
Molecular Vision  2015; 21:451-460 <http://www.molvis.org/molvis/v 21/451> © 2015 Molecular Vision  455between pathological and normal expression profiles in hAH  proteomes via LC-MS/MS.,Non-OADS,/arxiv_data1/oa_pdf/8a/e8/mv-v21-451.PMC4415580.pdf
"Molecular Vision  2015; 21:451-460 <http://www.molvis.org/molvis/v 21/451> © 2015 Molecular Vision  456ion homeostasis, regulation of blood coagulation, response  to retinoic acid, response to hydrogen peroxide, regulation of  angiogenesis, response to osmotic stress, regulation of cell  death, and response to vitamin D. We also performed morphological analysis of the FI  network and discovered six modules or groupings, as shown  in Figure 4.",Non-OADS,/arxiv_data1/oa_pdf/8a/e8/mv-v21-451.PMC4415580.pdf
Molecular Vision  2015; 21:451-460 <http://www.molvis.org/molvis/v 21/451> © 2015 Molecular Vision  457field of proteomics have allowed the investigation of low- abundance and low-mass proteins or peptides.,Non-OADS,/arxiv_data1/oa_pdf/8a/e8/mv-v21-451.PMC4415580.pdf
Molecular Vision  2015; 21:451-460 <http://www.molvis.org/molvis/v 21/451> © 2015 Molecular Vision  458this liquid might affect the structures of these tissues.,Non-OADS,/arxiv_data1/oa_pdf/8a/e8/mv-v21-451.PMC4415580.pdf
"Molecular Vision  2015; 21:451-460 <http://www.molvis.org/molvis/v 21/451> © 2015 Molecular Vision  459such changes is confirmed, the results should be validated in  future studies with increased statistical power.",Non-OADS,/arxiv_data1/oa_pdf/8a/e8/mv-v21-451.PMC4415580.pdf
Molecular Vision  2015; 21:451-460 <http://www.molvis.org/molvis/v 21/451> © 2015 Molecular Vision  460healing and reactive species-associated processes.,Non-OADS,/arxiv_data1/oa_pdf/8a/e8/mv-v21-451.PMC4415580.pdf
"In the  last decade, APEX chips have been developed for mutation Molecular Vision  2015; 21:461-476 <http://www.molvis.org/molvis/v 21/461> Received 8 February 2015 | Accepted 26 April 2015 | Published 28 April 2015© 2015 Molecular Vision 461The efficacy of microarray screening for autosomal recessive  retinitis pigmentosa in routine clinical practice Ramon A. C. van Huet,1 Laurence H.M. Pierrache,2,3 Magda A. Meester-Smoor,2,3 Caroline C.W.",Non-OADS,/arxiv_data1/oa_pdf/be/5f/mv-v21-461.PMC4415583.pdf
"Molecular Vision  2015; 21:461-476 <http://www.molvis.org/molvis/v 21/461> © 2015 Molecular Vision  462analysis of the ABCA4  gene (GeneID: 24; OMIM 601691 ) in  autosomal recessive Stargardt disease or cone–rod dystrophy  [16,19], as well as for multiple gene microarrays for Leber  congenital amaurosis (LCA) [ 15,20], Bardet–Biedl syndrome  (BBS) [ 21], Usher syndrome [ 22], and autosomal dominant  and recessive RP [ 23].",Non-OADS,/arxiv_data1/oa_pdf/be/5f/mv-v21-461.PMC4415583.pdf
Molecular Vision  2015; 21:461-476 <http://www.molvis.org/molvis/v 21/461> © 2015 Molecular Vision  463number of patients that had a molecular diagnosis after the  analysis with the microarray chip.,Non-OADS,/arxiv_data1/oa_pdf/be/5f/mv-v21-461.PMC4415583.pdf
"Molecular Vision  2015; 21:461-476 <http://www.molvis.org/molvis/v 21/461> © 2015 Molecular Vision  464Carlsbad, CA) after DNA enrichment with the Agilent Sure - SelectXT Human All Exon 50Mb Kit (Agilent Technologies,  Santa Clara, CA).",Non-OADS,/arxiv_data1/oa_pdf/be/5f/mv-v21-461.PMC4415583.pdf
Molecular Vision  2015; 21:461-476 <http://www.molvis.org/molvis/v 21/461> © 2015 Molecular Vision  465Table  3. m uTaTiOns iden Tified  by micr Oarray  chi P analysis  and addi TiOnal sanger  sequencing  in The PaTienTs included  in This sTudy.,Non-OADS,/arxiv_data1/oa_pdf/be/5f/mv-v21-461.PMC4415583.pdf
"Molecular Vision  2015; 21:461-476 <http://www.molvis.org/molvis/v 21/461> © 2015 Molecular Vision  466cDNA mutation (reference  sequence) Effect (RNA/protein)EVS minor allele  frequency in %† Predicted pathogenicity‡Frequency of variant in  this cohort (%) Reference PDE6B (NM_000283.3) 9 (7.5)   c.220C>T p.Arg74Cys 0.038 Pathogenic 1 (0.8)  [61] c.655T>C p.Tyr219His 0.538 Probably pathogenic 2 (1.7)  [17] c.1107+3A>G splicing 0.015 Probably pathogenic 1 (0.8)  [17] c.1401+4_1401+48del splicing NA Possibly pathogenic 1 (0.8) This study c.1798G>A p.Asp600Asn NA Possibly pathogenic 2 (1.7)  [58] c.2503+5G>C splicing NA Possibly pathogenic 1 (0.8)  [17] c.2503+2T>C splicing NA Probably pathogenic 1 (0.8) This study PROM1  (NM_006017.2) 1 (0.8)   c.1354dup p.Tyr452fs 0.049 Pathogenic 1 (0.8)  [62] RDH12  (NM_152443.2) 4 (3.3)   c.379G>T p.Gly127* NA Pathogenic 4 (3.3)  [63] RPE65  (NM_000329.2) 3 (2.5)   c.271C>T p.Arg91Trp 0.015 Probably pathogenic 1 (0.8)  [64,65] c.963T>G p.Asn321Lys 0.077 Possibly pathogenic 1 (0.8)  [66,67] c.1069dup p.Asn356fs NA Pathogenic 1 (0.8)  [68] USH2A  (NM_206933.2) 59 (49.2)   c.486–14G>A Splicing 0.008 Probably pathogenic 1 (0.8)  [69] c.949C>A p. Arg317Arg (Splicing) NA Possibly pathogenic 1 (0.8)  [70-74] c.1256G>T p.Cys419Phe 0.008 Pathogenic 3 (2.5)  [71,73,75] c.1876C>T p.Arg626* NA Pathogenic 1 (0.8)  [71] c.2276G>T p.Cys759Phe 0.154 Pathogenic 16 (13.3)  [52,76-80] c.2299delG p.Glu767fs*21 0.176 Pathogenic 3 (2.5)  [81] c.2522C>A p.Ser841Tyr 0.531 Possibly pathogenic 3 (2.5)  [73,82] c.3368A>G p.Tyr1123Cys NA Probably pathogenic 1 (0.8)  [83] c.5728C>T p.Gln1910* NA Pathogenic 1 (0.8) This study c.5975A>G p.Tyr1992Cys 0.361 Possibly pathogenic 2 (1.7)  [80] c.6049+1G>A Splicing NA Pathogenic 1 (0.8) This study c.7054C>T p.Pro2352Ser NA Probably pathogenic 1 (0.8) This study c.8723_8724del p.Val 2908fs NA Pathogenic 2 (1.7)  [70] c.9262G>A p.Glu3088Lys 0.450 Probably benign 2 (1.7)  [80] c.9413G>A p.Gly3138Asp NA Probably pathogenic 1 (0.8) This study c.9433C>T p.Leu3145Phe 0.008 Probably benign 1 (0.8) EVS  (rs267598373)",Non-OADS,/arxiv_data1/oa_pdf/be/5f/mv-v21-461.PMC4415583.pdf
"Molecular Vision  2015; 21:461-476 <http://www.molvis.org/molvis/v 21/461> © 2015 Molecular Vision  467cDNA mutation (reference  sequence) Effect (RNA/protein)EVS minor allele  frequency in %† Predicted pathogenicity‡Frequency of variant in  this cohort (%) Reference c.9815C>T p.Pro3272Leu NA Possibly pathogenic 1 (0.8)  [84,85] c.10073G>A p.Cys3358Tyr 0.054 Probably pathogenic 1 (0.8)  [25,80] c.10525A>T p.Lys3509* NA Pathogenic 1 (0.8)  [17] c.10561T>C p.Trp3521Arg NA Probably pathogenic 1 (0.8)  [74,80] c.11677C>A p.Pro3893Thr 1.653 Probably benign 2 (1.7)  [74,86] c.12328T>G p.Tyr4110Asp NA Probably pathogenic 1 (0.8) This study c.12343C>T p.Arg4115Cys 0.077 Probably pathogenic 5 (1.7)  [70,74,86] c.13274C>T p.Thr4425Met NA Probably pathogenic 3 (2.5)  [17,70,74,86] c.14803C>T p.Arg4935* 0.015 Pathogenic 1 (0.8)  [69,80,87] c.15091C>T p.Arg5031Trp 1.284 Probably benign 1 (0.8)  [74] c.15377T>C p.Ile5126Thr 2.422 Probably pathogenic 1 (0.8)  [11,80,88] c.15433G>A p.Val5145I le 0.408 Pathogenic 1 (0.8)  [52,78-80] †The overall allele frequency as provided in the Exome Variant Server in both European and African Americans.",Non-OADS,/arxiv_data1/oa_pdf/be/5f/mv-v21-461.PMC4415583.pdf
Molecular Vision  2015; 21:461-476 <http://www.molvis.org/molvis/v 21/461> © 2015 Molecular Vision  468Table  4. r esul Ts Of gene Tic analyses  OTher Than The micr Oarray  chi P fOr auTOsOmal recessive  rP in This sTudy cOhOrT.,Non-OADS,/arxiv_data1/oa_pdf/be/5f/mv-v21-461.PMC4415583.pdf
Molecular Vision  2015; 21:461-476 <http://www.molvis.org/molvis/v 21/461> © 2015 Molecular Vision  469Gene name Method N Results Molecular diagnosis ABCA4 Sanger sequencing 7 Homozygous or compound heterozygous mutations   ABCA4 c.5882G>A; p.Gly1961Glu ABCA4 -associated recessive retinal  dystrophyc.3602T>G; p.Leu1201Arg c.6320G>A;  p.Arg2107His c.5461–10T>C; splicing c.6155del; p.Asn2052fs c.4469G>A; p.Cys1490Tyr c.5056G>A; p.Val1686Met  c.6730–19G>A; splicing c.6658C>T; p.Gln2220* c.1622T>C; p.Leu541Pro c.3113C>T;  p.Ala1038Val (both homozygously present) 6 Heterozygous mutations   ABCA4 c.1411G>A; p.Glu471Lys (2x) Carrier of ABCA4  mutation c.3899G>A; p.Arg1300Gln c.4283C>T; p.Thr1428Met c.5882G>A; p.Gly1961Glu c.5908C>T; p.Leu1970Phe 50 No mutations identified N/A Microarray (APEX) 4 No mutation identified N/A BBS1 Sanger sequencing 1 Homozygous mutation   BBS1 c.1169T>G; p.Met390Arg BBS1 -associated recessive RP CHM Sanger sequencing 1 Hemizygous mutation   CHM c.50-?_116+?del; deletion of exon 2 Choroideremia 2 No mutations identified N/A CNGA3 Sanger sequencing 1 No mutations identified N/A CNGB3 Sanger sequencing 3 No mutations identified N/A CRB1 Sanger sequencing 3 No mutations identified N/A EYS Sanger sequencing 1 Homozygous mutation   EYS c.6714del; p.Ile2239fs EYS-associated recessive RP FAM161A Sanger sequencing 1 Compound heterozygous mutations   FAM161A c.1309A>T; p.Arg437* c.1501del; p.Cys501fs FAM161A -associated recessive RP KCNV2 Sanger sequencing 1 No mutations identified N/A MERTK Sanger sequencing 1 Homozygous mutation   MERTK c.1179dup; p.Leu394fs MERKT -associated recessive RP,Non-OADS,/arxiv_data1/oa_pdf/be/5f/mv-v21-461.PMC4415583.pdf
Molecular Vision  2015; 21:461-476 <http://www.molvis.org/molvis/v 21/461> © 2015 Molecular Vision  470Gene name Method N Results Molecular diagnosis NR2E3 Sanger sequencing 1 Compound heterozygous mutations   NR2E3 c.119–57_166del; frameshift c.1095C>G; splicing NR2E3 -associated recessive RP PDE6A Sanger sequencing 2 No mutations identified N/A PDE6C Sanger sequencing 1 No mutations identified N/A PRPH2 Sanger sequencing 1 Heterozygous mutations   PRPH2 c.424C>T; p.Arg142Trp PRPH2 -associated dominant RP RHO Sanger sequencing 1 Homozygous mutation   RHO c.759G>T; p.Met253Ile RHO -associated recessive RP RP1 Sanger sequencing 1 Homozygous mutation   RP1 c.686del; p.Pro229fs RP1-associated recessive RP RPE65 Sanger sequencing 1 Heterozygous mutation   RPE65 c.11+5G>A; splicing Carrier of RPE65  mutation RPGR Sanger sequencing 1 Hemizygous mutation   RPGR c.2993_2996del; p.Glu998fs RPGR -associated X-linked RP TRPM1 Sanger sequencing 1 Compound heterozygous mutations   TRPM1 c.1–27C>T; UTR 5′expressing defect c.2998C>T;  p.Arg1000*Congenitcal stationary night blindness  type 1C * indicates a premature stop; fs=frameshift; UTR=untranslated region,Non-OADS,/arxiv_data1/oa_pdf/be/5f/mv-v21-461.PMC4415583.pdf
"Molecular Vision  2015; 21:461-476 <http://www.molvis.org/molvis/v 21/461> © 2015 Molecular Vision  471DISCUSSION Only a decade ago, microarray screening boosted diag - nostic genetic analysis in genetic heterogeneous disorders  such as RP by facilitating reliable fast analysis of multiple  genes simultaneously with much lower costs than Sanger  sequencing of the same genes.",Non-OADS,/arxiv_data1/oa_pdf/be/5f/mv-v21-461.PMC4415583.pdf
"Molecular Vision  2015; 21:461-476 <http://www.molvis.org/molvis/v 21/461> © 2015 Molecular Vision  472However, NGS comes with its own difficulties, such as data  management and analysis of the large datasets, and confirma - tion of the pathogenicity of identified variants [ 10,17,33].",Non-OADS,/arxiv_data1/oa_pdf/be/5f/mv-v21-461.PMC4415583.pdf
Molecular Vision  2015; 21:461-476 <http://www.molvis.org/molvis/v 21/461> © 2015 Molecular Vision  473retinitis pigmentosa.,Non-OADS,/arxiv_data1/oa_pdf/be/5f/mv-v21-461.PMC4415583.pdf
Molecular Vision  2015; 21:461-476 <http://www.molvis.org/molvis/v 21/461> © 2015 Molecular Vision  474sequencing-based molecular diagnosis of 82 retinitis pigmen - tosa probands from Northern Ireland.,Non-OADS,/arxiv_data1/oa_pdf/be/5f/mv-v21-461.PMC4415583.pdf
Molecular Vision  2015; 21:461-476 <http://www.molvis.org/molvis/v 21/461> © 2015 Molecular Vision  47555.,Non-OADS,/arxiv_data1/oa_pdf/be/5f/mv-v21-461.PMC4415583.pdf
Molecular Vision  2015; 21:461-476 <http://www.molvis.org/molvis/v 21/461> © 2015 Molecular Vision  47676.,Non-OADS,/arxiv_data1/oa_pdf/be/5f/mv-v21-461.PMC4415583.pdf
"Written informed Molecular Vision  2015; 21:477-486 <http://www.molvis.org/molvis/v 21/477> Received 4 December 2014 | Accepted 26 April 2015 | Published 28 April 2015© 2015 Molecular Vision 477Mutation analysis in 129 genes associated with other forms of  retinal dystrophy in 157 families with retinitis pigmentosa based  on exome sequencing Yan Xu,1 Liping Guan,2 Xueshan Xiao,1 Jianguo Zhang,2 Shiqiang Li,1 Hui Jiang,2 Xiaoyun Jia,1 Jianhua  Yang,2 Xiangming Guo,1 Ye Yin,2 Jun Wang,2 Qingjiong Zhang1 (The first two and last two authors contributed equally to this work.)",Non-OADS,/arxiv_data1/oa_pdf/05/b0/mv-v21-477.PMC4415588.pdf
Molecular Vision  2015; 21:477-486 <http://www.molvis.org/molvis/v 21/477> © 2015 Molecular Vision  478consent was obtained from the participants or their guardians  before the collection of their clinical data and preparation  of genomic DNA from their peripheral venous leukocytes.,Non-OADS,/arxiv_data1/oa_pdf/05/b0/mv-v21-477.PMC4415588.pdf
"Molecular Vision  2015; 21:477-486 <http://www.molvis.org/molvis/v 21/477> © 2015 Molecular Vision  479and RP240) had BBS2  mutations; one had RP alone with  a missense mutation and a nonsense mutation, while the  other one had BBS syndrome (misdiagnosed as RP) and a homozygous nonsense mutation.",Non-OADS,/arxiv_data1/oa_pdf/05/b0/mv-v21-477.PMC4415588.pdf
Molecular Vision  2015; 21:477-486 <http://www.molvis.org/molvis/v 21/477> © 2015 Molecular Vision  480Table  1.,Non-OADS,/arxiv_data1/oa_pdf/05/b0/mv-v21-477.PMC4415588.pdf
Molecular Vision  2015; 21:477-486 <http://www.molvis.org/molvis/v 21/477> © 2015 Molecular Vision  481Table  2. c linical  fea Tures  of The five paTienTs wiTh muTaTions iden Tified  in This sTudy.,Non-OADS,/arxiv_data1/oa_pdf/05/b0/mv-v21-477.PMC4415588.pdf
Molecular Vision  2015; 21:477-486 <http://www.molvis.org/molvis/v 21/477> © 2015 Molecular Vision  482scan was not available).,Non-OADS,/arxiv_data1/oa_pdf/05/b0/mv-v21-477.PMC4415588.pdf
"Molecular Vision  2015; 21:477-486 <http://www.molvis.org/molvis/v 21/477> © 2015 Molecular Vision  483have been detected in 5 of 157 (3%, Figure 3) patients with  RP based on whole exome sequencing.",Non-OADS,/arxiv_data1/oa_pdf/05/b0/mv-v21-477.PMC4415588.pdf
"Molecular Vision  2015; 21:477-486 <http://www.molvis.org/molvis/v 21/477> © 2015 Molecular Vision  484truncation mutations in CACNA1F ; these kinds of mutations  have been identified in patients with congenital stationary  night blindness [ 37,38], cone-rod dystrophy [ 39], and Aland  Island eye disease [ 40], but not in patients with RP.",Non-OADS,/arxiv_data1/oa_pdf/05/b0/mv-v21-477.PMC4415588.pdf
Molecular Vision  2015; 21:477-486 <http://www.molvis.org/molvis/v 21/477> © 2015 Molecular Vision  485autosomal recessive retinitis pigmentosa.,Non-OADS,/arxiv_data1/oa_pdf/05/b0/mv-v21-477.PMC4415588.pdf
"Molecular Vision  2015; 21:477-486 <http://www.molvis.org/molvis/v 21/477> © 2015 Molecular Vision  486Boycott K, Heon E. BBS genotype-phenotype assessment of  a multiethnic patient cohort calls for a revision of the disease  definition.",Non-OADS,/arxiv_data1/oa_pdf/05/b0/mv-v21-477.PMC4415588.pdf
"Since XLRS is a recessive disease caused by a mutation  in the RS1 gene that encodes retinoschisin, gene therapy has Molecular Vision  2015; 21:487-501 <http://www.molvis.org/molvis/v 21/487> Received 18 January 2015 | Accepted 26 April 2015 | Published 28 April 2015© 2015 Molecular Vision 487Clinical presentations of X-linked retinoschisis in Taiwanese  patients confirmed with genetic sequencing Nan-Kai Wang,1,2 Laura Liu,1,2 Ho-Min Chen,1,2 Shawn Tsai,3,4 Tsong-Chi Chang,5 Tzu-Hsun Tsai,6,7 Chung- May Yang,6,7 An-Ning Chao,1,2 Kuan-Jen Chen,1,2 Ling-Yuh Kao,1,2 Ling Yeung,2,8 Lung-Kun Yeh,1,2 Yih-Shiou  Hwang,1,2 Wei-Chi Wu,1,2 Chi-Chun Lai1,2 (The first two authors contributed equally to this work.)",Non-OADS,/arxiv_data1/oa_pdf/63/44/mv-v21-487.PMC4415592.pdf
Molecular Vision  2015; 21:487-501 <http://www.molvis.org/molvis/v 21/487> © 2015 Molecular Vision  488been considered a potential treatment for the near future.,Non-OADS,/arxiv_data1/oa_pdf/63/44/mv-v21-487.PMC4415592.pdf
"Molecular Vision  2015; 21:487-501 <http://www.molvis.org/molvis/v 21/487> © 2015 Molecular Vision  489(22%; Figure 2D,H,J,K).",Non-OADS,/arxiv_data1/oa_pdf/63/44/mv-v21-487.PMC4415592.pdf
Molecular Vision  2015; 21:487-501 <http://www.molvis.org/molvis/v 21/487> © 2015 Molecular Vision  490Table  2.,Non-OADS,/arxiv_data1/oa_pdf/63/44/mv-v21-487.PMC4415592.pdf
Molecular Vision  2015; 21:487-501 <http://www.molvis.org/molvis/v 21/487> © 2015 Molecular Vision  491Family CaseNucleotide  changeAmino acid  changeAge at  Dx (y)BCVA (OD; OS) Macula  abnormalitiesPeriph - eral RSVitreous  hemorrhageRetinal detachment ERG Scot.,Non-OADS,/arxiv_data1/oa_pdf/63/44/mv-v21-487.PMC4415592.pdf
Molecular Vision  2015; 21:487-501 <http://www.molvis.org/molvis/v 21/487> © 2015 Molecular Vision  492 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/63/44/mv-v21-487.PMC4415592.pdf
Molecular Vision  2015; 21:487-501 <http://www.molvis.org/molvis/v 21/487> © 2015 Molecular Vision  493 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/63/44/mv-v21-487.PMC4415592.pdf
Molecular Vision  2015; 21:487-501 <http://www.molvis.org/molvis/v 21/487> © 2015 Molecular Vision  494 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/63/44/mv-v21-487.PMC4415592.pdf
"Molecular Vision  2015; 21:487-501 <http://www.molvis.org/molvis/v 21/487> © 2015 Molecular Vision  495Clinical features:  Although a spoke wheel–like appearance  in the macula is the most typical characteristic feature of  XLRS, this feature may be obscured when there is a vitreous  hemorrhage in a young patient or may be absent in older  patients.",Non-OADS,/arxiv_data1/oa_pdf/63/44/mv-v21-487.PMC4415592.pdf
"Molecular Vision  2015; 21:487-501 <http://www.molvis.org/molvis/v 21/487> © 2015 Molecular Vision  496hypo-FAF in the macular area (Figure 3A), which is most  likely due to changed light transmission in the area of reti - noschisis [ 13].",Non-OADS,/arxiv_data1/oa_pdf/63/44/mv-v21-487.PMC4415592.pdf
Molecular Vision  2015; 21:487-501 <http://www.molvis.org/molvis/v 21/487> © 2015 Molecular Vision  497 Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/63/44/mv-v21-487.PMC4415592.pdf
Molecular Vision  2015; 21:487-501 <http://www.molvis.org/molvis/v 21/487> © 2015 Molecular Vision  498 Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/63/44/mv-v21-487.PMC4415592.pdf
"Molecular Vision  2015; 21:487-501 <http://www.molvis.org/molvis/v 21/487> © 2015 Molecular Vision  499first demonstrated a cleavage plane in the neural retina [ 14],  and since then, several classifications have been proposed  based on clinical and OCT examinations [ 15,16].",Non-OADS,/arxiv_data1/oa_pdf/63/44/mv-v21-487.PMC4415592.pdf
Molecular Vision  2015; 21:487-501 <http://www.molvis.org/molvis/v 21/487> © 2015 Molecular Vision  500been reported to be effective for improving cystoid macular  edema in patients with XLRS [ 27-30].,Non-OADS,/arxiv_data1/oa_pdf/63/44/mv-v21-487.PMC4415592.pdf
Molecular Vision  2015; 21:487-501 <http://www.molvis.org/molvis/v 21/487> © 2015 Molecular Vision  501RDH5 mutation: a newly identified compound heterozygous  mutation and review of the literature.,Non-OADS,/arxiv_data1/oa_pdf/63/44/mv-v21-487.PMC4415592.pdf
"Recent studies have found that Molecular Vision  2015; 21:502-514 <http://www.molvis.org/molvis/v 21/502> Received 10 February 2015 | Accepted 27 April 2015 | Published 29 April 2015© 2015 Molecular Vision 502Effect of HDAC Inhibitors on Corneal Keratocyte Mechanical  Phenotypes in 3-D Collagen Matrices Vindhya Koppaka, Neema Lakshman, W. Matthew Petroll Department of Ophthalmology, University of Texas Southwestern Medical Center,  Dallas, TX Purpose :: Histone deacetylase inhibitors (HDAC) have been shown to inhibit the TGFβ-induced myofibroblast trans - formation of corneal fibroblasts in 2-D culture.",Non-OADS,/arxiv_data1/oa_pdf/b7/85/mv-v21-502.PMC4415596.pdf
"Molecular Vision  2015; 21:502-514 <http://www.molvis.org/molvis/v 21/502> © 2015 Molecular Vision  503inhibitors of these classes selectively alter the acetylation and  transcription of genes involved in smooth muscle differentia - tion and fibrosis in cardiac fibroblasts [ 21,22].",Non-OADS,/arxiv_data1/oa_pdf/b7/85/mv-v21-502.PMC4415596.pdf
Molecular Vision  2015; 21:502-514 <http://www.molvis.org/molvis/v 21/502> © 2015 Molecular Vision  504min and permeabilized with 0.5% Triton X-100 in PBS for  3 min.,Non-OADS,/arxiv_data1/oa_pdf/b7/85/mv-v21-502.PMC4415596.pdf
Molecular Vision  2015; 21:502-514 <http://www.molvis.org/molvis/v 21/502> © 2015 Molecular Vision  505form stress fibers or induce ECM compaction (Figure 1D).,Non-OADS,/arxiv_data1/oa_pdf/b7/85/mv-v21-502.PMC4415596.pdf
Molecular Vision  2015; 21:502-514 <http://www.molvis.org/molvis/v 21/502> © 2015 Molecular Vision  506 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/b7/85/mv-v21-502.PMC4415596.pdf
Molecular Vision  2015; 21:502-514 <http://www.molvis.org/molvis/v 21/502> © 2015 Molecular Vision  507 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/b7/85/mv-v21-502.PMC4415596.pdf
Molecular Vision  2015; 21:502-514 <http://www.molvis.org/molvis/v 21/502> © 2015 Molecular Vision  508 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/b7/85/mv-v21-502.PMC4415596.pdf
Molecular Vision  2015; 21:502-514 <http://www.molvis.org/molvis/v 21/502> © 2015 Molecular Vision  509 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/b7/85/mv-v21-502.PMC4415596.pdf
Molecular Vision  2015; 21:502-514 <http://www.molvis.org/molvis/v 21/502> © 2015 Molecular Vision  510 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/b7/85/mv-v21-502.PMC4415596.pdf
Molecular Vision  2015; 21:502-514 <http://www.molvis.org/molvis/v 21/502> © 2015 Molecular Vision  511phenotypes in 3-D culture using defined serum-free culture  conditions.,Non-OADS,/arxiv_data1/oa_pdf/b7/85/mv-v21-502.PMC4415596.pdf
Molecular Vision  2015; 21:502-514 <http://www.molvis.org/molvis/v 21/502> © 2015 Molecular Vision  512stroma surrounding the wound.,Non-OADS,/arxiv_data1/oa_pdf/b7/85/mv-v21-502.PMC4415596.pdf
Molecular Vision  2015; 21:502-514 <http://www.molvis.org/molvis/v 21/502> © 2015 Molecular Vision  513growth factor-beta-induced reactive oxygen species accu - mulation and myofibroblast differentiation via enhanced  NF-E2-related factor 2-antioxidant response element  s i g n a l i n g .,Non-OADS,/arxiv_data1/oa_pdf/b7/85/mv-v21-502.PMC4415596.pdf
Molecular Vision  2015; 21:502-514 <http://www.molvis.org/molvis/v 21/502> © 2015 Molecular Vision  514inflammatory and fibrogenic disorders of the ocular surface.,Non-OADS,/arxiv_data1/oa_pdf/b7/85/mv-v21-502.PMC4415596.pdf
"19 GermanFederalInstituteforRisk Assessment.Chromium(VI)inleatherclothingandshoesproblematicforallergysufferers!,2007.Availableat:http://www.bfr.bund.de/en/press_information/2007/10/chromium__vi__in_leather_clothing_and_shoes_problematic_for_allergy_sufferers_-9575.html(lastaccessed14November2014).",Non-OADS,/arxiv_data1/oa_pdf/9e/16/cod0072-0206.PMC4415597.pdf
"8 Some allostatic models of drug addiction suggest that the dysregu-lated overcompensation of the dependent measure can motivatebehavior(e.g., increased drug consumption) that opposes the © Douglas S Ramsay, Stephen C Woods, and Karl J Kaiyala *Correspondence to: Douglas S Ramsay; Email: ramsay@uw.eduSubmitted: 03/31/2014; Revised: 06/19/2014; Accepted: 06/26/2014 http://dx.doi.org/10.4161/23328940.2014.944802 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License http://creativecommons.or g/licenses/ by-nc/3.0/, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/ea/8f/ktmp-01-03-944802.PMC4415621.pdf
Curr Dir Psychol Sci 2006; 15:232–36; http://dx.doi.org/10.1111/j.1467-8721.2006.00442.x 2.,Non-OADS,/arxiv_data1/oa_pdf/ea/8f/ktmp-01-03-944802.PMC4415621.pdf
Psychol Rev 2004; 111:33–51; PMID: 14756584;http://dx.doi.org/10.1037/0033-295X.111.1.33 3.,Non-OADS,/arxiv_data1/oa_pdf/ea/8f/ktmp-01-03-944802.PMC4415621.pdf
Arch Intern Med 1942; 69:766–72; http://dx.doi.org/10.1001/archinte.1942.00200170048004 4.,Non-OADS,/arxiv_data1/oa_pdf/ea/8f/ktmp-01-03-944802.PMC4415621.pdf
Curr Opin Neurobiol 2013;23:559–63; PMID: 23628232; http://dx.doi.org/ 10.1016/j.conb.2013.03.011 8.,OADS,/arxiv_data1/oa_pdf/ea/8f/ktmp-01-03-944802.PMC4415621.pdf
Clarifying the roles of homeostasis and allostasis in physiological regulation.Psychol Rev 2014; 121:225–47; PMID: 24730599; http://dx.doi.org/10.1037/a0035942 9.,Non-OADS,/arxiv_data1/oa_pdf/ea/8f/ktmp-01-03-944802.PMC4415621.pdf
Neuropsychopharmacology 2001; 24:97–129; PMID: 11120394; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ea/8f/ktmp-01-03-944802.PMC4415621.pdf
Annu Rev Psychol 2008; 59:29–53; PMID: 18154498; http://dx.doi.org/10.1146/ annurev.psych.59.103006.093548 12.,Non-OADS,/arxiv_data1/oa_pdf/ea/8f/ktmp-01-03-944802.PMC4415621.pdf
J Pharmacol Exp Ther 2006; 316:892–9; PMID: 16254131; http://dx.doi.org/ 10.1124/jpet.105.095109 13.,Non-OADS,/arxiv_data1/oa_pdf/ea/8f/ktmp-01-03-944802.PMC4415621.pdf
J Neurobiol 2004; 61:126–48; PMID: 15362157; http://dx.doi.org/ 10.1002/neu.20091 14.,Non-OADS,/arxiv_data1/oa_pdf/ea/8f/ktmp-01-03-944802.PMC4415621.pdf
Psychopharmacology (Berl) 2007; 191:233–42; PMID: 17216156; http://dx.doi.org/10.1007/s00213-006-0655-1 1 5 .,Non-OADS,/arxiv_data1/oa_pdf/ea/8f/ktmp-01-03-944802.PMC4415621.pdf
J Therm Biol 2012; 37:30– 40; PMID: 22247586; http://dx.doi.org/10.1016/ j.jtherbio.2011.10.00416.,OADS,/arxiv_data1/oa_pdf/ea/8f/ktmp-01-03-944802.PMC4415621.pdf
Psy- chopharmacology (Berl) 2005; 181:48–59; PMID: 15778887; http://dx.doi.org/10.1007/s00213-005-2219-1 17.,Non-OADS,/arxiv_data1/oa_pdf/ea/8f/ktmp-01-03-944802.PMC4415621.pdf
BMC Med Res Methodol 2002; 2:8; PMID: 12069695; http://dx.doi.org/10.1186/ 1471-2288-2-8 20.,Non-OADS,/arxiv_data1/oa_pdf/ea/8f/ktmp-01-03-944802.PMC4415621.pdf
Epidemiology 1990; 1:43–46;PMID: 2081237; http://dx.doi.org/10.1097/ 00001648-199001000-00010 22.,Non-OADS,/arxiv_data1/oa_pdf/ea/8f/ktmp-01-03-944802.PMC4415621.pdf
J Appl Physiol 2006; 100:1338–46; PMID: 16540712; http://dx.doi.org/10.1152/ japplphysiol.01021.2005 24.,Non-OADS,/arxiv_data1/oa_pdf/ea/8f/ktmp-01-03-944802.PMC4415621.pdf
"4, 241~249, December , 2014   http://dx.doi.org/10.12717/DR.2014.18.",Non-OADS,/arxiv_data1/oa_pdf/bd/ff/devrep-18-241.PMC4415634.pdf
"4, 275~286, December , 2014   http://dx.doi.org/10.12717/DR.2014.18.",Non-OADS,/arxiv_data1/oa_pdf/2a/d6/devrep-18-275.PMC4415635.pdf
"4, 251~258, December , 2014   http://dx.doi.org/10.12717/DR.2014.18.",Non-OADS,/arxiv_data1/oa_pdf/13/93/devrep-18-251.PMC4415636.pdf
The nucleotide sequence was analyzed and compared  using the BLASTX se arch program (http://www.ncbilnlm .,OADS,/arxiv_data1/oa_pdf/13/93/devrep-18-251.PMC4415636.pdf
Multiple sequence alignment and phylogenetic  analysis   The relevant sequences were compared using the BLASTX   search program ( http://www.ncbi.nlm .nih.gov/BLAST/) and   retrieved from GenBank for multiple sequence alignments  using CLUSTALW  (http://www.genome.jp/tools -bin/clustalw).,OADS,/arxiv_data1/oa_pdf/13/93/devrep-18-251.PMC4415636.pdf
"A search  using the BLASTP program ( http://www.ncbi.nlm .nih.gov/   blast/Blast.cgi) revealed that the ded uced amino acids of  RuLuc7l have a  serin e/arginine -rich region (amino acids  R243-R355), which is found commonly in other Luc7l pro - teins .",OADS,/arxiv_data1/oa_pdf/13/93/devrep-18-251.PMC4415636.pdf
"4, 213~224, December , 2014   http://dx.doi.org/10.12717/DR.2014.18.",Non-OADS,/arxiv_data1/oa_pdf/99/20/devrep-18-213.PMC4415637.pdf
"4, 321~327, December, 2014  http://dx.doi.org/10.12717/DR.2014.18.4.321  ISSN 1226-6752 (Print)  ISSN 2287-7967 (Online)    Manuscript received 9 December 2014, Received in re vised form 17 December 2014, Accepted 18 December 2014   † Corresponding Author : Ki-Young Lee, Dept.",Non-OADS,/arxiv_data1/oa_pdf/4b/4d/devrep-18-321.PMC4415638.pdf
"4, 301~309, December , 2014   http://dx.doi.org/10.12717/DR.2014.18.",Non-OADS,/arxiv_data1/oa_pdf/47/de/devrep-18-301.PMC4415639.pdf
"4, 197~212, December , 2014   http://dx.doi.org/10.12717/DR.2014.18.",Non-OADS,/arxiv_data1/oa_pdf/82/7c/devrep-18-197.PMC4415640.pdf
"4, 259~266, December , 2014   http://dx.doi.org/10.12717/DR.2014.18.",Non-OADS,/arxiv_data1/oa_pdf/35/e2/devrep-18-259.PMC4415641.pdf
"4, 225~231, December , 2014   http://dx.doi.org/10.12717/DR.2014.18.",Non-OADS,/arxiv_data1/oa_pdf/7f/43/devrep-18-225.PMC4415643.pdf
"4, 187~195, December , 2014   http://dx.doi.org/10.12717/DR.2014.18.",Non-OADS,/arxiv_data1/oa_pdf/d1/83/devrep-18-187.PMC4415645.pdf
"Washington,   DC: United States Government; http://www.epa.gov/   endo/pub s/edspoverview/finalrpt.htm   US EPA  (1999 ) Compendium of methods for the deter - mination of toxic organic compounds in ambient air.",Non-OADS,/arxiv_data1/oa_pdf/d1/83/devrep-18-187.PMC4415645.pdf
"4, 311~319, December, 2014  http://dx.doi.org/10.12717/DR.2014.18.4.311  ISSN 1226-6752 (Print)  ISSN 2287-7967 (Online)    Manuscript received 12 December 2014, Received in revi sed form 18 December 2014, Accepted 19 December 2014   † Corresponding Author : Kyeong-Ho Han, Dept .",Non-OADS,/arxiv_data1/oa_pdf/14/a8/devrep-18-311.PMC4415646.pdf
"4, 293~300, December , 2014   http://dx.doi.org/10.12717/DR.2014.18.",Non-OADS,/arxiv_data1/oa_pdf/3b/50/devrep-18-293.PMC4415647.pdf
"1, 33~41, March , 201 5  http://dx.doi.org/10.12717/DR.201 5.19.1.033  ISSN 1226 -6752 (Print)   ISSN 2287 -7967 (Online)     Manuscript received 28 January  2015, Received in revised form 10 February  2015, Accepted 25 February  2015   † Corresponding Author : Jong Youn Park, Southw est Sea Fisheries Research Institute, Yeosu 556 -823, Korea.",Non-OADS,/arxiv_data1/oa_pdf/85/56/devrep-19-33.PMC4415661.pdf
"1, 19~24, March , 201 5  http://dx.doi.org/10.12717/DR.201 5.19.1.019  ISSN 1226 -6752 (Print)   ISSN 2287 -7967 (Online)     Manuscript received 3 January  2015, Received in revised form 15 January  2015, Accepted 10 February  2015   † Corresponding Author : Hea Ja Baek  , Dept .",Non-OADS,/arxiv_data1/oa_pdf/0e/61/devrep-19-19.PMC4415662.pdf
"1, 43~51, March , 201 5  http://dx.doi.org/10.12717/DR.201 5.19.1.043  ISSN 1226 -6752 (Print)   ISSN  2287 -7967 (Online)     Manuscript received 10 February  2015, Received in revised form 23 February  2015, Accepted 10 March  2015   † Corresponding Author : Ki-Ho Lee, Dept .",Non-OADS,/arxiv_data1/oa_pdf/e1/6f/devrep-19-43.PMC4415663.pdf
"1, 53~60, March , 201 5  http://dx.doi.org/10.12717/DR.201 5.19.1.053  ISSN 1226 -6752 (Print)   ISSN 2287 -7967 (Online)     Manuscript received 5 March  2015, Received in revised form 16 March  2015, Accepted 23 March  2015   † Corresponding Author : Yong -Pil Cheon, Division of Developmental Biology and Physiology, School of Biosciences and Chemistry , Sungshin  University , 173-1 Dongs eondong 3ga, Seongbuk -gu, Seoul  136-742, Korea .",Non-OADS,/arxiv_data1/oa_pdf/b1/b2/devrep-19-53.PMC4415664.pdf
"1, 25~31, March , 201 5  http://dx.doi.org/10.12717/DR.201 5.19.1.025  ISSN 1226 -6752 (Print)   ISSN 2287 -7967 (Online)     Manuscript received 20 January  2015, Received in revised form 5 February  2015, Accepted 17 February  2015   † Corresponding Author : Ran Han, Lotteworld Aquarium, Seoul, 138 -240, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b8/df/devrep-19-25.PMC4415665.pdf
"1, 11~17, March , 201 5  http://dx.doi.org/10.12717/DR.201 5.19.1.011  ISSN 1226 -6752 (Print)   ISSN 2287 -7967 (Online)     Manuscript received 11 December 2014 , Received in revised form 27 December  2014 , Accepted 3 February  2015    † Corresponding Author : Young -Don Lee, Marine Science  Institute, Jeju National University, 19-5, Hamdeok 5(o) -gill, Jocheon, Jeju Special Self - Governing Province 695 -965, Korea.",Non-OADS,/arxiv_data1/oa_pdf/88/a5/devrep-19-11.PMC4415666.pdf
"1, 1~10, March , 201 5  http://dx.doi.org/10.12717/DR.201 5.19.1.001  ISSN 1226 -6752 (Print)   ISSN 2287 -7967 (Online)     Manuscript received 5 December 2014, Received in revised form 20 December  2014, Accepted 3 February 2015   † Corresponding Author : Jung-Hun Lee, Dept .",Non-OADS,/arxiv_data1/oa_pdf/99/6d/devrep-19-1.PMC4415667.pdf
"Competing Interests The author has completed the Uniﬁed Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (avail- able on request from the corresponding author) and declares DS had support from Novartis for the submitted work and DS has received sponsorship to attend interna- tional meetings, honoraria for lecturing or attending advisory boards and research grants from various phar- maceutical companies who may have an interest in the submitted work, or could appear to have inﬂuenced this work, including Almirall, AstraZeneca, Boehringer D. Singh 704 /79:5 / Br J Clin Pharmacol",Non-OADS,/arxiv_data1/oa_pdf/7e/ab/bcp0079-0695.PMC4415707.pdf
Available at http://www.goldcopd.org/guidelines-global-strategy -for-diagnosis-management.html (last accessed 10 February 2014).,Non-OADS,/arxiv_data1/oa_pdf/7e/ab/bcp0079-0695.PMC4415707.pdf
"Available at http://www.nice.org .uk/guidance/cg101 (last accessed 24 January 2014).Table 5 Important ongoing or recently completed clinical trials assessing ﬁxed dose combination dual bronchodilators Fixed dose combination Identiﬁer and study name Comparator Patients n Evaluation QVA149 NCT01709903* LANTERNSalmeterol/ﬂuticasone 500/50 μg twice dailyModerate to severe COPD 679 QVA149 vs.SFC for lung function and rate of exacerbations NCT01574651† QUANTIFYTiotropium 18 μg once daily plus formoterol 12 mg twice dailyModerate to severe COPD 934 QVA149 vs.LABA and LAMA co-prescribing for lung function and dyspnoea UMEC/VI NCT01822899‡ Salmeterol/ﬂuticasone twice daily Moderate to severe COPD without recent history of exacerbation716 UMEC/VI vs.SFC for lung function NCT02014480§ and NCT01716520Crossover study, UMEC 62.5 μg once daily, VI 25 μg once dailyCOPD 389 Effect of UMEC/VI vs. mono-components in responders/non-responders Tiotropium/ olodaterolNCT01525615¶ TORRACTO Placebo Moderate to severe COPD 404 Impact on exercise tolerance vs. placebo NCT01431274** (TONADO 1) and NCT01431287†† (TONADO 2)O5 μg, T 2.5 μg ,T5 μg, T +O 2.5/5 μgo rT +O 5/5 μgModerate to very severe COPD 5162 T +O 5/5 μgvs.monotherapy for lung function and symptoms FF/UMEC/VI NCT02164513‡‡ IMPACT FF/UMEC/VI 100/62.5/25 μg, FF/VI 100/25 μg or UMEC/VI 62.5/25 μgCOPD with CAT score >10 10,000 Superiority of triple therapy over dual therapy for moderate/severe exacerbations *Clinicaltrials.gov.",Non-OADS,/arxiv_data1/oa_pdf/7e/ab/bcp0079-0695.PMC4415707.pdf
http://clinicaltrials.gov/ct2/ show/NCT01574651 [Accessed 22 Sept 2014].,Non-OADS,/arxiv_data1/oa_pdf/7e/ab/bcp0079-0695.PMC4415707.pdf
http://clinicaltrials.gov/ct2/show/NCT01822899 [Accessed 22 Sept 2014].,Non-OADS,/arxiv_data1/oa_pdf/7e/ab/bcp0079-0695.PMC4415707.pdf
http://clinicaltrials.gov/ct2/show/NCT01525615 [Accessed 22 Sept 2014].,Non-OADS,/arxiv_data1/oa_pdf/7e/ab/bcp0079-0695.PMC4415707.pdf
"A Study Comparing the Efﬁcacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) http://clinicaltrials.gov/ct2/show/NCT 02164513 [Accessed 22 Sept 2014].",Non-OADS,/arxiv_data1/oa_pdf/7e/ab/bcp0079-0695.PMC4415707.pdf
Available at http://bidocs.boehringer -ingelheim.com/BIWebAccess/ViewServlet.ser?docBase =renetnt&folderPath =/Prescribing +Information/PIs/ Combivent +Respimat/CMVTRSPT.pdf (last accessed 31 January 2014).,Non-OADS,/arxiv_data1/oa_pdf/7e/ab/bcp0079-0695.PMC4415707.pdf
"Press release May 2, 2013.Available at http://investors.almirall.es/phoenix.zhtml?c =209345&p =irol-newsArticle&ID =1814070&highlight (last accessed 28 February 2014).",Non-OADS,/arxiv_data1/oa_pdf/7e/ab/bcp0079-0695.PMC4415707.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/99/jer-11-2-101.PMC4415748.pdf
"Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 101*Corresponding author:  Hyun-Bae Kim Department of Physical Education, College of Physical Education, Kyung Hee  University, 1732 Deokyoungdae-ro, Giheung-gu, Y ongin 446-701, Korea Tel: +82-31-201-2716, Fax: +82-31-204-8117, E-mail: hbkim5@khu.ac.kr Received:  March 30, 2015 / Accepted:  April 8, 2015Effect of 8 weeks of pre-season training on body  composition, physical fitness, anaerobic capacity, and  isokinetic muscle strength in male and female collegiate  taekwondo athletes Myong-Won Seo, Hyun-Chul Jung, Jong-Kook Song, Hyun-Bae Kim* Department of Physical Education, College of Physical Education, Kyung Hee University, Yongin, Korea The purpose of the study was to determine the effect of 8 weeks  pre-season training on body composition, physical fitness, anaerobic capacity, and isokinetic strength in collegiate taekwondo athletes.",Non-OADS,/arxiv_data1/oa_pdf/98/99/jer-11-2-101.PMC4415748.pdf
"In addition, during a two-minute, http://dx.doi.org/10.12965/jer.150196Original Article Journal of Exercise Rehabilitation 2015;11(2):101-107",Non-OADS,/arxiv_data1/oa_pdf/98/99/jer-11-2-101.PMC4415748.pdf
"http://dx.doi.org/10.12965/jer.150196Seo M-W, et al.",OADS,/arxiv_data1/oa_pdf/98/99/jer-11-2-101.PMC4415748.pdf
"•  Effect of pre-season training 102    http://www.e-jer.orgthree-round taekwondo match, mean heart rates (Mean HR) of  athletes can reach 85% of maximum (HR max), validating it as a  high-intensity sport (Bridge et al., 2013; Chiodo et al., 2011;  Matsushigue et al., 2009); thus, performance relies heavily on an - aerobic metabolism, since scoring is achieved through attacks  within very brief time intervals, e.g.",Non-OADS,/arxiv_data1/oa_pdf/98/99/jer-11-2-101.PMC4415748.pdf
"http://www.e-jer.org     103 http://dx.doi.org/10.12965/jer.150196Seo M-W, et al.",OADS,/arxiv_data1/oa_pdf/98/99/jer-11-2-101.PMC4415748.pdf
"http://dx.doi.org/10.12965/jer.150196Seo M-W, et al.",OADS,/arxiv_data1/oa_pdf/98/99/jer-11-2-101.PMC4415748.pdf
"•  Effect of pre-season training 104    http://www.e-jer.orgshuttle run) significantly positive effect for males, from 17.0 ±0.92  sec before to 16.2 ±0.99 sec after training ( P<0.0001); there was  also an improvement for females, from 19.1 ±0.92 sec before to  18.4±0.70 sec after training ( P<0.01).",Non-OADS,/arxiv_data1/oa_pdf/98/99/jer-11-2-101.PMC4415748.pdf
"http://www.e-jer.org     105 http://dx.doi.org/10.12965/jer.150196Seo M-W, et al.",OADS,/arxiv_data1/oa_pdf/98/99/jer-11-2-101.PMC4415748.pdf
"http://dx.doi.org/10.12965/jer.150196Seo M-W, et al.",OADS,/arxiv_data1/oa_pdf/98/99/jer-11-2-101.PMC4415748.pdf
"•  Effect of pre-season training 106    http://www.e-jer.orgtistage endurance run results for males and females, but did not  change sit and reach and standing long jump results.",Non-OADS,/arxiv_data1/oa_pdf/98/99/jer-11-2-101.PMC4415748.pdf
"http://www.e-jer.org     107 http://dx.doi.org/10.12965/jer.150196Seo M-W, et al.",OADS,/arxiv_data1/oa_pdf/98/99/jer-11-2-101.PMC4415748.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/2a/jer-11-2-108.PMC4415749.pdf
"Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 108*Corresponding author:  Hye-Sang Park Department of Sports Health Management, University of Suwon, 17 Wauan-gil,  Bongdam-eup, Hwaseong 445-743, Korea  Tel: +82-31-229-8103, Fax: +82-31-229-2563, E-mail: wini-phs@hanmail.net Received:  February 12, 2015 / Accepted:  April 7, 2015Relation of the factor to menstrual pain and  musculoskeletal pain Jang-Won Lee1, Hye-Sang Park2,* 1Department of Sports Health Medicine, College of Health Science, Jungwon University, Geosan-gun, Chungcheongbuk-do, Korea  2Department of Sports Health Management, College of Physical Education, University of Suwon, Hwaseong, Korea The purpose of the present study is to investigate the relationship be - tween the regions of menstrual pain and of myofascial pain syndrome,  which is the main cause of musculoskeletal pain, as well as to examine the changes and relationships among the menstrual pain-related fac - tors, which are pain level, pain area, activity, appetite, mood, and sleep - ing pattern.",Non-OADS,/arxiv_data1/oa_pdf/05/2a/jer-11-2-108.PMC4415749.pdf
"In addition, we  evaluated the changes and relationships among the menstrual  pain-related factors, pain level, pain area, activity, appetite, mood,  and sleeping pattern.http://dx.doi.org/10.12965/jer.150188Original Article Journal of Exercise Rehabilitation 2015;11(2):108-111",Non-OADS,/arxiv_data1/oa_pdf/05/2a/jer-11-2-108.PMC4415749.pdf
"http://www.e-jer.org     109 http://dx.doi.org/10.12965/jer.150188Lee J-W, et al.",OADS,/arxiv_data1/oa_pdf/05/2a/jer-11-2-108.PMC4415749.pdf
"http://dx.doi.org/10.12965/jer.150188Lee J-W, et al.",OADS,/arxiv_data1/oa_pdf/05/2a/jer-11-2-108.PMC4415749.pdf
•  Menstrual pain and musculoskeletal pain 110    http://www.e-jer.orgAppetite Appetite in suffer group and non-suffer group was decreased  before menstruation however was increased at starting menstrua - tion.,Non-OADS,/arxiv_data1/oa_pdf/05/2a/jer-11-2-108.PMC4415749.pdf
"http://www.e-jer.org     111 http://dx.doi.org/10.12965/jer.150188Lee J-W, et al.",OADS,/arxiv_data1/oa_pdf/05/2a/jer-11-2-108.PMC4415749.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/jer-11-2-112.PMC4415750.pdf
"Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 112*Corresponding author:  Chang Hwa Joo Department of Football Science, College of Health Science, Ho Nam University,   417 Eodeung-daero, Gwangsan-gu, Gwangju 506-714, Korea Tel: +82-62-940-3602, Fax: +82-62-940-3741, E-mail: footballer@honam.ac.kr Received:  March 29, 2015 / Accepted:  April 8, 2015Development of a non-damaging high-intensity  intermittent running protocol Chang Hwa Joo* Department of Football Science, College of Health Science, Ho Nam University, Gwangju, Korea The aim of the present study was to devise a non-damaging high-inten - sity intermittent running protocol.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/jer-11-2-112.PMC4415750.pdf
"Symp - toms generally occur within 24 h, peaking between 24 and 72 h,  and lasting up to 5-7 days post-exercise (Cleak and Eston, 1992,  Jones et al., 1986), and these symptoms are frequently referred to http://dx.doi.org/10.12965/jer.15195Original Article Journal of Exercise Rehabilitation 2015;11(2):112-118",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/jer-11-2-112.PMC4415750.pdf
http://www.e-jer.org     113 http://dx.doi.org/10.12965/jer.15195Joo CH  •  Non-damaging high-intensity intermittent running protocol as delayed-onset muscle soreness.,Non-OADS,/arxiv_data1/oa_pdf/e3/b0/jer-11-2-112.PMC4415750.pdf
"http://dx.doi.org/10.12965/jer.15195Joo CH  •  Non-damaging high-intensity intermittent running protocol 114    http://www.e-jer.orgExercise protocols Each subject completed a standard incremental treadmill test  on a motorized treadmill (HP Cosmos, Pulsar, Germany) for de - termination of maximal oxygen uptake.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/jer-11-2-112.PMC4415750.pdf
http://www.e-jer.org     115 http://dx.doi.org/10.12965/jer.15195Joo CH  •  Non-damaging high-intensity intermittent running protocol Indices of muscle damage Mean baseline MVC score for the quadriceps was 648.3 ±148.5  N. No significant reduction in MVC was observed immediately  following completion of the last exercise bout (623.9 ±143.6 N) or  during the subsequent 7-d period compared to pre-exercise values  (P=0.59) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/e3/b0/jer-11-2-112.PMC4415750.pdf
http://dx.doi.org/10.12965/jer.15195Joo CH  •  Non-damaging high-intensity intermittent running protocol 116    http://www.e-jer.orgstudies to determine the influence of high-intensity exercise on  physiological responses to molecular adaptation in moderately  trained individuals.,Non-OADS,/arxiv_data1/oa_pdf/e3/b0/jer-11-2-112.PMC4415750.pdf
http://www.e-jer.org     117 http://dx.doi.org/10.12965/jer.15195Joo CH  •  Non-damaging high-intensity intermittent running protocol nificantly increased following exercise but returned to pre-exercise  levels at 24 h post exercise.,Non-OADS,/arxiv_data1/oa_pdf/e3/b0/jer-11-2-112.PMC4415750.pdf
http://dx.doi.org/10.12965/jer.15195Joo CH  •  Non-damaging high-intensity intermittent running protocol 118    http://www.e-jer.orgJ Physiol 2010;588:1011-1022.,Non-OADS,/arxiv_data1/oa_pdf/e3/b0/jer-11-2-112.PMC4415750.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/3b/jer-11-2-65.PMC4415751.pdf
Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 65Usefulness of measuring isokinetic torque and balance  ability for exercise rehabilitation Yong-Seok Jee The goal of exercise rehabilitation is to return to the conditions  necessary to be able to engage in specific sports or general physical  activity.,Non-OADS,/arxiv_data1/oa_pdf/50/3b/jer-11-2-65.PMC4415751.pdf
"In particular, isokinetic training may be used to quan -http://dx.doi.org/10.12965/jer.150197Editorial Journal of Exercise Rehabilitation 2015;11(2):65-66",Non-OADS,/arxiv_data1/oa_pdf/50/3b/jer-11-2-65.PMC4415751.pdf
"http://dx.doi.org/10.12965/jer.150197Jee Y-S 66    http://www.e-jer.orgtify a muscle group’s ability to generate torque or force, and it is  also useful as an exercise modality in the restoration of a muscle  group’s pre-injury level of strength.",Non-OADS,/arxiv_data1/oa_pdf/50/3b/jer-11-2-65.PMC4415751.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/bd/jer-11-2-67.PMC4415752.pdf
"Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 67*Corresponding author:  Zeevi Dvir  Department of Physical Therapy, Sackler Faculty of Medicine, Tel Aviv University,  Ramat Aviv, Israel  Tel: +972-3-640-5429, Fax: +972-3-640-9223, E-mail: zdvir@post.tau.ac.il Received:  April 10, 2015 / Accepted:  April 13, 2015Difference, significant difference and clinically  meaningful difference: The meaning of change in  rehabilitation Zeevi Dvir  Department of Physical Therapy, Sackler Faculty of Medicine, Tel Aviv University, Israel  The valid confirmation of a positive change (improvement) in a patient’s  health status due to intervention has been at the core of medicine and rehabilitation since their very inception as clinicians always aspired to ensure that treating their patients had led to successful outcomes both in acute and chronic conditions.",Non-OADS,/arxiv_data1/oa_pdf/ef/bd/jer-11-2-67.PMC4415752.pdf
change is judged based on a difference in some measurable  http://dx.doi.org/10.12965/jer.150199Review Article Journal of Exercise Rehabilitation 2015;11(2):67-73,Non-OADS,/arxiv_data1/oa_pdf/ef/bd/jer-11-2-67.PMC4415752.pdf
"http://dx.doi.org/10.12965/jer.150199Dvir Z  •  Difference, significant difference, clinically meaningful difference 68    http://www.e-jer.orgentity and almost always it relates to a time span.",Non-OADS,/arxiv_data1/oa_pdf/ef/bd/jer-11-2-67.PMC4415752.pdf
"http://www.e-jer.org     69 http://dx.doi.org/10.12965/jer.150199Dvir Z  •  Difference, significant difference, clinically meaningful difference Thus in assessing change, irrespective of the measurement in - strument (the most sophisticated or a simple questionnaire), two  critical factors must be addressed: the reproducibility (consistency)  and the accuracy of the measurement.",Non-OADS,/arxiv_data1/oa_pdf/ef/bd/jer-11-2-67.PMC4415752.pdf
Source:http://en.wikipedia.org/wiki/ File:Accuracy_and_precision.,OADS,/arxiv_data1/oa_pdf/ef/bd/jer-11-2-67.PMC4415752.pdf
"http://dx.doi.org/10.12965/jer.150199Dvir Z  •  Difference, significant difference, clinically meaningful difference 70    http://www.e-jer.org-5 then the clinical content is much higher but as the reproduc - ibility is extremely low, there is little that can be inferred from  such measurements.",Non-OADS,/arxiv_data1/oa_pdf/ef/bd/jer-11-2-67.PMC4415752.pdf
"http://www.e-jer.org     71 http://dx.doi.org/10.12965/jer.150199Dvir Z  •  Difference, significant difference, clinically meaningful difference tainty regarding an individual subject/patient are much wider  than those acting for the group.",Non-OADS,/arxiv_data1/oa_pdf/ef/bd/jer-11-2-67.PMC4415752.pdf
"http://dx.doi.org/10.12965/jer.150199Dvir Z  •  Difference, significant difference, clinically meaningful difference 72    http://www.e-jer.orgdown the SRD.",Non-OADS,/arxiv_data1/oa_pdf/ef/bd/jer-11-2-67.PMC4415752.pdf
https://www.google.co.il/search?q = nu - meric+pain+rating+scale+(nprs) [pictures].,Non-OADS,/arxiv_data1/oa_pdf/ef/bd/jer-11-2-67.PMC4415752.pdf
"http://www.e-jer.org     73 http://dx.doi.org/10.12965/jer.150199Dvir Z  •  Difference, significant difference, clinically meaningful difference and the level of statistical significance when an intervention is ap - plied.",Non-OADS,/arxiv_data1/oa_pdf/ef/bd/jer-11-2-67.PMC4415752.pdf
"http://qol.thoracic.org/sections/measure - ment-properties/minimal-clinically-significant-difference.html, 2007.",Non-OADS,/arxiv_data1/oa_pdf/ef/bd/jer-11-2-67.PMC4415752.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/a1/jer-11-2-74.PMC4415753.pdf
"Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 74*Corresponding author:  Arunabh Talwar  North Shore - Long Island Jewish Health System, Department of Pulmonary,  Critical Care and Sleep Medicine, 410 Lakeville Rd.",Non-OADS,/arxiv_data1/oa_pdf/82/a1/jer-11-2-74.PMC4415753.pdf
Evidence based medicine has determined that pulmonary http://dx.doi.org/10.12965/jer.150190Review Article Journal of Exercise Rehabilitation 2015;11(2):74-79,Non-OADS,/arxiv_data1/oa_pdf/82/a1/jer-11-2-74.PMC4415753.pdf
"http://www.e-jer.org     75 http://dx.doi.org/10.12965/jer.150190Sahni S, et al.",OADS,/arxiv_data1/oa_pdf/82/a1/jer-11-2-74.PMC4415753.pdf
"http://dx.doi.org/10.12965/jer.150190Sahni S, et al.",OADS,/arxiv_data1/oa_pdf/82/a1/jer-11-2-74.PMC4415753.pdf
•  Pulmonary rehabilitation in pulmonary arterial hypertension 76    http://www.e-jer.orgExercise capacity is reduced in the setting of pulmonary hyper - tension which is associated with depression and anxiety disorders  as demonstrated by Lowe et al.,Non-OADS,/arxiv_data1/oa_pdf/82/a1/jer-11-2-74.PMC4415753.pdf
"http://www.e-jer.org     77 http://dx.doi.org/10.12965/jer.150190Sahni S, et al.",OADS,/arxiv_data1/oa_pdf/82/a1/jer-11-2-74.PMC4415753.pdf
"http://dx.doi.org/10.12965/jer.150190Sahni S, et al.",OADS,/arxiv_data1/oa_pdf/82/a1/jer-11-2-74.PMC4415753.pdf
•  Pulmonary rehabilitation in pulmonary arterial hypertension 78    http://www.e-jer.org2014) which provide evidence of further benefits of such programs.,Non-OADS,/arxiv_data1/oa_pdf/82/a1/jer-11-2-74.PMC4415753.pdf
"http://www.e-jer.org     79 http://dx.doi.org/10.12965/jer.150190Sahni S, et al.",OADS,/arxiv_data1/oa_pdf/82/a1/jer-11-2-74.PMC4415753.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/67/jer-11-2-80.PMC4415754.pdf
"Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 80*Corresponding author:  Jin-Hee Seo  Division of Sports Science, Baekseok University, 76 Munam-ro, Dongnam-gu,  Cheonan 330-704,  Korea Tel: +82-41-550-2207, Fax: +82-41-550-2109, E-mail: sjh0521@bu.ac.kr Received:  March 22, 2015 / Accepted:  April 8, 2015Treadmill exercise prevents GABAergic neuronal loss  with suppression of neuronal activation in the  pilocarpine-induced epileptic rats Baek-Vin Lim1, Mal-Soon Shin2, Jae-Min Lee2, Jin-Hee Seo3,* 1Department of Exercise Prescription, Division of Leisure & Sports Science, Dongseo University, Busan, Korea 2Department of Physiology, College of Medicine, Kyung Hee University, Seoul, Korea 3Division of Sports Science, Baekseok University, Cheonan, Korea Epilepsy is a common neurological disorder characterized by seizure  and loss of neuronal cells by abnormal rhythmic firing of neurons in the brain.",Non-OADS,/arxiv_data1/oa_pdf/00/67/jer-11-2-80.PMC4415754.pdf
Epileptic seizure activity induces http://dx.doi.org/10.12965/jer.150193Original Article Journal of Exercise Rehabilitation 2015;11(2):80-86,Non-OADS,/arxiv_data1/oa_pdf/00/67/jer-11-2-80.PMC4415754.pdf
"http://www.e-jer.org     81 http://dx.doi.org/10.12965/jer.150193Lim B-V, et al.",OADS,/arxiv_data1/oa_pdf/00/67/jer-11-2-80.PMC4415754.pdf
"http://dx.doi.org/10.12965/jer.150193Lim B-V, et al.",OADS,/arxiv_data1/oa_pdf/00/67/jer-11-2-80.PMC4415754.pdf
•  Treadmill exercise prevents GABAergic neuronal loss  82    http://www.e-jer.orgPermount® (Fisher Scientific).,Non-OADS,/arxiv_data1/oa_pdf/00/67/jer-11-2-80.PMC4415754.pdf
"http://www.e-jer.org     83 http://dx.doi.org/10.12965/jer.150193Lim B-V, et al.",OADS,/arxiv_data1/oa_pdf/00/67/jer-11-2-80.PMC4415754.pdf
"http://dx.doi.org/10.12965/jer.150193Lim B-V, et al.",OADS,/arxiv_data1/oa_pdf/00/67/jer-11-2-80.PMC4415754.pdf
"•  Treadmill exercise prevents GABAergic neuronal loss  84    http://www.e-jer.orgcells was 14.14 ±2.32 in the control group, 14.47 ±1.76 in the  control and treadmill exercise group, 37.47 ±3.07 in the pilocar - pine-induced epilepsy group, and 25.90 ±2.53 in the pilocar - pine-induced epilepsy and treadmill exercise group.",OADS,/arxiv_data1/oa_pdf/00/67/jer-11-2-80.PMC4415754.pdf
"http://www.e-jer.org     85 http://dx.doi.org/10.12965/jer.150193Lim B-V, et al.",OADS,/arxiv_data1/oa_pdf/00/67/jer-11-2-80.PMC4415754.pdf
"http://dx.doi.org/10.12965/jer.150193Lim B-V, et al.",OADS,/arxiv_data1/oa_pdf/00/67/jer-11-2-80.PMC4415754.pdf
•  Treadmill exercise prevents GABAergic neuronal loss  86    http://www.e-jer.orgin the pilocarpine model of spontaneous recurrent seizures.,Non-OADS,/arxiv_data1/oa_pdf/00/67/jer-11-2-80.PMC4415754.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/2b/jer-11-2-87.PMC4415755.pdf
"Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 87*Corresponding author:  Kijeong Kim  Department of Exercise & Sport Science, College of Natural Sciences, University of  Ulsan, 93 Daehak-ro, Nam-gu, Ulsan 680-749, Korea Tel: +82-52-259-2381, Fax: +82-52-259-1696, E-mail: kijeongk@ulsan.ac.kr Received:  March 30, 2015 / Accepted:  April 8, 2015Treadmill exercise decreases incidence of Alzheimer’s  disease by suppressing glycogen synthase kinase-3 β  expression in streptozotocin-induced diabetic rats Dae-Young Kim1, Sun-Young Jung2, Tae-Woon Kim3, Kwang-Sik Lee4, Kijeong Kim5,* 1Department of Sports Healthcare, College of Humanities & Social Sciences, Inje University, Gimhae, Korea 2Department of Physical Therapy, Hosan University, Gyeongsan, Korea 3Department of Physiology, College of Medicine, Kyung Hee University, Seoul, Korea 4Research Institute of Sports Science, National University of Incheon, Incheon, Korea 5Department of Exercise & Sport Science, College of Natural Sciences, University of Ulsan, Ulsan, Korea Diabetes is a metabolic disorder, and it is considered as a major risk  factor for Alzheimer’s disease (AD).",Non-OADS,/arxiv_data1/oa_pdf/61/2b/jer-11-2-87.PMC4415755.pdf
"Presence of neurofibrillary tangles, composed of aggregat - ed and hyperphosphorylated forms of tau protein, is one of the http://dx.doi.org/10.12965/jer.150198Original Article Journal of Exercise Rehabilitation 2015;11(2):87-94",Non-OADS,/arxiv_data1/oa_pdf/61/2b/jer-11-2-87.PMC4415755.pdf
"http://dx.doi.org/10.12965/jer.150198Kim D-Y, et al.",OADS,/arxiv_data1/oa_pdf/61/2b/jer-11-2-87.PMC4415755.pdf
"•  Treadmill exercise decreases Alzheimer’s disease incidence 88    http://www.e-jer.orgpathological hallmarks of AD (Hartig et al., 2007).",Non-OADS,/arxiv_data1/oa_pdf/61/2b/jer-11-2-87.PMC4415755.pdf
"http://www.e-jer.org     89 http://dx.doi.org/10.12965/jer.150198Kim D-Y, et al.",OADS,/arxiv_data1/oa_pdf/61/2b/jer-11-2-87.PMC4415755.pdf
"http://dx.doi.org/10.12965/jer.150198Kim D-Y, et al.",OADS,/arxiv_data1/oa_pdf/61/2b/jer-11-2-87.PMC4415755.pdf
"•  Treadmill exercise decreases Alzheimer’s disease incidence 90    http://www.e-jer.org268.83 ±31.16 sec in the exercise group, 93.60 ±17.06 sec in the  diabetes-induction group, and 282.60 ±17.40 sec in the diabe - tes-induction and exercise group (Fig 1, right).",Non-OADS,/arxiv_data1/oa_pdf/61/2b/jer-11-2-87.PMC4415755.pdf
"http://www.e-jer.org     91 http://dx.doi.org/10.12965/jer.150198Kim D-Y, et al.",OADS,/arxiv_data1/oa_pdf/61/2b/jer-11-2-87.PMC4415755.pdf
"http://dx.doi.org/10.12965/jer.150198Kim D-Y, et al.",OADS,/arxiv_data1/oa_pdf/61/2b/jer-11-2-87.PMC4415755.pdf
"•  Treadmill exercise decreases Alzheimer’s disease incidence 92    http://www.e-jer.orgthe hippocampal dentate gyrus was 51.19 ±5.42/mm2 in the con - trol group, 47.98 ±5.03/mm2 in the exercise group, 186.34 ±18.54/ mm2 in the diabetes-induction group, and 147.29 ±11.32/mm2 in  the diabetes-induction and exercise group.",Non-OADS,/arxiv_data1/oa_pdf/61/2b/jer-11-2-87.PMC4415755.pdf
"http://www.e-jer.org     93 http://dx.doi.org/10.12965/jer.150198Kim D-Y, et al.",OADS,/arxiv_data1/oa_pdf/61/2b/jer-11-2-87.PMC4415755.pdf
"http://dx.doi.org/10.12965/jer.150198Kim D-Y, et al.",OADS,/arxiv_data1/oa_pdf/61/2b/jer-11-2-87.PMC4415755.pdf
"•  Treadmill exercise decreases Alzheimer’s disease incidence 94    http://www.e-jer.orgOu HC, Huang CY, Lee SD.",Non-OADS,/arxiv_data1/oa_pdf/61/2b/jer-11-2-87.PMC4415755.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/0b/jer-11-2-95.PMC4415756.pdf
"Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 95*Corresponding author:  Bekir Eray Kılınç Igdir State Hospital Orthopaedics and Traumatology Department, Devlet Hastanesi  Kışla Mahallesi 76000 Iğdır, Turkey Tel: +90-530-606-1884, Fax: +90-530-606-1884, E-mail: dreraykilinc@gmail.com Received:  February 12, 2015 / Accepted:  April 8, 2015Isokinetic dynamometer evaluation of the effects of early  thigh diameter difference on thigh muscle strength in  patients undergoing anterior cruciate ligament   reconstruction with hamstring tendon graft Bekir Eray Kılınç1,*, Adnan Kara2, Savas Camur3, Yunus Oc4, Haluk Celik4  1Igdir State Hospital Orthopaedics and Traumatology Department, Igdir, Turkey 2Istanbul Medipol University Orthopaedics and Traumatology Department, Istanbuk, Turkey 3Agri Dogubayazıd State Hospital Orthopaedics and Traumatology Department, Agri, Turkey 4Sisli Etfal Training and Research Hospital Orthopaedics and Traumatology Department, Istanbul, Turkey After anterior cruciate ligament (ACL) reconstruction, which muscle  groups are more affected from frequently developing thigh muscle atro - phy is a matter of debate.",Non-OADS,/arxiv_data1/oa_pdf/13/0b/jer-11-2-95.PMC4415756.pdf
"However, morphologi -http://dx.doi.org/10.12965/jer.150100Original Article Journal of Exercise Rehabilitation 2015;11(2):95-100",Non-OADS,/arxiv_data1/oa_pdf/13/0b/jer-11-2-95.PMC4415756.pdf
"http://dx.doi.org/10.12965/jer.150100Kılınç BE, et al.",OADS,/arxiv_data1/oa_pdf/13/0b/jer-11-2-95.PMC4415756.pdf
"•  Early thigh diameter difference on thigh muscle 96    http://www.e-jer.orgcal factors such as muscle atrophy in these patients is not the only  factor that determines the maximum power; in previous studies,  it is shown that despite the absence of morphological abnormali - ties the afferent feedback deficiency from ACL may interfere with  the activation of gamma motor unit of the muscles around the  knee (Konishi et al., 2002a; 2002b; 2003; 2007a; 2007b).",Non-OADS,/arxiv_data1/oa_pdf/13/0b/jer-11-2-95.PMC4415756.pdf
"http://www.e-jer.org     97 http://dx.doi.org/10.12965/jer.150100Kılınç BE, et al.",Non-OADS,/arxiv_data1/oa_pdf/13/0b/jer-11-2-95.PMC4415756.pdf
"http://dx.doi.org/10.12965/jer.150100Kılınç BE, et al.",OADS,/arxiv_data1/oa_pdf/13/0b/jer-11-2-95.PMC4415756.pdf
"•  Early thigh diameter difference on thigh muscle 98    http://www.e-jer.organd Cybex Flexion 240 of patients in negative direction (while the  thigh diameter difference increasing the Cybex Flexion 240 per - cent decreasing) at the level of 28.1% percent and this situation  was found to be statistically significant (r: -0,281; P=0.079;  P>0.05) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/13/0b/jer-11-2-95.PMC4415756.pdf
"http://www.e-jer.org     99 http://dx.doi.org/10.12965/jer.150100Kılınç BE, et al.",Non-OADS,/arxiv_data1/oa_pdf/13/0b/jer-11-2-95.PMC4415756.pdf
"http://dx.doi.org/10.12965/jer.150100Kılınç BE, et al.",OADS,/arxiv_data1/oa_pdf/13/0b/jer-11-2-95.PMC4415756.pdf
•  Early thigh diameter difference on thigh muscle 100    http://www.e-jer.orgtary quadriceps muscle activation after unilateral ACL tear.,Non-OADS,/arxiv_data1/oa_pdf/13/0b/jer-11-2-95.PMC4415756.pdf
http://www.ginasthma.com .,Non-OADS,/arxiv_data1/oa_pdf/27/57/12325_2015_Article_201.PMC4415938.pdf
http://www.nih.gov/news/health/ nov2014/nhlbi-19.htm .,Non-OADS,/arxiv_data1/oa_pdf/78/1f/12325_2015_Article_197.PMC4415939.pdf
U.S. Department of Health & Human Services Web site.http://www.hhs.gov/healthcare/facts/timeline/timeline-text.html .,Non-OADS,/arxiv_data1/oa_pdf/78/1f/12325_2015_Article_197.PMC4415939.pdf
http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/78/1f/12325_2015_Article_197.PMC4415939.pdf
https://innovations.ahrq.,Non-OADS,/arxiv_data1/oa_pdf/78/1f/12325_2015_Article_197.PMC4415939.pdf
http://www.erswhitebook.org/about/ .,Non-OADS,/arxiv_data1/oa_pdf/78/8e/12325_2015_Article_204.PMC4415944.pdf
2008. http://www.sign.ac.,Non-OADS,/arxiv_data1/oa_pdf/78/8e/12325_2015_Article_204.PMC4415944.pdf
2013. http://www.awmf.org/uploads/tx_ szleitlinien/nvl-002k_S3_Asthma_2013-09.pdf .,Non-OADS,/arxiv_data1/oa_pdf/78/8e/12325_2015_Article_204.PMC4415944.pdf
"However, as the doseincreased, CGA induced a significant inhibition of HepG2 cell viability; 500 μmol/l CGA decreased viability to 61.56% and 1 mmol/l decreased viability to 38% (Fig.S1, Supplemental digital content 1, http://links.lww.com/ ACD/A98 ).",Non-OADS,/arxiv_data1/oa_pdf/88/a8/cad-26-540.PMC4415958.pdf
http://links.lww.com/ACD/A99 ).,Non-OADS,/arxiv_data1/oa_pdf/88/a8/cad-26-540.PMC4415958.pdf
"S3,Supplemental digital content 3, http://links.lww.com/ACD/A100 ).",Non-OADS,/arxiv_data1/oa_pdf/88/a8/cad-26-540.PMC4415958.pdf
"In the ﬁrst analysis, the rates of attributable risk were modiﬁ ed as described in methods (see Table 1 Supplementary data, Supplemental digitalcontent 1, http://links.lww.com/EJGH/A21 ).",OADS,/arxiv_data1/oa_pdf/8f/84/meg-27-631.PMC4415959.pdf
2012; Available at: http://www.ine.es/dyngs/INEbase/en/operacion.,Non-OADS,/arxiv_data1/oa_pdf/8f/84/meg-27-631.PMC4415959.pdf
Availableat: http://www.ine.es/dyngs/INEbase/en/opera cion.htm?c =Estadistica_C&cid =1254736176918&menu = ultiDatos&idp =1254735976595.,OADS,/arxiv_data1/oa_pdf/8f/84/meg-27-631.PMC4415959.pdf
Available at: http://www.ine.es/jaxi/menu.do?type = pcaxis&path =%2Ft15/p417& ﬁle=inebase&L =1 [Accessed 23 December 2014].,Non-OADS,/arxiv_data1/oa_pdf/8f/84/meg-27-631.PMC4415959.pdf
2014; Available at: http://www.ine.es/jaxi/menu.do?type =pcaxis&path =% 2Ft25/p138& ﬁle=inebase&L =1.,Non-OADS,/arxiv_data1/oa_pdf/8f/84/meg-27-631.PMC4415959.pdf
Available at: http://www.who.int/mediacentre/ factsheets/fs204/en/ .,Non-OADS,/arxiv_data1/oa_pdf/b4/58/meg-27-638.PMC4415961.pdf
"Circulation is available at http://circ.ahajournals.org DOI:  10.1161/CIRCULATIONAHA.114.013789Received May 28, 2013; accepted February 26, 2015.From Sate Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China  (X.W., B.W., J.Z., Z.Z., W.X., S.C., X.H., D.X., J.B., M.K., Y .L.",Non-OADS,/arxiv_data1/oa_pdf/29/d7/cir-131-1506.PMC4415966.pdf
*Drs Wei and Wu contributed equally.The online-only Data Supplement is available with this article at http://circ.ahajournals.org/lookup/suppl/doi:10.1161/CIRCULATIONAHA.,Non-OADS,/arxiv_data1/oa_pdf/29/d7/cir-131-1506.PMC4415966.pdf
"Atlanta, GA. 2014. http://www.cdc.gov/ diabetes/pubs/statsreport14/national-diabetes-report- web.pdf .",Non-OADS,/arxiv_data1/oa_pdf/64/38/12325_2015_Article_199.PMC4415988.pdf
2014. http://pqaalliance.org/measures/ default.asp .,OADS,/arxiv_data1/oa_pdf/64/38/12325_2015_Article_199.PMC4415988.pdf
2013. http://www.cms.gov/ Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn/Downloads/Technical-Notes-2013-.pdf.,OADS,/arxiv_data1/oa_pdf/64/38/12325_2015_Article_199.PMC4415988.pdf
2014. http://www.hcup- us.ahrq.gov/toolssoftware/ccs/ccs.jsp .,OADS,/arxiv_data1/oa_pdf/64/38/12325_2015_Article_199.PMC4415988.pdf
Outlier determination was performed with GraphPad QuickCalcs ( http://graphpad.com/quickcalcs/ );Z-values greater than 2.5 were calculated using the Grubbs method foridentification of single extreme studentized deviates.,OADS,/arxiv_data1/oa_pdf/e2/77/fbp-26-353.PMC4416029.pdf
Available at:http://www.r-project.org [Accessed 20 February 2015].,Non-OADS,/arxiv_data1/oa_pdf/e2/77/fbp-26-353.PMC4416029.pdf
"Published by Oxford University Press on behalf of the British Society for Rheumatology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/d8/keu389.PMC4416082.pdf
"Health Economists Study Group 2010, http://hesg.org.uk/papers (24 September 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/07/d8/keu389.PMC4416082.pdf
"https://www.gov.uk/government/publications/2010-11-reference-costs-publication (7 August 2013, date lastaccessed).",Non-OADS,/arxiv_data1/oa_pdf/07/d8/keu389.PMC4416082.pdf
http://www.controlled-trials.com/ISRCTN06984617/mosaics.,Non-OADS,/arxiv_data1/oa_pdf/60/e0/keu411.PMC4416084.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/e0/keu411.PMC4416084.pdf
"@ERSpublications MDR-TB patients treated with 6 months or more of delamanid had significantly lower likelihood of mortality http://ow.ly/HOv1d Charles D. Wells1, Rajesh Gupta1, Norbert Hittel2and Lawrence J. Geiter1 1Otsuka Pharmaceutical Development and Commercialization, Rockville, MD, USA.2Otsuka Novel Products, Munich, Germany.",Non-OADS,/arxiv_data1/oa_pdf/bc/cd/ERJ-01763-2014.PMC4416109.pdf
"fibroblast proliferation, migration and differentiation http://ow.ly/Iae9z Copyright ©ERS 2015 ERJ Open articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.This article has supplementary material available from erj.ersjournals.com Received: Sept 23 2014 | Accepted after revision: Jan 05 2015 | First published online: March 05 2015 Support statement: This article and the studies of nintedanib described in this article were funded by Boehringer Ingelheim.",Non-OADS,/arxiv_data1/oa_pdf/f6/6f/ERJ-01749-2014.PMC4416110.pdf
@ERSpublications ATS/ERS end of test criteria for spirometry exclude too many subjects while having minimalimpact on predicted values http://ow.ly/DQRCD Copyright ©ERS 2015 ERJ Open articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.This article has supplementary material available from erj.ersjournals.com Received: June 26 2014 | Accepted after revision: Oct 23 2014 | First published online: Dec 23 2014 Conflict of interest: Disclosures can be found alongside the online version of this article at erj.ersjournals.com Eur Respir J 2015; 45: 1283 –1292 | DOI: 10.1183/09031936.00116814 1283|ORIGINAL ARTICLE LUNG FUNCTION,Non-OADS,/arxiv_data1/oa_pdf/aa/c1/ERJ-01168-2014.PMC4416111.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/b8/nou140.PMC4416132.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/3f/eht543.PMC4416137.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/83/ehu041.PMC4416138.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/01/ehv043.PMC4416140.pdf
http://my.americanheart.org/idc/groups/ahamah- public/@wcm/@sop/@scon/documents/downloadable/ucm_469669.pdf(22 November 2014).,Non-OADS,/arxiv_data1/oa_pdf/60/01/ehv043.PMC4416140.pdf
http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@ sop/@scon/documents/downloadable/ucm_469684.pdf (22 November 2014).,Non-OADS,/arxiv_data1/oa_pdf/60/01/ehv043.PMC4416140.pdf
http://clinicaltrials.gov/show/NCT01764633 (10 December 2014).,Non-OADS,/arxiv_data1/oa_pdf/60/01/ehv043.PMC4416140.pdf
http://clinicaltrials.gov/ct2/show/ NCT01975376 (10 December 2014).,Non-OADS,/arxiv_data1/oa_pdf/60/01/ehv043.PMC4416140.pdf
https://clinicaltrials.gov/ct2/show/ NCT01975389 (10 December 2014).,Non-OADS,/arxiv_data1/oa_pdf/60/01/ehv043.PMC4416140.pdf
http://clinicaltrials.gov/ show/NCT01687998 (10 December 2014).,Non-OADS,/arxiv_data1/oa_pdf/60/01/ehv043.PMC4416140.pdf
"2: 223-226, April 2015   http://dx.doi.org/ 10.3347/kjp.2015.53.2.223 ▣CASE REPORT  •Received 7 January 2015, revised 24 February 2015, accepted 25 February 2015.",Non-OADS,/arxiv_data1/oa_pdf/06/e4/kjp-53-2-223.PMC4416364.pdf
"*Corresponding author (dwryang@chonnam.ac.kr) © 2015, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Strongyloidiasis in a Diabetic Patient Accompanied by  Gastrointestinal Stromal Tumor: Cause of Eosinophilia  Unresponsive to Steroid Therapy Eun Jeong Won1, Jin Jeon2, Young-Il Koh2, Dong Wook Ryang1,* 1Department of Laboratory Medicine, Chonnam National University Hospital, Gwangju 501-757, Korea; 2Department of Allergy, Asthma and Clinical  Immunology, Chonnam National University Medical School, Gwangju 501-757, Korea Abstract:  We report here a case of strongyloidiasis in a 72-year-old diabetic patient (woman) accompanied by gastroin - testinal stromal tumor receiving imatinib therapy, first diagnosed as hypereosinophilic syndrome and treated with steroids  for uncontrolled eosinophilia.",Non-OADS,/arxiv_data1/oa_pdf/06/e4/kjp-53-2-223.PMC4416364.pdf
"2: 155-162, April 2015   http://dx.doi.org/ 10.3347/kjp.2015.53.2.155 ▣ORIGINAL ARTICLE  •Received 21 July 2014, revised 29 January 2015, accepted 29 January 2015.",Non-OADS,/arxiv_data1/oa_pdf/c9/f0/kjp-53-2-155.PMC4416365.pdf
"*Corresponding author (lixiangrui@njau.edu.cn) © 2015, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Pathogenicity of Five Strains of Toxoplasma gondii  from  Different Animals to Chickens  Shuai Wang†, Guang-Wei Zhao†, Wang Wang, Zhen-Chao Zhang, Bo Shen, I.",Non-OADS,/arxiv_data1/oa_pdf/c9/f0/kjp-53-2-155.PMC4416365.pdf
"2: 233-236, April 2015   http://dx.doi.org/ 10.3347/kjp.2015.53.2.233 ▣ BRIEF COMMUNICATION •Received 19 August 2014, revised 25 December 2014, accepted 21 January 2015.",Non-OADS,/arxiv_data1/oa_pdf/b0/52/kjp-53-2-233.PMC4416366.pdf
"*Corresponding author (bbbenji@naver.com) © 2015, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Seroprevalence of Trichinella  sp.",Non-OADS,/arxiv_data1/oa_pdf/b0/52/kjp-53-2-233.PMC4416366.pdf
"2: 169-175, April 2015   http://dx.doi.org/ 10.3347/kjp.2015.53.2.169 ▣ ORIGINAL ARTICLE  •Received 23 September 2014, revised 2 January 2015, accepted 25 February  2015.",Non-OADS,/arxiv_data1/oa_pdf/df/56/kjp-53-2-169.PMC4416367.pdf
"*Corresponding author (tongsookim@inha.ac.kr; youngjoos@khu.ac.kr) © 2015, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Relationship between Antibody-Positive Rate against  Plasmodium vivax  Circumsporozoite Protein and  Incidence of Malaria Hyeong-Woo Lee1,†, Yoon-Joong Kang2,†, Shin-Hyeong Cho3, Byoung-Kuk Na4, Jhang Ho Pak5, Ho-Woo Nam6,  Yun-Kyu Park7, Youngjoo Sohn8,*, Tong-Soo Kim7,* 1Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, FL 32610, USA; 2Department of  Biomedical Science, Jungwon University, Goesan, Chungbuk 367-805, Korea; 3Division of Malaria and Parasitic Diseases, National Institute of  Health, Korea Centers for Disease Control and Prevention, Osong 363-951, Korea; 4Department of Parasitology and Tropical Medicine and Institute  of Health Sciences, Gyeongsang National University School of Medicine, Jinju 660-751, Korea; 5Asan Institute for Life Sciences, University of Ulsan  College of Medicine Asan Medical Center, Seoul 138-736, Korea; 6Department of Parasitology, College of Medicine, Catholic University of Korea,  Seoul 137-701, Korea; 7Department of Parasitology and Tropical Medicine and Inha Research Institute for Medical Sciences, Inha University School  of Medicine, Incheon 400-712, Korea; 8Department of Anatomy, College of Korean Medicine, Institute of Korean Medicine, Kyung Hee University,  Seoul 130-701, Korea Abstract:  The relationship between anti- Plasmodium vivax  circumsporozoite protein (CSP) antibody levels and the preva - lence of malaria in epidemic areas of South Korea was evaluated.",Non-OADS,/arxiv_data1/oa_pdf/df/56/kjp-53-2-169.PMC4416367.pdf
"2: 237-242, April 2015   http://dx.doi.org/ 10.3347/kjp.2015.53.2.237 ▣BRIEF COMMUNICATION •Received 11 December 2014, revised 25 February 2015, accepted 3 March 2015.",Non-OADS,/arxiv_data1/oa_pdf/51/b1/kjp-53-2-237.PMC4416368.pdf
"*Corresponding author (cuteminjae@gmail.com) © 2015, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Ancient Mitochondrial DNA Analyses of Ascaris  Eggs  Discovered in Coprolites from Joseon Tomb Chang Seok Oh1, Min Seo2, Jong Ha Hong1, Jong-Yil Chai3, Seung Whan Oh4, Jun Bum Park5, Dong Hoon Shin1,* 1Bioanthropology and Paleopathology Lab, Institute of Forensic Science, Seoul National University College of Medicine, Seoul 110-799, Korea;  2Department of Parasitology and Research Center for Mummy, Dankook University, Cheonan 330-715, Korea; 3Department of Parasitology and  Tropical Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea; 4Hangang Institute of Cultural Heritage, Seoul 143-904,  Korea; 5Sangmyung University, Seoul 110-743, Korea Abstract:  Analysis of ancient DNA (aDNA) extracted from Ascaris  is very important for understanding the phylogenetic  lineage of the parasite species.",Non-OADS,/arxiv_data1/oa_pdf/51/b1/kjp-53-2-237.PMC4416368.pdf
"2: 177-187, April 2015   http://dx.doi.org/ 10.3347/kjp.2015.53.2.177 ▣ ORIGINAL ARTICLE  •Received 30 November 2014, revised 9 January 2015, accepted 25 February 2015.",Non-OADS,/arxiv_data1/oa_pdf/7e/12/kjp-53-2-177.PMC4416369.pdf
"*Corresponding author (Sittiporn.P@Chula.ac.th) © 2015, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Allelic Diversity and Geographical Distribution of the Gene  Encoding Plasmodium falciparum  Merozoite Surface  Protein-3 in Thailand Vorthon Sawaswong1, Phumin Simpalipan1, Napaporn Siripoon2, Pongchai Harnyuttanakorn1,   Sittiporn Pattaradilokrat1,* 1Department of Biology, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand; 2College of Public Health Sciences, Chulalongkorn  University, Bangkok 10330, Thailand Abstract:  Merozoite surface proteins (MSPs) of malaria parasites play critical roles during the erythrocyte invasion and so  are potential candidates for malaria vaccine development.",Non-OADS,/arxiv_data1/oa_pdf/7e/12/kjp-53-2-177.PMC4416369.pdf
"2: 209-213, April 2015   http://dx.doi.org/ 10.3347/kjp.2015.53.2.209 ▣ORIGINAL ARTICLE  •Received 20 February 2015, revised 4 March 2015, accepted 5 March 2015.",Non-OADS,/arxiv_data1/oa_pdf/14/4e/kjp-53-2-209.PMC4416370.pdf
"*Corresponding author (wmsohn@gnu.ac.kr) © 2015, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Zoonotic Intestinal Trematodes in Stray Cats ( Felis catus )  from Riverside Areas of the Republic of Korea Sung-Shik Shin1, Dae-Sung Oh1, Kyu-Sung Ahn1, Shin-Hyeong Cho2, Won-Ja Lee2, Byoung-Kuk Na3,   Woon-Mok Sohn3,* 1Department of Parasitology, College of Veterinary Medicine, Chonnam National University, Gwangju 500-757, Korea; 2Division of Malaria and  Parasitic Diseases, National Institute of Health, Centers for Disease Control and Prevention, Osong 363-951, Korea; 3Department of Parasitology  and Tropical Medicine, and Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju 660-751, Korea Abstract:  The present study was performed to survey the infection status of zoonotic intestinal trematode (ZIT) in stray  cats from 5 major riverside areas in the Republic of Korea.",Non-OADS,/arxiv_data1/oa_pdf/14/4e/kjp-53-2-209.PMC4416370.pdf
"2: 247-247, April 2015   http://dx.doi.org/ 10.3347/kjp.2015.53.2.247 ▣LETTER TO THE EDITOR •Received 20 November 2014, accepted 26 February 2015.",Non-OADS,/arxiv_data1/oa_pdf/b4/db/kjp-53-2-247.PMC4416371.pdf
"*Corresponding author (rmartinezgiron@hotmail.com) © 2015, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.On Cilia, Flagella, and Pulmonary Pseudoprotozoa Rafael Martínez-Girón1,*, Hugo Cornelis van Woerden2 1Protozoal Respiratory Patholgy Research Unit, INCLÍNICA Foundation, Calvo Sotelo, Oviedo, Spain; 2Institute of Primary Care and Public Health,  School of Medicine, Cardiff University, U.K.",Non-OADS,/arxiv_data1/oa_pdf/b4/db/kjp-53-2-247.PMC4416371.pdf
"2: 201-207, April 2015   http://dx.doi.org/ 10.3347/kjp.2015.53.2.201 ▣ORIGINAL ARTICLE •Received 11 April 2014, revised 20 February 2015, accepted 5 March 2015.",Non-OADS,/arxiv_data1/oa_pdf/ad/0e/kjp-53-2-201.PMC4416372.pdf
"*Corresponding author (wchalobol@gmail.com) © 2015, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Developmental and Phylogenetic Characteristics of  Stellantchasmus falcatus  (Trematoda: Heterophyidae)  from Thailand Pralongyut Sripalwit1,2, Chalobol Wongsawad1,*, Thapana Chontananarth3, Somboon Anuntalabhochai4,   Pheravut Wongsawad1, Jong-Yil Chai5 1Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand; 2Biology Program, School of Science, University of  Phayao, Muang, Phayao 56000, Thailand; 3Department of Biology, Faculty of Science, Srinakharinwirot University, Bangkok 10110, Thailand;  4Biotechnology Unit, Biology Department, Science Faculty, Phayao University, Phayao 56000, Thailand; 5Department of Parasitology and Tropical  Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea Abstract:  This study aimed to investigate the infection status, worm development, and phylogenetic characteristics of  the intestinal trematode, Stellantchasmus falcatus .",Non-OADS,/arxiv_data1/oa_pdf/ad/0e/kjp-53-2-201.PMC4416372.pdf
"2: 215-218, April 2015   http://dx.doi.org/ 10.3347/kjp.2015.53.2.215 ▣ CASE REPORT  •Received 2 October 2014, revised 31 December 2014, accepted 1 January 2015.",Non-OADS,/arxiv_data1/oa_pdf/72/50/kjp-53-2-215.PMC4416373.pdf
"*Corresponding author (jhkim7227@gmail.com) © 2015, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Spontaneous Splenic Rupture in a Vivax Malaria Case  Treated with Transcatheter Coil Embolization of the  Splenic Artery Na Hee Kim, Kyung Hee Lee, Yong Sun Jeon, Soon Gu Cho, Jun Ho Kim * Department of Radiology, Inha University Hospital, Inha University School of Medicine, Incheon, Korea Abstract:  An enlarged spleen is considered one of the most common signs of malaria, and splenic rupture rarely occurs  as an important life-threatening complication.",Non-OADS,/arxiv_data1/oa_pdf/72/50/kjp-53-2-215.PMC4416373.pdf
"2: 219-222, April 2015   http://dx.doi.org/ 10.3347/kjp.2015.53.2.219 ▣CASE REPORT •Received 18 September 2014, revised 10 March 2015, accepted 14 March 2015.",Non-OADS,/arxiv_data1/oa_pdf/6e/3d/kjp-53-2-219.PMC4416374.pdf
"*Corresponding author (amoxj@yonsei.ac.kr) © 2015, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.An Outbreak of Trichinellosis by Consumption of Raw  Soft-Shelled Turtle Meat in Korea Joon Taek Jeong1, Min Seo2, Sung-Tae Hong3, Young Keun Kim1,* 1Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju 220-701, Korea; 2Department of Parasitology, Dankook  University College of Medicine, Cheonan 330-714, Korea; 3Department of Parasitology and Tropical Medicine, Seoul National University College of  Medicine, Seoul 110-799, Korea Abstract:  Trichinellosis transmission to humans via the consumption of reptile meat is rare worldwide.",Non-OADS,/arxiv_data1/oa_pdf/6e/3d/kjp-53-2-219.PMC4416374.pdf
"2: 189-196, April 2015   http://dx.doi.org/ 10.3347/kjp.2015.53.2.189 ▣ORIGINAL ARTICLE  •Received 8 July 2014, revised 10 November 2014, accepted 10 January 2015.",Non-OADS,/arxiv_data1/oa_pdf/2e/87/kjp-53-2-189.PMC4416375.pdf
"*Corresponding author (lukief@ub.ac.id) © 2015, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Low Fetal Weight is Directly Caused by Sequestration of  Parasites and Indirectly by IL-17 and IL-10 Imbalance in  the Placenta of Pregnant Mice with Malaria Loeki Enggar Fitri1,*, Teguh Wahju Sardjono1, Zainabur Rahmah2, Budi Siswanto3, Kusworini Handono4,   Yoes Prijatna Dachlan5 1Department of Parasitology, Faculty of Medicine, Universitas Brawijaya, Jalan Veteran Malang, East Java 65145, Indonesia; 2Reproductive Biology  Doctoral Program in Medical Science, Faculty of Medicine, Universitas Brawijaya, Jalan Veteran Malang, East Java 65145, Indonesia; 3Department  of Obstetrics and Gynecology, dr. Saiful Anwar Hospital/Faculty of Medicine, Universitas Brawijaya, Jalan Jaksa Agung Suprapto No.2, Malang, East  Java 65122, Indonesia; 4Department Clinical Pathology, Faculty of Medicine, Universitas Brawijaya, Jalan Veteran Malang, East Java 65145,  Indonesia; 5Department of Parasitology, Faculty of Medicine, Universitas Airlangga, Jalan Mayjen Prof. Dr. Moestopo No.",Non-OADS,/arxiv_data1/oa_pdf/2e/87/kjp-53-2-189.PMC4416375.pdf
"2: 227-232, April 2015   http://dx.doi.org/ 10.3347/kjp.2015.53.2.227 ▣BRIEF COMMUNICATION  • Received 24 November 2014, revised 27 February 2015, accepted 25 January  2015.",Non-OADS,/arxiv_data1/oa_pdf/1c/d3/kjp-53-2-227.PMC4416376.pdf
"*Corresponding author (kesaratmu@yahoo.com) © 2015, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Genetic Polymorphisms in Plasmodium vivax   Dihydrofolate Reductase and Dihydropteroate Synthase in  Isolates from the Philippines, Bangladesh, and Nepal Pimwan Thongdee1,2, Jiraporn Kuesap2, Kanchana Rungsihirunrat3, Shyam Prakash Dumre4, Effie Espino5,   Harald Noedl6, Kesara Na-Bangchang1,7,* 1Graduate Program in Bioclinical Sciences, Chulabhorn International College of Medicine, Thammasat University, Pathumthani, Thailand; 2Graduate  Program in Biomedical Sciences, Faculty of Allied Health Sciences, Thammasat University, Pathumthani, Thailand; 3Malaria Research Program,  College of Public Health Sciences, Chulalongkorn University, Bangkok, Thailand; 4World Health Organization-Nepal/Epidemiology and Disease  Control Division (EDCD), DoHS, Teku Kathmandu, Nepal; 5Research Institute for Tropical Medicine (RITM), Department of Health (DOH), Muntinlupa,  Metro Manila, The Philippines; 6Institute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Vienna, Austria; 7Center of  Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma, Thammasat University, Pathumthani, Thailand Abstract:  Genetic polymorphisms of pvdhfr  and pvdhps  genes of Plasmodium vivax  were investigated in 83 blood sam - ples collected from patients in the Philippines, Bangladesh, and Nepal.",Non-OADS,/arxiv_data1/oa_pdf/1c/d3/kjp-53-2-227.PMC4416376.pdf
Available  from: http://www.who.int/malaria/publications/.../profile_phl_ en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1c/d3/kjp-53-2-227.PMC4416376.pdf
"2: 163-167, April 2015   http://dx.doi.org/ 10.3347/kjp.2015.53.2.163 ▣ORIGINAL ARTICLE  • Received 26 November 2014, revised 19 January 2015, accepted 25 January  2015.",Non-OADS,/arxiv_data1/oa_pdf/0b/61/kjp-53-2-163.PMC4416377.pdf
"*Corresponding author (talafha@just.edu.jo) © 2015, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Seroprevalence and Potential Risk Factors Associated  with Neospora  spp.",Non-OADS,/arxiv_data1/oa_pdf/0b/61/kjp-53-2-163.PMC4416377.pdf
"2: 197-200, April 2015   http://dx.doi.org/ 10.3347/kjp.2015.53.2.197 ▣ORIGINAL ARTICLE  •Received 25 November 2014, revised 21 January 2015, accepted 12 March 2015.",Non-OADS,/arxiv_data1/oa_pdf/01/aa/kjp-53-2-197.PMC4416378.pdf
"*Corresponding author (pdorny@itg.be) © 2015, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Prevalence and Associated Risk Factors of Toxocara  vitulorum  Infections in Buffalo and Cattle Calves in Three  Provinces of Central Cambodia Pierre Dorny1,2,*, Brecht Devleesschauwer1, Valérie Stoliaroff1, Meas Sothy3, Rortana Chea3, Bunthon Chea3,   Hor Sourloing3, Sum Samuth3, Seth Kong3, Koemseang Nguong3, San Sorn4, Davun Holl4, Jozef Vercruysse1 1Department of Virology, Parasitology and Immunology, Faculty of Veterinary Medicine, Ghent University, Belgium; 2Department of Biomedical  Sciences, Institute of Tropical Medicine, Antwerp, Belgium; 3Division of Research and Extension, Royal University of Agriculture, Phnom Penh,  Cambodia; 4National Veterinary Research Institute, Department of Animal Health and Production, Phnom Penh, Cambodia Abstract:  The prevalence and associated risk factors of Toxocara vitulorum  infection in buffalo and cattle calves was  studied in 3 provinces in central Cambodia.",Non-OADS,/arxiv_data1/oa_pdf/01/aa/kjp-53-2-197.PMC4416378.pdf
2014. http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/01/aa/kjp-53-2-197.PMC4416378.pdf
2014. http://CRAN.R-project.org/package=lme4.,Non-OADS,/arxiv_data1/oa_pdf/01/aa/kjp-53-2-197.PMC4416378.pdf
"2: 147-154, April 2015   http://dx.doi.org/ 10.3347/kjp.2015.53.2.147 ▣ORIGINAL ARTICLE  •Received 13 December 2014, revised 17 February 2015, accepted 25 February 2015.",Non-OADS,/arxiv_data1/oa_pdf/cf/d5/kjp-53-2-147.PMC4416379.pdf
"*Corresponding author (yousryhawash@gmail.com) © 2015, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Internal Amplification Control for a Cryptosporidium   Diagnostic PCR: Construction and Clinical Evaluation Yousry Hawash1,2,*, M. M. Ghonaim2,3, Ayman S. Al-Hazmi2 1Department of Medical Parasitology, National Liver Institute, Menoufia University, Menoufia, Egypt; 2Department of Medical Laboratory Science,  College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia; 3Medical Microbiology and Immunology Department, Faculty of Medicine,  Menoufia University, Menoufia, Egypt Abstract:  Various constituents in clinical specimens, particularly feces, can inhibit the PCR assay and lead to false-nega - tive results.",Non-OADS,/arxiv_data1/oa_pdf/cf/d5/kjp-53-2-147.PMC4416379.pdf
"2: 243-246, April 2015   http://dx.doi.org/ 10.3347/kjp.2015.53.2.243 ▣ BRIEF COMMUNICATION •Received 30 September 2014, revised 10 March 2015, 14 March 2015.",Non-OADS,/arxiv_data1/oa_pdf/1a/ea/kjp-53-2-243.PMC4416380.pdf
"*Corresponding author (bbbenji@naver.com) © 2015, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Infection Status of Endoparasites in Foreigner Workers  Living in Cheonan City, Chungnam Province, Korea Suk-Yul Jung1, Mi-Jung Ahn1, Joo-Yeon Oh1, Hae-Seon Nam2, Sung-Tae Hong3, Yeon-Han Yun4, Min Seo5,* 1Department of Biomedical Laboratory Science, Namseoul University, Cheonan 331-707, Korea; 2Department of Clinical Parasitology, School of  Medicine, Soonchunhyang University, Cheonan 330-090, Korea; 3Department of Parasitology and Tropical Medicine, Seoul National University  College of Medicine, Seoul 110-799, Korea; 4Cheonansi Multicultural Support Center, Cheonan 331-979, Korea; 5Department of Parasitology and  Research Center for Mummy, College of Medicine, Dankook University, Cheonan 330-714, Korea Abstract:  At present, more than 500,000 foreigner workers, most of them from Asian countries with high parasitic infec - tion rates, are working in Korea.",Non-OADS,/arxiv_data1/oa_pdf/1a/ea/kjp-53-2-243.PMC4416380.pdf
2013; 1 1. http://www.keis.or.kr.,Non-OADS,/arxiv_data1/oa_pdf/1a/ea/kjp-53-2-243.PMC4416380.pdf
"Most approaches toextinction-based therapy have focused on traditional exterocep-tive cues (e.g., environmental cues such as drug paraphernalia),whereas evidence suggests that interoceptive cues exerted by thedrug itself during a drug administration can play dominant roles © Karl J Kaiyala, Stephen C Woods, and Douglas S Ramsay *Correspondence to: Karl J Kaiyala; Email: kkaiyala@uw.eduSubmitted: 03/31/2014; Revised: 06/19/2014; Accepted: 06/26/2014 http://dx.doi.org/10.4161/23328940.2014.944811 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License http://creativecommons.or g/licenses/ by-nc/3.0/, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Psychopharmacol- ogy (Berl) 2013; 229:387-413; PMID:23963530; http://dx.doi.org/10.1007/s00213-013-3224-4 2.,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Exp Clin Psychophar- macol 2000; 8:276-93; PMID:10975617; http://dx.doi.org/10.1037/1064-1297.8.3.2763.,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Exp Clin Psychopharmacol 2002; 10:162-83; PMID: 12233979; http://dx.doi.org/10.1037/1064- 1297.10.3.162 4.,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Psychol Rev 1997; 104:170-93;PMID:9009884; http://dx.doi.org/10.1037/0033- 295X.104.1.170 6 .,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Sci- ence 1979; 206:1109-10; http://dx.doi.org/10.1126/science.493999 274 Volume 1 Issue 3 Temperature,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
J Comp Physiol Psychol 1980; 94:962-9; PMID:7430477; http://dx.doi.org/10.1037/h0077824 9.,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Integr Physiol Behav Sci 2002; 37:165-77; PMID:12435209; http://dx.doi.org/ 10.1007/BF02734179 10.,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Addiction 2002; 97:155-67; PMID: 11860387; http://dx.doi.org/10.1046/j.1360-0443.2002.00014.x 13.,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Psychopharmacology (Berl) 1984; 83:159-62; PMID:6431466; http://dx.doi.org/10.1007/BF00429726 14.,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
J Exp Psychol Anim Behav Process 1999; 25:491-504; PMID:10531660; http://dx.doi.org/ 10.1037/0097-7403.25.4.491 15.,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Exp Clin Psychopharmacol 2004a; 12:3-11; http://dx.doi.org/10.1037/1064- 1297.12.1.3 16.,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
J Exp Psychol Anim Behav Process2002; 28:309-20; PMID:12136706; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Psychopharmacology (Berl) 2007a; 191:243-51; http://dx.doi.org/10.1007/s00213-006- 0657-z 1 9 .,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Psychopha rmacology (Berl) 2007b;191:233-42; http://dx.doi.org/10.1007/s00213- 006-0655-1 20.,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Am J Physiol Regul Integr Comp Physiol 2005; 288:R692-701; PMID: 15563578; http://dx.doi.org/10.1152/ ajpregu.00412.2004 21.,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
J Therm Biol 2012; 37:30-40; PMID:22247586; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Psychol Rev 2014; 121:225-47; PMID:24730599; http://dx.doi.org/10.1037/a0035942 25.,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
BMC Med Res Methodol 2002; 2:8; PMID:12069695; http://dx.doi.org/10.1186/ 1471-2288-2-8 27.,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Epidemiology 1990; 1:43-6; PMID:2081237; http://dx.doi.org/10.1097/ 00001648-199001000-00010 29.,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Learn Mem 2004; 11:485-94; PMID:15466298; http://dx.doi.org/10.1101/lm.78804 31.,OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
"Quirk GJ, Mueller D. Neural mechanisms of extinc- tion learning and retrieval.Neuropsychopharmacology 2008; 33:56-72; PMID:17882236; http://dx.doi.org/10.1038/sj.",OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Nat Neurosci 2005;8:1471-80; PMID:16251990; http://dx.doi.org/ 10.1038/nn1581 35.,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Pharmacol Ther 1983; 23:365-91; PMID:6371843; http://dx.doi.org/10.1016/0163- 7258(83)90019-0 36.,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Anim Learn Behav 1995;23:9-16; http://dx.doi.org/10.3758/BF03198010 38.,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Behav Neurosci 1991; 105:599-602; PMID:1930727; http://dx.doi.org/10.1037/0735-7044.105.4.599 39.,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
N Engl J Med 2009; 361:302-3; PMID:19605837; http://dx.doi.org/10.1056/NEJMcibr0902052 42.,OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
Learn Motiv 1999; 30:1-14;http://dx.doi.org/10.1006/lmot.1998.1022 43.,Non-OADS,/arxiv_data1/oa_pdf/73/2e/ktmp-01-03-944811.PMC4416485.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 1-2 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.937  Journal of Microbiology & Biology Education   1 Volume 16, Number 1 ©2015 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/ef/e7/jmbe-16-1.PMC4416495.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/ef/e7/jmbe-16-1.PMC4416495.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 100-104 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.915 Inside ASM Education Journal of Microbiology & Biology Education  Volume 16, Number 1 100©2015 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/d4/9f/jmbe-16-100.PMC4416496.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/d4/9f/jmbe-16-100.PMC4416496.pdf
http://visionandchange.org.,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/jmbe-16-100.PMC4416496.pdf
http://www.nap.edu/catalog/12764/a-new-biology- for-the-21st-century.,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/jmbe-16-100.PMC4416496.pdf
http://www.whitehouse.gov/sites/default/files/microsites/ ostp/pcast-engage-to-excel-final_2-25-12.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/jmbe-16-100.PMC4416496.pdf
http://www.nap.edu/catalog/13362/discipline- based-education-research-understanding-and-improving-learning-in-undergraduate  18.,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/jmbe-16-100.PMC4416496.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 105-122 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.932 Journal of Microbiology & Biology Education   105 Volume 16, Number 1ASMCUE Abstracts ©2015 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/db/bf/jmbe-16-105.PMC4416497.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/db/bf/jmbe-16-105.PMC4416497.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 13-20 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.828 Journal of Microbiology & Biology Education   13 Volume 16, Number 1 ©2015 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/17/3e/jmbe-16-13.PMC4416498.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/17/3e/jmbe-16-13.PMC4416498.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 21-28 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.846 Journal of Microbiology & Biology Education   21 Volume 16, Number 1 ©2015 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/9b/1f/jmbe-16-21.PMC4416499.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/9b/1f/jmbe-16-21.PMC4416499.pdf
"Student perceptions of learning gains were assessed using a modified version of the Student Assessment of Learning Gains (SALG) course evaluation tool (http://www.salgsite.org), distributed in hardcopy and completed anonymously during the last week of the course.",Non-OADS,/arxiv_data1/oa_pdf/9b/1f/jmbe-16-21.PMC4416499.pdf
Case study repositories  are also maintained by BioQUEST Curriculum Consortium (http://www.bioquest.org/icbl/cases.php ) and the Science  Case Network ( http://sciencecasenet.org ); both are avail - able for use by instructors from outside institutions.,Non-OADS,/arxiv_data1/oa_pdf/9b/1f/jmbe-16-21.PMC4416499.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 29-33 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.818 Journal of Microbiology & Biology Education   29 Volume 16, Number 1 ©2015 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/17/31/jmbe-16-29.PMC4416500.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/17/31/jmbe-16-29.PMC4416500.pdf
http://www.istl.org/10-fall/refereed2.html.,Non-OADS,/arxiv_data1/oa_pdf/17/31/jmbe-16-29.PMC4416500.pdf
http://www.istl.org/09-summer/refereed1.html   29.,Non-OADS,/arxiv_data1/oa_pdf/17/31/jmbe-16-29.PMC4416500.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 3-4 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.801 Journal of Microbiology & Biology Education   3 Volume 16, Number 1 ©2015 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/6f/a3/jmbe-16-3.PMC4416501.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/6f/a3/jmbe-16-3.PMC4416501.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 34-40 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.780 Journal of Microbiology & Biology Education  Volume 16, Number 1 34 *Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/b0/88/jmbe-16-34.PMC4416502.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/b0/88/jmbe-16-34.PMC4416502.pdf
"The metagenomic modules we developed make use  of the Minnesota Mississippi Metagenomics Project (M3P) (http://www.mississippi-metagenome-project.umn.edu/), which is an ongoing project that examines the microbial pop - ulations in different regions of the Mississippi River extending from its origin at Lake Itasca to its confluence with the Zumbro River.",Non-OADS,/arxiv_data1/oa_pdf/b0/88/jmbe-16-34.PMC4416502.pdf
"Table   hypothesis PCR = polymerase chain reaction; IMG = Integrated Microbial Genomes website, https://img.jgi.doe.gov/cgi-bin/w/main.cgi.",OADS,/arxiv_data1/oa_pdf/b0/88/jmbe-16-34.PMC4416502.pdf
http://omicsonline.org/using- metagenomics-to-teach-biodiversity-2157-7625.1000e117.,Non-OADS,/arxiv_data1/oa_pdf/b0/88/jmbe-16-34.PMC4416502.pdf
http://www.ploscompbiol.org/article/ info%3Adoi%2F10.1371%2Fjournal.pcbi.1000667 .,Non-OADS,/arxiv_data1/oa_pdf/b0/88/jmbe-16-34.PMC4416502.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 41-49 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.809 Journal of Microbiology & Biology Education   41 Volume 16, Number 1 ©2015 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/96/2f/jmbe-16-41.PMC4416503.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/96/2f/jmbe-16-41.PMC4416503.pdf
http://serendip.brynmawr.edu/ exchange/bioactivities .,Non-OADS,/arxiv_data1/oa_pdf/96/2f/jmbe-16-41.PMC4416503.pdf
http://serendip.brynmawr.edu/exchange/bioactivities.,Non-OADS,/arxiv_data1/oa_pdf/96/2f/jmbe-16-41.PMC4416503.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 5 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.910 Journal of Microbiology & Biology Education   5 Volume 16, Number 1 ©2015 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/2e/8e/jmbe-16-5.PMC4416504.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/2e/8e/jmbe-16-5.PMC4416504.pdf
"So, he paused, faced the class and asked, “Is there anyone who cannot hear what I am saying?” A young man at the very back of the room stood up and shouted back, “Yeah, I haven’t been able to hear a single thing you’ve said.” At that point, a young woman in the front row stood up, turned around and replied to her classmate, “I’ll trade places with you!” Sincerely, Elise N. Griswold  Ypsilanti, MI http://elisegriswold.blogspot.com Daniel J. Klionsky Life Sciences Institute University of Michigan Ann Arbor, MI klionsky@umich.edu REFERENCES  1.",Non-OADS,/arxiv_data1/oa_pdf/2e/8e/jmbe-16-5.PMC4416504.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 50-60 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.816 Journal of Microbiology & Biology Education  Volume 16, Number 1 50 *Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/f5/b4/jmbe-16-50.PMC4416505.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/f5/b4/jmbe-16-50.PMC4416505.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 6-12 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.756 Journal of Microbiology & Biology Education  Volume 16, Number 1 6 *Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/ea/39/jmbe-16-6.PMC4416506.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/ea/39/jmbe-16-6.PMC4416506.pdf
"The description of two of the demonstrations is published in the Tips and Tools section of this issue, and a complete description for the other three can be found at: https://sites.google.com/site/tamarif26 .",Non-OADS,/arxiv_data1/oa_pdf/ea/39/jmbe-16-6.PMC4416506.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 61-68 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.884 Journal of Microbiology & Biology Education   61 Volume 16, Number 1 ©2015 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/f1/83/jmbe-16-61.PMC4416507.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/f1/83/jmbe-16-61.PMC4416507.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 69-71 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.787 Journal of Microbiology & Biology Education   69 Volume 16, Number 1 ©2015 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/94/b1/jmbe-16-69.PMC4416508.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/94/b1/jmbe-16-69.PMC4416508.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 72-74 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.813 Journal of Microbiology & Biology Education  Volume 16, Number 1 72 *Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/33/08/jmbe-16-72.PMC4416509.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/33/08/jmbe-16-72.PMC4416509.pdf
http://www.uab.,Non-OADS,/arxiv_data1/oa_pdf/33/08/jmbe-16-72.PMC4416509.pdf
http://www.biosci-intl.,OADS,/arxiv_data1/oa_pdf/33/08/jmbe-16-72.PMC4416509.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 75-76 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.817 Journal of Microbiology & Biology Education   75 Volume 16, Number 1 ©2015 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/d4/1d/jmbe-16-75.PMC4416510.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/d4/1d/jmbe-16-75.PMC4416510.pdf
"PROCEDURE Creating BEDC game decks The Biology Experimental Design Challenge activity  was modeled on the Television Food Network© program Chopped , which requires contestants to create several dishes  based on a series of mystery ingredients presented to them at the beginning of each round ( http://www.foodnetwork.",Non-OADS,/arxiv_data1/oa_pdf/d4/1d/jmbe-16-75.PMC4416510.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 77-78 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.830 Journal of Microbiology & Biology Education   77 Volume 16, Number 1 ©2015 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/31/f3/jmbe-16-77.PMC4416511.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/31/f3/jmbe-16-77.PMC4416511.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 79-81 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.840 Journal of Microbiology & Biology Education   79 Volume 16, Number 1 ©2015 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/4c/2a/jmbe-16-79.PMC4416512.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/4c/2a/jmbe-16-79.PMC4416512.pdf
"We conducted an IRB-approved study showing that student performance is enhanced using these and three additional demonstrations, the description of which can be found at: https://sites.google.com/site/tamarif26 .",Non-OADS,/arxiv_data1/oa_pdf/4c/2a/jmbe-16-79.PMC4416512.pdf
To evaluate the effectiveness of these demonstrations  (and three additional ones described at: https://sites.google.,Non-OADS,/arxiv_data1/oa_pdf/4c/2a/jmbe-16-79.PMC4416512.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 82-84 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.847 Journal of Microbiology & Biology Education  Volume 16, Number 1 82 Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/37/81/jmbe-16-82.PMC4416513.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/37/81/jmbe-16-82.PMC4416513.pdf
BLASTN analysis (1)was conducted on sequences following comparison in Gen - Bank ( http://www.ncbi.nlm.nih.gov/GenBank/index/html )  to determine the most likely identification of each isolate.,OADS,/arxiv_data1/oa_pdf/37/81/jmbe-16-82.PMC4416513.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 85-86 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.889 Journal of Microbiology & Biology Education   85 Volume 16, Number 1 ©2015 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/77/13/jmbe-16-85.PMC4416514.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/77/13/jmbe-16-85.PMC4416514.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 87-89 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.890 Journal of Microbiology & Biology Education   87 Volume 16, Number 1 ©2015 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/01/f3/jmbe-16-87.PMC4416515.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/01/f3/jmbe-16-87.PMC4416515.pdf
PROCEDURE Use of Socrative The beta version of Socrative (http://beta.Socrative.,Non-OADS,/arxiv_data1/oa_pdf/01/f3/jmbe-16-87.PMC4416515.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2015, p. 90-92 DOI: http://dx.doi.org/10.1128/jmbe.v16i1.892 Journal of Microbiology & Biology Education  Volume 16, Number 1 90*Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/0e/c2/jmbe-16-90.PMC4416516.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/0e/c2/jmbe-16-90.PMC4416516.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f6/b4/bctt-7-099.PMC4416637.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2015:7 99–109Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  99Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S5900 6Role of the wASP and wAve family proteins   in breast cancer invasion and metastasis Bethan Frugtniet wen G Jiang Tracey A Martin Cardiff-China Medical Research  Collaborative, Cardiff University  School of Medicine, Cardiff University,  Cardiff, UK Correspondence: Tracey A Martin   Cardiff-China Medical Research  Collaborative, Cardiff University School  of Medicine, Cardiff University, Henry  wellcome Building, Heath Park, Cardiff  CF14  4XN, UK   Tel +44 29 2068 7209  email martinta1@cf.ac.u kAbstract:  The Wiskott–Aldrich syndrome protein (WASP) and WASP family verprolin- homologous protein (WA VE) family are a group of molecules that form a key link between  GTPases and the actin cytoskeleton.",Non-OADS,/arxiv_data1/oa_pdf/f6/b4/bctt-7-099.PMC4416637.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/f6/b4/bctt-7-099.PMC4416637.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f7/f8/cia-10-795.PMC4416638.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Interventions in Aging 2015:10 795–801Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  795OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8089 5Physical exercise and functional fitness  in independently living vs institutionalized elderly  women: a comparison of 60- to 79-year-old  city dwellers hélio l Furtado1 nelson sousa2 roberto simão3 Fabio Dutra Pereira1 José Vilaça-Alves2 1Castelo Branco University, rio de  Janeiro, Brazil; 2research Center  for sport, health, and human  Development, University of Trás-os-   Montes and Alto Douro, Vila real,   Portugal; 3school of Physical education  and sports, rio de Janeiro Federal  University, rio de Janeiro, BrazilPurpose:  To compare functional fitness (FF) levels among independent-living (IL) and day  care (DC) elderly women of different age groups and to analyze changes in FF after 8 months  of participation in an exercise program intervention for the IL elderly women.",Non-OADS,/arxiv_data1/oa_pdf/f7/f8/cia-10-795.PMC4416638.pdf
"Previous studies  indicate that physically active older women have performance patterns of flexibility,  balance, and agility that are more similar to younger participants than to their older Correspondence: nelson sousa Parque Desportivo da UTAD, Apartado  1013, 5001-801 Vila real, Portugal Tel +351 9 3640 7801 Fax +351 2 5935 0756 email nelsons@utad.p t Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Furtado et al Running head recto: Physical exercise and functional fitness DOI: http://dx.doi.org/10.2147/CIA.S80895",Non-OADS,/arxiv_data1/oa_pdf/f7/f8/cia-10-795.PMC4416638.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/f7/f8/cia-10-795.PMC4416638.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/f7/f8/cia-10-795.PMC4416638.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/6f/ceor-7-227.PMC4416639.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 227–233ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  227ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S8406 5a potential gender bias in assessing quality of life –   a standard gamble experiment among university  students leath al Obaidi1 Jörg Mahlich2,3 1University of nottingham, school of  Economics, nottingham, UK; 2health  Economics, Janssen KK, T okyo, Japan;   3Düsseldorf institute for Competition  Economics (D iCE), University of  Düsseldorf, Düsseldorf, germany Correspondence: Jörg Mahlich   health Economics, Janssen Pharmaceutical  K.K., 5-2, nishi-kanda 3-chome,  Chiyoda-ku, T okyo 101-0065, Japan   Email jmahlich@its.jnj.co mBackground:  There are several methodologies that can be used for evaluating patients’ per - ception of their quality of life.",Non-OADS,/arxiv_data1/oa_pdf/09/6f/ceor-7-227.PMC4416639.pdf
"Available from:  http://www.sozialerhebung.at/Ergebniss e. Accessed March 29, 2015.",Non-OADS,/arxiv_data1/oa_pdf/09/6f/ceor-7-227.PMC4416639.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/09/6f/ceor-7-227.PMC4416639.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/6f/ceor-7-227.PMC4416639.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/1c/ccid-8-223.PMC4416640.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 223–229Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  223OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S7880 9TriCalm® hydrogel is significantly superior   to 2% diphenhydramine and  1% hydrocortisone   in reducing the peak intensity, duration, and   overall magnitude of cowhage-induced itch alexandru DP Papoiu1 hunza Chaudhry2 erin C hayes2 Yiong-huak Chan3 Kenneth D herbst4 1Independent contractor, san Diego,   Ca, Usa: 2Cosmederm Bioscience,   Inc., san Diego, C a, Usa;  3Biostatistics  Unit, Y ong loo lin school of Medicine,   national University of singapore,   singapore;  4Department of Medicine,   University of California, san Diego,   san Diego, C a, Usa Correspondence: alexandru DP Papoiu   8910 University Center lane, suite  420,   san Diego, Ca  92122, Usa   Tel +1 858 550 7070  Fax +1 858 550 0119  email alexandru.papoiu@gmail.co mBackground:  Itch is one of the most frequent skin complaints and its treatment is challenging.",Non-OADS,/arxiv_data1/oa_pdf/6f/1c/ccid-8-223.PMC4416640.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/6f/1c/ccid-8-223.PMC4416640.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/1c/ccid-8-223.PMC4416640.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/ca/main.PMC4417049.pdf
JAMDA journal homepage: www.jamda.com http://dx.doi.org/10.1016/j.jamda.2015.01.086 1525-8610/ /C2112015 AMDA eThe Society for Post-Acute and Long-Term Care Medicine.,Non-OADS,/arxiv_data1/oa_pdf/1f/ca/main.PMC4417049.pdf
Please refer to the Whitehall II data sharing policy at http://www.ucl.ac.uk/ whitehallII/data-sharing .,Non-OADS,/arxiv_data1/oa_pdf/1f/ca/main.PMC4417049.pdf
"For each item, the participants were required to takeinto account activity patterns over the past 4 weeks to give an indication of usual activity and provide the total number of hours spent in that activity per week (see question 82 of the health survey questionnaire online available at http://www.ucl.ac.uk/whitehallII/ pdf/S7_HSQ.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/1f/ca/main.PMC4417049.pdf
"In addition, we calculated the total number of hours per week in moderate-and- vigorous physical activity (MVPA) de ﬁned as activities with associ- ated MET /C213 (eg, cycling, weeding, swimming, mowing).27 Accelerometer-Assessed Physical Activity Participants with no contraindications (that is, allergies to plastic or metal, traveling abroad the following week) were asked to wear a triaxial accelerometer (GeneActiv; Activinsights Ltd, Kimbolton, Cambs, UK, http://www.geneactiv.org/ ) on their nondominant wrist for 9 consecutive (24-hour) days.",Non-OADS,/arxiv_data1/oa_pdf/1f/ca/main.PMC4417049.pdf
"Calibration error was estimated based on static periods in the data and corrected if necessary.31The Euclidean norm (magnitude) of the 3 raw signals minus 1 g, with negative numbers rounded to zero, was used to quantify the acceleration related to the movement registered and expressed in milligravity (mg, 1m g ¼0.00981 m.s/C02).32 Accelerometer data were processed in R ( cran.r-project.org/ ) using the GGIR package and executed on MOVEeCloud ( http://movelab.org/ research/moveecloud/ ), a computing facility for physical activity research.33Data extracted between the ﬁrst and last midnight were retained for the analysis leading to a maximum of 24-hour mea- surements for 8 days.",OADS,/arxiv_data1/oa_pdf/1f/ca/main.PMC4417049.pdf
Available at: http://www.hscic.gov.uk/catalogue/ PUB13218/HSE2012 eCh10eAdulteBMI.pdf [serial online] 2014;1.,Non-OADS,/arxiv_data1/oa_pdf/1f/ca/main.PMC4417049.pdf
"Available at: http://www.who.int/mediacentre/factsheets/fs385/en/ [serial online] 2014; Accessed July, 2014.",Non-OADS,/arxiv_data1/oa_pdf/1f/ca/main.PMC4417049.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.184473.114.© 2015 Lambert et al.",OADS,/arxiv_data1/oa_pdf/87/ab/624.PMC4417111.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/87/ab/624.PMC4417111.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by- nc/4.0/.Research 624 Genome Research 25:624 –632 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",OADS,/arxiv_data1/oa_pdf/87/ab/624.PMC4417111.pdf
"Gene expression UniGene EST expression profiles were downloaded from UniGene(ftp://ftp.ncbi.nih.gov/repository/UniGene/; April 18, 2014).",OADS,/arxiv_data1/oa_pdf/87/ab/624.PMC4417111.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.178426.114.© 2015 Guantes et al.",OADS,/arxiv_data1/oa_pdf/0e/0f/633.PMC4417112.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/0e/0f/633.PMC4417112.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by- nc/4.0/.Research 25:633 –644 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org Genome Research 633 www.genome.org",OADS,/arxiv_data1/oa_pdf/0e/0f/633.PMC4417112.pdf
Data access RNA sequencing data from this study have been submitted to theEuropean Nucleotide Archive (ENA; http://www.ebi.ac.uk/ena/) under accession numbers ERS327027 (High mitochondrial condi- tion) and ERS327026 (Low mitochondrial condition).,Non-OADS,/arxiv_data1/oa_pdf/0e/0f/633.PMC4417112.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.188573.114.© 2015 Zampini et al.",OADS,/arxiv_data1/oa_pdf/c5/fd/645.PMC4417113.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/c5/fd/645.PMC4417113.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/ by-nc/4.0/.Research 25:645 –654 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org Genome Research 645 www.genome.org",OADS,/arxiv_data1/oa_pdf/c5/fd/645.PMC4417113.pdf
"For both sensitivity and specificity, the online BLAST interface (http://blast.st-va.ncbi.nlm.nih.gov/Blast.cgi) was used with thelowest stringency settings.",OADS,/arxiv_data1/oa_pdf/c5/fd/645.PMC4417113.pdf
Data access All newly generated sequencing data have been submitted to theNCBI Sequence Read Archive (SRA; http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/c5/fd/645.PMC4417113.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.181974.114.© 2015 Tan et al.",OADS,/arxiv_data1/oa_pdf/8f/b7/655.PMC4417114.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (seehttp://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/8f/b7/655.PMC4417114.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 4.0 Inter- national), as described at http://creativecommons.org/licenses/by-nc/4.0/.Research 25:655 –666 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org Genome Research 655 www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/8f/b7/655.PMC4417114.pdf
Data access The raw sequencing data and estimated transcript expression for the temporal profiling of mouse mESCs following loss of Dicer1 function have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under acces-sion number GSE58757.,OADS,/arxiv_data1/oa_pdf/8f/b7/655.PMC4417114.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.187237.114.© 2015 Thomas et al.",OADS,/arxiv_data1/oa_pdf/ad/b3/667.PMC4417115.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ad/b3/667.PMC4417115.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by- nc/4.0/.Research 25:667 –678 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org Genome Research 667 www.genome.org",OADS,/arxiv_data1/oa_pdf/ad/b3/667.PMC4417115.pdf
"briggsae strain AF16 (http://www.wormbase.org), which also was used later for annotated feature extraction.",OADS,/arxiv_data1/oa_pdf/ad/b3/667.PMC4417115.pdf
(2012) (http://wormgenomes.caltech.edu).,OADS,/arxiv_data1/oa_pdf/ad/b3/667.PMC4417115.pdf
Data access Sequence data have been submitted to the NCBI Sequence ReadArchive (SRA; http://www.ncbi.nlm.nih.gov/sra) under acces- sion number PRJNA274705.,OADS,/arxiv_data1/oa_pdf/ad/b3/667.PMC4417115.pdf
"Variant calls have been submittedto dbSNP (http://www.ncbi.nlm.nih.gov/SNP/; SNP numbers 1699546001 –1703191050), WormBase (http://www.wormbase.",Non-OADS,/arxiv_data1/oa_pdf/ad/b3/667.PMC4417115.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.187427.114.© 2015 Liu et al.",OADS,/arxiv_data1/oa_pdf/17/8b/679.PMC4417116.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date(see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/17/8b/679.PMC4417116.pdf
"After six months, it isavailable under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/ by-nc/4.0/.Research 25:679 –689 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org Genome Research 679 www.genome.org",OADS,/arxiv_data1/oa_pdf/17/8b/679.PMC4417116.pdf
We used theUpstream Regulator Analytic from the Ingenuity Pathway Analysis software (Ingenuity Systems; http://www.ingenuity.com) to iden- tify signaling proteins whose downstream signaling pathwayswere potentially activated or repressed during the course of infec-tion.,OADS,/arxiv_data1/oa_pdf/17/8b/679.PMC4417116.pdf
Identification of signal transduction pathways We used the Upstream Regulator Analytic of IPA (Ingenuity Systems; http://www.ingenuity.com) to identify signaling pro- teins that are potentially activated or repressed during the courseof infection.,OADS,/arxiv_data1/oa_pdf/17/8b/679.PMC4417116.pdf
Data access All of the raw sequencing reads from this study have been submit-ted to the NCBI Sequence Read Archive (SRA; http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/17/8b/679.PMC4417116.pdf
All of the raw and processed gene expression data from this study have been submitted to the NCBI Gene ExpressionOmnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under acces- sion number GSE56093.,OADS,/arxiv_data1/oa_pdf/17/8b/679.PMC4417116.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.184101.114.© 2015 Maier et al.",OADS,/arxiv_data1/oa_pdf/97/93/690.PMC4417117.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (seehttp://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/97/93/690.PMC4417117.pdf
"After six months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter- national), as described at http://creativecommons.org/licenses/by-nc/4.0/.Method 690 Genome Research 25:690 –700 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",OADS,/arxiv_data1/oa_pdf/97/93/690.PMC4417117.pdf
Data access All generated RNA-seq and ChIP-seq data have been submitted tothe NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/97/93/690.PMC4417117.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.182444.114.© 2015 Stroedicke et al.",OADS,/arxiv_data1/oa_pdf/2d/6c/701.PMC4417118.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/2d/6c/701.PMC4417118.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by- nc/4.0/.Method 25:701 –713 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org Genome Research 701 www.genome.org",OADS,/arxiv_data1/oa_pdf/2d/6c/701.PMC4417118.pdf
Methods Data sets Protein interaction data were extracted from the UniHI database (http://www.unihi.org/).,OADS,/arxiv_data1/oa_pdf/2d/6c/701.PMC4417118.pdf
"Analysis of gene expression data For detection of differentially expressed genes in brain versus non-brain tissues ( ΔEG 1), gene expression data of normal tissues were obtained from the SymAtlas database (http://biogps.org) (see also Supplemental Table S1).",OADS,/arxiv_data1/oa_pdf/2d/6c/701.PMC4417118.pdf
Data access We have established a web server (http://artemis.mdc-berlin.de/ crmp1/ppi_search.php) to highlight network proteins and their direct and indirect interaction partners within interaction net- works (Supplemental Tables S1 –S12).,OADS,/arxiv_data1/oa_pdf/2d/6c/701.PMC4417118.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.183848.114.© 2015 Foulk et al.",OADS,/arxiv_data1/oa_pdf/60/19/725.PMC4417120.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (seehttp://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/60/19/725.PMC4417120.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 4.0 Inter- national), as described at http://creativecommons.org/licenses/by-nc/4.0/.Method 25:725 –735 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org Genome Research 725 www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/60/19/725.PMC4417120.pdf
"Data access The raw sequencing reads for NS-seq, LexoG0, and G0gDNAhave been submitted to the NCBI Sequence Read Archive (SRA; http://www.ncbi.nlm.nih.gov/sra) under accession numberSRP045284.",OADS,/arxiv_data1/oa_pdf/60/19/725.PMC4417120.pdf
http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/60/19/725.PMC4417120.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.185892.114.© 2015 Fungtammasan et al.",OADS,/arxiv_data1/oa_pdf/6d/f6/736.PMC4417121.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/6d/f6/736.PMC4417121.pdf
Methods Data sets used to assess STR error rates The PCR+ data were downloaded from the NCBI Sequence Read Archive (http://www.ncbi.nlm.nih.gov/sra) with accession num-bers SRR345592 –SRR345594.,OADS,/arxiv_data1/oa_pdf/6d/f6/736.PMC4417121.pdf
"The PCR −data were downloaded from the European Se- quence Read Archive (http://www.ebi.ac.uk/ena/) with accession numbers ERR194151, and ERR174342 –ERR174360.",OADS,/arxiv_data1/oa_pdf/6d/f6/736.PMC4417121.pdf
The genotype concordance/discordance rate was evaluated on libraries ERR194151 and ERR324433 from the European Sequence Read Archive (http://www.ebi.ac.uk/ena/).,OADS,/arxiv_data1/oa_pdf/6d/f6/736.PMC4417121.pdf
2011)was downloaded from http://www.ebi.ac.uk/ena/data/view/ ERP001960.,OADS,/arxiv_data1/oa_pdf/6d/f6/736.PMC4417121.pdf
Galaxy tool description The tools from the STR-FM pipeline are freely available on Galaxy (https://usegalaxy.org/) (Giardine et al.,OADS,/arxiv_data1/oa_pdf/6d/f6/736.PMC4417121.pdf
These tools are also available at github (https://github.com/Arkarachai/STR-FM).,Non-OADS,/arxiv_data1/oa_pdf/6d/f6/736.PMC4417121.pdf
TheSTR error rates estimated in this study can be downloaded from https://usegalaxy.org/u/guru%40psu.edu/h/error-rates-files.,OADS,/arxiv_data1/oa_pdf/6d/f6/736.PMC4417121.pdf
"Data access The sequencing data of the plasmid containing artificially insertedtandem repeat sequences in both PCR+ and PCR −systems, all the ratios of heterogeneous genetic samples, and the original plasmids before mixing have been submitted to the NCBI Sequence Read Archive (SRA; http://www.ncbi.nlm.nih.gov/sra) under accessionnumber SRP047377.",OADS,/arxiv_data1/oa_pdf/6d/f6/736.PMC4417121.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.182212.114.© 2015 Carlson et al.",OADS,/arxiv_data1/oa_pdf/46/2b/750.PMC4417122.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/46/2b/750.PMC4417122.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by- nc/4.0/.Method 750 Genome Research 25:750 –761 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",OADS,/arxiv_data1/oa_pdf/46/2b/750.PMC4417122.pdf
Data access All raw sequencing data collected for this study have been submit- ted to the NCBI Sequence Read Archive (SRA; http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/46/2b/750.PMC4417122.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.185538.114.© 2015 Strope et al.",OADS,/arxiv_data1/oa_pdf/a8/b9/762.PMC4417123.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/a8/b9/762.PMC4417123.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by- nc/4.0/.Resource 762 Genome Research 25:762 –774 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",OADS,/arxiv_data1/oa_pdf/a8/b9/762.PMC4417123.pdf
The table file was then utilized by the NCBI tool tbl2asn (http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/a8/b9/762.PMC4417123.pdf
"Colony areas (i.e., pheno-types) were quantified using ImageJ 1.47v (http://imagej.nih.",OADS,/arxiv_data1/oa_pdf/a8/b9/762.PMC4417123.pdf
gov/ij/index.html) and Patch Detector Plus plug-in (University of Graz Microscopy Facility website: http://microscopy.uni-graz.,OADS,/arxiv_data1/oa_pdf/a8/b9/762.PMC4417123.pdf
Data access The genome sequence data from this study have been submitted toGenBank (http://www.ncbi.nlm.nih.gov/genbank).,OADS,/arxiv_data1/oa_pdf/a8/b9/762.PMC4417123.pdf
All strains used in this study have been deposited to the Fungal Genetic StockCenter (http://www.fgsc.net).,Non-OADS,/arxiv_data1/oa_pdf/a8/b9/762.PMC4417123.pdf
http://www.broadinstitute.org/ annotation/genome/saccharomyces_cerevisiae/Home.html.,Non-OADS,/arxiv_data1/oa_pdf/a8/b9/762.PMC4417123.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/",Non-OADS,/arxiv_data1/oa_pdf/93/bc/mtna201511a.PMC4417124.pdf
ODN sec- ondary structure predictions were obtained using the Internet tool NUPACK nucleic acid package (http://www.nupack.org/) with the default settings.,OADS,/arxiv_data1/oa_pdf/90/f5/mtna20159a.PMC4417125.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/90/f5/mtna20159a.PMC4417125.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/a1/rjv050.PMC4417130.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/66/rjv039.PMC4417131.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/3b/rjv049.PMC4417135.pdf
RNA interferencein T. brucei The targeted sequences were identified using TrypanoFAN (http://trypanofan.path.cam.ac.uk/software/RNAit.html ) and PCR-amplified from genomic DNA.,OADS,/arxiv_data1/oa_pdf/31/87/gkv056.PMC4417144.pdf
"Movies were made from stack overlays obtained from Metamorph using Image J 1.37v (National Instituteof Health, USA, http://rsb.info.nih.gov/ij/ ).",Non-OADS,/arxiv_data1/oa_pdf/31/87/gkv056.PMC4417144.pdf
"For statistical significance of the localizations of TbMlp2 and the cen- tromeres, the Chi-square test was used with Yates’ cor-rection (with 1 degree of freedom) and Pvalue (calcu- latedwithtwotails)andcalculatedonlineusingQuickCalcs fromGraphPadsoftware( http://graphpad.com/quickcalcs/ contingency1.cfm ).",OADS,/arxiv_data1/oa_pdf/31/87/gkv056.PMC4417144.pdf
brucei The orthologous gene of TbMlp2 identified in T. brucei (11) was also found in L. major by sequence homology in the genome database GeneDB ( http://www.genedb.org ).,OADS,/arxiv_data1/oa_pdf/31/87/gkv056.PMC4417144.pdf
"Bioinformatic analysis The whole genome sequences determined by SMRT se- quencing were annotated using the Prokka bacterial genomeannotationtools(ProkaryoticGenomeAnnotation System,http://vicbioinformatics.com/ )andthepreparedfile submitted to GenBank.",OADS,/arxiv_data1/oa_pdf/08/75/gkv219.PMC4417156.pdf
"Vienna, http://www.R-project.org .",Non-OADS,/arxiv_data1/oa_pdf/08/75/gkv219.PMC4417156.pdf
"However, based on Arabidopsis CDS sizes (75% being shorter than 2000 bp (TAIR10: ftp://ftp.arabidopsis.",Non-OADS,/arxiv_data1/oa_pdf/d6/6b/gkv234.PMC4417158.pdf
"Alignment was performed using CLC Ge-nomics Workbench 7 and an additional analysis was per- formed by Piledriver software ( https://github.com/arq5x/ piledriver )andcustomscripts.The mboIIM2 referencegene (GenBank KM192157) was used for the mapping of se- quencingreads,and identificationofmutations.",OADS,/arxiv_data1/oa_pdf/fe/e8/gkv269.PMC4417176.pdf
"All synony-mouscodonsusedherehaveapreferablecodonusageindex forE.coli(http://www.kazusa.or.jp/codon/ ).Afterinducing ofmboIIM2 ΔA356replacement mutants expression, the M2.MboII product pattern was immunodetected by west- ernblotting(Figure 2C).Therelativeamountoffull-length M2.MboIIinrelationtotheshortformoftheproteinvaries depending on the type and number of exchanges intro- duced.Therestorationofthefull-lengthproteinwasalmostcompletely eliminated only after six nucleotide alterations ([A 5]mutLMR6,Figure 2C,andcorresponding2D,lane9).",Non-OADS,/arxiv_data1/oa_pdf/fe/e8/gkv269.PMC4417176.pdf
Chromatin immunoprecipitation (ChIP) and quantitative PCR A detailed protocol for ChIP and quantitative PCR analysis can be found at http://www.mimo.unige.ch/ STRUBIN LABb.htm .,Non-OADS,/arxiv_data1/oa_pdf/7f/5c/gkv282.PMC4417181.pdf
"(32), the adaptor-trimmedreadsweremappedtothemousegenome(mm9) using Bismark (v. 0.76, http://www.bioinformatics.",OADS,/arxiv_data1/oa_pdf/ca/76/gkv283.PMC4417182.pdf
Data were analyzed by an on- linecalledBISMA( 38)(http://services.ibc.uni-stuttgart.de/ BDPC/BISMA/ )andduplicatedclonesweredeletedbythis software.,OADS,/arxiv_data1/oa_pdf/ca/76/gkv283.PMC4417182.pdf
"The ‘Draw in Browser’ button, within this panel, aids the user in the gap filling process by showing enzymes and reactions annotated by merlindirectly in the selected KEGG pathwaybrowser.MATERIALS AND METHODS Specifications and architecture merlinisanopen-sourceapplication,currentlyavailablefor LinuxandWindows.ItisdistributedundertheGNUGen- eralPublicLicenseatthewebsite http://www.merlin-sysbio.",OADS,/arxiv_data1/oa_pdf/9c/94/gkv294.PMC4417185.pdf
merlinwas built on top of the AIBench ( http://www.aibench.org ) software development framework ( 24).,OADS,/arxiv_data1/oa_pdf/9c/94/gkv294.PMC4417185.pdf
"Genomes retrieved fromNCBI’sFTPwebsiteareautomaticallyprocessed.The input of other genomes requires the introduction of the taxonomy ID, retrieved from the NCBI Taxonomy web-site (http://www.ncbi.nlm.nih.gov/taxonomy ).",OADS,/arxiv_data1/oa_pdf/9c/94/gkv294.PMC4417185.pdf
"These data can be retrieved from thePSORTdb database at http://db.psort.org/browse .O t h e r - wise, the target genome sequence files should be submitted to thePSORTb 3.0 web interface.",OADS,/arxiv_data1/oa_pdf/9c/94/gkv294.PMC4417185.pdf
"AVAILABILITY merlinisanopen-sourceapplication,currentlyavailablefor LinuxandWindows.ItisdistributedundertheGNUGen- eralPublicLicenseatthewebsite http://www.merlin-sysbio.",Non-OADS,/arxiv_data1/oa_pdf/9c/94/gkv294.PMC4417185.pdf
"5, 509–520 doi:10.1093/carcin/bgv013 Advance Access publication March 4, 2015 Original Manuscript 509 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/11/bgv013.PMC4417340.pdf
"Among the 3861 genes listed in Supplementary Table 4    (available at Carcinogenesis  Online), DNA methylation data for  3404 obtained using more than 5 paired samples of N and T were  deposited in the TCGA database ( https://tcga-data.nci.nih.gov/ tcga/ ).",OADS,/arxiv_data1/oa_pdf/55/11/bgv013.PMC4417340.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/d4/64/ircmj-17-03-19714.PMC4417476.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/93/96/aapm-05-02-17978.PMC4417505.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/80/e0/jjm-08-03-14311.PMC4417547.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/5c/42/jjm-08-03-15514.PMC4417555.pdf
Available from: http://physics.nist.gov/PhysRefData/Star/Text/ES-TAR.html.,OADS,/arxiv_data1/oa_pdf/f5/35/jbpe-5-15.PMC4417615.pdf
"The sections were mounted on the slide and examined by H&E staining as described previously.25 M2e 3D structure prediction The 3D structures of the A/Vietnam/1194/04 (H5N1), A/Hong Kong/ 156/97 (H5N1), A/Anhui/01/13 (H7N9), and A/Beijing/501/09(H1N1) M2e were predicted using the online software PEP-FOLD (http://bioserv.rpbs.univ-paris-diderot.fr/PEP-FOLD/) as described previously.",Non-OADS,/arxiv_data1/oa_pdf/aa/fb/emi201522a.PMC4417706.pdf
"Available at http://www.who.int/influenza/human_animal_interface/20140131_background_ and_summary_H7N9_v1.pdf?ua 51 3 Zhou J, Wang D, Gao R et al.",Non-OADS,/arxiv_data1/oa_pdf/aa/fb/emi201522a.PMC4417706.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/An H5N1-M2e vaccine provides protection against H7N9 infection HC Leung et al 7 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/aa/fb/emi201522a.PMC4417706.pdf
©2015TheAuthors.PublishedbyElsevierLtdonbehalf of AustralianSocietyforParasitology.Thisisan openaccessarticleundertheCCBY-NC-NDlicense( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/b2/main.PMC4417838.pdf
http://dx.doi.org/10.1016/j.ijpddr.2015.03.002 2211-3207/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/b2/main.PMC4417838.pdf
This is an open access article under the CC B Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).International Journal for Parasitology: Drugs and Drug Resistance 5 (2015) 48–57 Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com/locate/ijpddr,Non-OADS,/arxiv_data1/oa_pdf/4f/b2/main.PMC4417838.pdf
"Code Substituents LogP MeanIC 50 ±SD(μM) MeanCC 50 ±SD(μM) Selectivityindex(SI) R2 R3 R7 R8 NF54 Dd2 MCF7 SI(NF54) SI(Dd2) NT1 H Cl H NO 23.2 0.033 ±0.004 0.031 ±0.005 5.15 ±0.11 155.9 168.7 NT2 Cl H H NO 23.2 0.129 ±0.022 0.091 ±0,013 12.47 ±0.23 96.7 136.5 NT3 OCH3 OCH3 H NO 22.2 0.283 ±0.093 0.134 ±0.047 15.17 ±4.41 53.6 113.2 NT4 H COOH H NO 22.4 NE NE >100 ND ND NT5 H COOCH3 H NO 22.7 0.167 ±0.067 0.166 ±0.036 11.98 ±0.50 71.7 72.1 NT6 H Br H NO 23.3 0.072 ±0.023 0.101 ±0.068 17.52 ±0.77 243.3 174 T1 H H H CH3 3 0.085 ±0.037 0.216 ±0.116 >100 >1000 >400 T2 H H H Br 3.4 0.081 ±0.008 0.095 ±0.058 10.47 ±1.52 129.3 110.2 T3 H H CH3 H 3 0.450 ±0.098 0.602 ±0.115 17.65 ±0.30 39.2 29.3 T4 H H H NO 22.5 0.106 ±0.038 0.165 ±0.055 4.78 ±0.49 45.1 29 T6 H H H F 2.4 0.057 ±0.010 0.100 ±0.015 17.47 ±0.65 306.5 175.6 T7 H H H Cl 3.3 0.095 ±0.033 0.172 ±0.018 27.18 ±6.68 286.1 158.5 T8 H Cl H H 3.3 0.092 ±0.003 0.165 ±0.081 17.12 ±4.26 186 103.5 BT1 H Cl H Br 4.1 0.036 ±0.017 0.238 ±0.080 2.38 ±0.001 66 10 BT2 Cl H H Br 4.1 0.036 ±0.024 0.123 ±0.062 >100 >2000 >800 BT3 OCH3 OCH3 H Br 3 0.088 ±0.041 0.761 ±0.194 >100 >1000 >100 BT4 H COOH H Br 3.3 NE NE 71 ±39.73 ND ND BT5 H COOCH3 H Br 3.5 0.162 ±0.093 0.287 ±0.024 11.49 ±5.42 70.9 40 TRYP H H H H 2.6 0.288 ±0.087 0.114 ±0.017 45.90 ±0.70 159.4 318 CQ / / / / / 0.021 ±0.002 0.294 ±0.030 >100 >4000 >4000 TRYP:Tryptanthrin;CQ:Chloroquine;CC 50:CytotoxicConcentration50;NE:Noteffective.SI:Selectivityindex(CC50/IC50).LogPofcompoundswerecalculatedwithMolinspiration (http://www.molinspiration.com ).",Non-OADS,/arxiv_data1/oa_pdf/4f/b2/main.PMC4417838.pdf
<http://www.who.int/malaria/publications/atoz/9789241547925/ en/index.html >.,Non-OADS,/arxiv_data1/oa_pdf/4f/b2/main.PMC4417838.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/bd/a9/jjm-08-03-14571.PMC4417903.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/79/fc/jjm-08-03-14810.PMC4417945.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/8a/main.PMC4418028.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2015.03.002 2352-2895/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/8a/main.PMC4418028.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 2 (2015) 20 e27,Non-OADS,/arxiv_data1/oa_pdf/a6/8a/main.PMC4418028.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Kazinol C and isokazinol D prevent β-cell damage U-J Bae et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/e3/71/emm201516a.PMC4418042.pdf
Available from:  https://www.nrhm -mis.nic.in/SitePages/DLHS -4.aspx.,Non-OADS,/arxiv_data1/oa_pdf/10/a5/SAJC-4-100.PMC4418075.pdf
Available from:  http://www.mohfw.nic.in/WriteReadData/l892s/1455618937GATS%20 India.pdf.,Non-OADS,/arxiv_data1/oa_pdf/10/a5/SAJC-4-100.PMC4418075.pdf
Available from: http://www.ijird.com.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/SAJC-4-55.PMC4418081.pdf
Available from: http://www.ncrpindia.org/Annual_Reports.aspx.,OADS,/arxiv_data1/oa_pdf/3e/0a/SAJC-4-55.PMC4418081.pdf
Available from: http://www.jop.ascopubs.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/SAJC-4-55.PMC4418081.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/SAJC-4-55.PMC4418081.pdf
Available from:  http://www.globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/30/4e/SAJC-4-61.PMC4418083.pdf
Available from:  http://www.icmr.nic.in/guide/cancer/Cancer.,Non-OADS,/arxiv_data1/oa_pdf/30/4e/SAJC-4-61.PMC4418083.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/30/4e/SAJC-4-61.PMC4418083.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/30/4e/SAJC-4-61.PMC4418083.pdf
Available from: http://www.icmr.nic.in/ncrp/ bcifuture.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/24/SAJC-4-75.PMC4418087.pdf
Available from:  https://www.nrhm -mis.nic.in/SitePages/DLHS -4.aspx.,Non-OADS,/arxiv_data1/oa_pdf/2d/00/SAJC-4-99.PMC4418094.pdf
Available from:  http://www.mohfw.nic.in/WriteReadData/l892s/1455618937GATS%20 India.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2d/00/SAJC-4-99.PMC4418094.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report The combined treatment of stenting and surgery in a giant  unruptured aneurysm of the middle cerebral artery Miran Skrap, Benedetto Petralia1, Giovanni Toniato Departments of Neurosurgery, 1Neuroradiology, Udine University‑Hospital P .",Non-OADS,/arxiv_data1/oa_pdf/05/e1/SNI-6-67.PMC4418101.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/67/155802 Copyright: © 2015 Skrap M.  This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/05/e1/SNI-6-67.PMC4418101.pdf
"Surgical Neurology International 2015, 6:67  http://www.surgicalneurologyint.com/content/6/1/67computed tomographic angiogram (CTA) scans,  carried out at admission, showed a right giant MCA  aneurysm without subarachnoid hemorrhage (SAH)  but with mass effect [Figure 1].",Non-OADS,/arxiv_data1/oa_pdf/05/e1/SNI-6-67.PMC4418101.pdf
"Surgical Neurology International 2015, 6:67  http://www.surgicalneurologyint.com/content/6/1/675 days of double antiplatelet theraphy before the  procedure with acetylsalicylic acid (100 mg once daily)  and clopidrogel (75 mg once daily), a bolus of 5000 UI of  heparin at benning of the treatment followed by 1000 UI  of heparin hourly during the procedure.",Non-OADS,/arxiv_data1/oa_pdf/05/e1/SNI-6-67.PMC4418101.pdf
"Surgical Neurology International 2015, 6:67  http://www.surgicalneurologyint.com/content/6/1/67aspect, incorporation of M1 tract‑M2 branches into  the base or dome becoming consequently challenging  for either surgical clipping or coiling alone.",Non-OADS,/arxiv_data1/oa_pdf/05/e1/SNI-6-67.PMC4418101.pdf
"Surgical Neurology International 2015, 6:67  http://www.surgicalneurologyint.com/content/6/1/67Another issue in this case was the antiplatelet and  heparinic anticoagulant drug therapy before, during,  and after the combined treatment.",Non-OADS,/arxiv_data1/oa_pdf/05/e1/SNI-6-67.PMC4418101.pdf
"Surgical Neurology International 2015, 6:67  http://www.surgicalneurologyint.com/content/6/1/67Surgical	results	with	a	 “clip	first”	policy.",Non-OADS,/arxiv_data1/oa_pdf/05/e1/SNI-6-67.PMC4418101.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Clinical outcome and cost effectiveness of early tracheostomy in  isolated severe head injury patients Usman Tariq Siddiqui, Muhammad Zubair Tahir, Muhammad Shahzad Shamim, Syed Ather Enam Department of Neurosurgery, Aga Khan University Hospital, Karachi, Pakistan E‑mail:   Usman Tariq Siddiqui ‑ usmantsiddiqui@hotmail.com; Muhammad Zubair Tahir ‑ zubair.tahir@aku.edu;   *Muhammad Shahzad Shamim ‑ shahzad.shamim@aku.edu; Syed Ather Enam ‑ ather.enam@aku.edu   *Corresponding author Received: 10 November 14  Accepted: 15 January 15  Published: 23 April 15 Abstract Background:  Early tracheostomy (ET) has been shown to be effective in reducing  complications associated with prolong mechanical ventilation.",Non-OADS,/arxiv_data1/oa_pdf/7d/5c/SNI-6-65.PMC4418102.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/65/155757 Copyright: © 2015 Siddiqui UT.,Non-OADS,/arxiv_data1/oa_pdf/7d/5c/SNI-6-65.PMC4418102.pdf
"Surgical Neurology International 2015, 6:65  http://www.surgicalneurologyint.com/content/6/1/65avoids any oropharangeal and/or laryngeal injury  usually observed with endotracheal intubation (EI).",Non-OADS,/arxiv_data1/oa_pdf/7d/5c/SNI-6-65.PMC4418102.pdf
"Surgical Neurology International 2015, 6:65  http://www.surgicalneurologyint.com/content/6/1/65RESULTS This 8‑year review included 100 ICU patients with severe  traumatic head injury requiring mechanical ventilation  and tracheostomy.",Non-OADS,/arxiv_data1/oa_pdf/7d/5c/SNI-6-65.PMC4418102.pdf
"Surgical Neurology International 2015, 6:65  http://www.surgicalneurologyint.com/content/6/1/65pulmonary toilet.",Non-OADS,/arxiv_data1/oa_pdf/7d/5c/SNI-6-65.PMC4418102.pdf
"Surgical Neurology International 2015, 6:65  http://www.surgicalneurologyint.com/content/6/1/65infusions in critically ill patients undergoing mechanical ventilation.",Non-OADS,/arxiv_data1/oa_pdf/7d/5c/SNI-6-65.PMC4418102.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Endoscopic approaches to brainstem cavernous  malformations: Case series and review of the literature Nikhil R. Nayak, Jayesh P .",Non-OADS,/arxiv_data1/oa_pdf/bf/a2/SNI-6-68.PMC4418103.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/68/155807 Copyright: © 2015 Nayak NR.,Non-OADS,/arxiv_data1/oa_pdf/bf/a2/SNI-6-68.PMC4418103.pdf
"Surgical Neurology International 2015, 6:68  http://www.surgicalneurologyint.com/content/6/1/68INTRODUCTION Cavernous malformations (CMs) are angiographically  occult vascular lesions lined with a single layer of  endothelium that displace adjacent brain tissue.",Non-OADS,/arxiv_data1/oa_pdf/bf/a2/SNI-6-68.PMC4418103.pdf
"Surgical Neurology International 2015, 6:68  http://www.surgicalneurologyint.com/content/6/1/68The patient’s left hemiparesis had worsened in the  immediate postoperative period, as had the right‑sided  facial weakness.",Non-OADS,/arxiv_data1/oa_pdf/bf/a2/SNI-6-68.PMC4418103.pdf
"Surgical Neurology International 2015, 6:68  http://www.surgicalneurologyint.com/content/6/1/68A significant amount of blood clot was evacuated with  suction and bipolar electrocautery.",Non-OADS,/arxiv_data1/oa_pdf/bf/a2/SNI-6-68.PMC4418103.pdf
"Surgical Neurology International 2015, 6:68  http://www.surgicalneurologyint.com/content/6/1/68was identified.",Non-OADS,/arxiv_data1/oa_pdf/bf/a2/SNI-6-68.PMC4418103.pdf
"Surgical Neurology International 2015, 6:68  http://www.surgicalneurologyint.com/content/6/1/68exposure inferiorly to the foramen magnum.",Non-OADS,/arxiv_data1/oa_pdf/bf/a2/SNI-6-68.PMC4418103.pdf
"Surgical Neurology International 2015, 6:68  http://www.surgicalneurologyint.com/content/6/1/68cranial nerve nuclei, and specifically limit pial incisions  to 1 cm.",Non-OADS,/arxiv_data1/oa_pdf/bf/a2/SNI-6-68.PMC4418103.pdf
"Surgical Neurology International 2015, 6:68  http://www.surgicalneurologyint.com/content/6/1/68of an underlying lesion.",Non-OADS,/arxiv_data1/oa_pdf/bf/a2/SNI-6-68.PMC4418103.pdf
"Surgical Neurology International 2015, 6:68  http://www.surgicalneurologyint.com/content/6/1/68or endoscope, the benefit of the endoscope is that  extended approaches can potentially be exploited.",Non-OADS,/arxiv_data1/oa_pdf/bf/a2/SNI-6-68.PMC4418103.pdf
"Surgical Neurology International 2015, 6:68  http://www.surgicalneurologyint.com/content/6/1/6834.",Non-OADS,/arxiv_data1/oa_pdf/bf/a2/SNI-6-68.PMC4418103.pdf
International Network for Rational Use of  Drugs (INRUD) Available from: http://www.inrud.org/,Non-OADS,/arxiv_data1/oa_pdf/3e/2b/JRPP-4-45.PMC4418135.pdf
Available from: http://www.rdis.ir/ CMPAnnouncements.asp.,Non-OADS,/arxiv_data1/oa_pdf/59/c5/JRPP-4-51.PMC4418136.pdf
Available from: http://www.whocc.no/atc/structure_and_ principles/.,Non-OADS,/arxiv_data1/oa_pdf/c8/94/JRPP-4-64.PMC4418138.pdf
Available from: http://www.ema.europa.eu/ema/ index.jsp?curl=pages/news_and_events/news/2010/09/ news_detail_001119.jsp and mid=WC0b01ac058004d5c1.,Non-OADS,/arxiv_data1/oa_pdf/c8/94/JRPP-4-64.PMC4418138.pdf
Available from: http://www.who‑umc.,Non-OADS,/arxiv_data1/oa_pdf/c8/94/JRPP-4-64.PMC4418138.pdf
Available  from: http://www.who.int/medicines/areas/quality_safety/ safety_efficacy/WHOcausality_assessment.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c8/94/JRPP-4-64.PMC4418138.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/c8/94/JRPP-4-64.PMC4418138.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/c8/94/JRPP-4-64.PMC4418138.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/c8/94/JRPP-4-64.PMC4418138.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/c8/94/JRPP-4-64.PMC4418138.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/c8/94/JRPP-4-64.PMC4418138.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/c8/94/JRPP-4-64.PMC4418138.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/c8/94/JRPP-4-64.PMC4418138.pdf
Available from: http://www.ich.org/products/meddra.,OADS,/arxiv_data1/oa_pdf/c8/94/JRPP-4-64.PMC4418138.pdf
Available from: http://www.ema.europa.eu/docs/ en_GB/document_library/Scientific_guideline/2009/09/ WC500002749.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c8/94/JRPP-4-64.PMC4418138.pdf
Available from:  http://www.healthplus.org/uploadedFiles/PDFs/Medicare/ PDBMChap6FormularyReqrmts_03.09.07.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a1/63/JRPP-4-85.PMC4418141.pdf
Available from: http://www.Dartmouthatlas.,Non-OADS,/arxiv_data1/oa_pdf/a1/63/JRPP-4-85.PMC4418141.pdf
Available from:  http://www.popcouncil.org/uploads/ pdfs/frontiers/Manuals/ECP_manual.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d4/f7/JRPP-4-94.PMC4418143.pdf
"Available from: http://www.who.int/mediacentre/ factsheets/fs999/en/ , accessed on March 1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ba/77/IJMR-141-143.PMC4418146.pdf
"Avaialble  from: http://planningcommission.nic.in/reports/genrep/rep_ uhc0812.pdf , accessed on August 6, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d8/e9/IJMR-141-151.PMC4418149.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/d8/e9/IJMR-141-151.PMC4418149.pdf
"The National Guidelines  for stem Cells Research and therapy became available  in 2007, and has been recently revised ( http://icmr.nic.",Non-OADS,/arxiv_data1/oa_pdf/72/f0/IJMR-141-154a.PMC4418150.pdf
"Design of probes and printing the microarray : DNA  sequence of Homo sapiens ATP7B  was downloaded  from NCBI database ( http://ncbi.nlm.nih.gov ,  Accession No.",OADS,/arxiv_data1/oa_pdf/46/cf/IJMR-141-175.PMC4418154.pdf
Information regarding  Wilson’s disease causing mutations specific to Indian  population was extracted from Wilson Disease  Mutation Database (http://www.wilsondisease.med.,OADS,/arxiv_data1/oa_pdf/46/cf/IJMR-141-175.PMC4418154.pdf
"of studies$ Reference* P_48_14 c.3147delC deletion p.Thr1050HisfsX71 14 2 4,120 P_50_14 c.3182G>A substitution p.Gly1061Glu 14 2 121,126 E14_fs_P c.3207C>A substitution p.His1069Gln 14 ** ** P_52_15 c.3282C>G substitution p.Phe1094Leu 14 2 121,115 P_54_15@ c.3301G>A substitution p.Gly1101Arg 15 1 4 P_55_15@ c.3305T>C substitution p.ile1102thr 15 4 4,74,106,120 P_59_15 c.3311G>A substitution p.Cys1104t yr 15 1 74 P_60_15 c.3412+1G>A substitution na 15 1 120 P_61_16 c.3418delt deletion p.Val1140Ala-fs 16 1 74 P_62_16 c.3424dupC insertion p.Gln1142ProfsX11 16 1 74 P_63_16 c.3532A>G substitution p.Thr1178Ala 16 1 120 P_64_18 c.3722C>T substitution p.Ala1241Val 18 1 121 P_65_18 c.3767A>G substitution p.Gln1256Arg 18 2 74,106 P_67_18 c.3770_3771insG insertion p.Asn1257LysfsX2 18 1 74 P_68_18 c.3809A>G substitution p.Asn1270Ser 18 1 121 P_69_18 c.3839_3840insTAC insertion p.Met1280delinsIleThr 18 1 74 P_70_18 c.3890T>A substitution p.Val1297Asp 18 1 121 P_71_18 c.3895C>T substitution p.Leu1299Phe 18 1 121 P_71_18 c.3895delC deletion p.Ile1300SerfsX30 18 1 121 P_73_18# c.3903+6T>C substitution na 18 1 121 P_74_19 c.4021G>A substitution p.Gly1341Ser 19 2 121,126 P_76_19 c.4021+3A>G substitution na 19 1 121 P_77_21 c.4310dupA insertion p.Pro1438AlafsX11 21 2 74,73 *The references numbered as per the listing in the Wilson disease Database ( http://www.wilsondisease.med.ualberta.ca/database.asp ) **One of the most preponderant mutations across different countries and reported by many groups, but not in Indian patients $ Number of independent studies reporting this variant @ SDM mutations (Mutations tested by generating site directed mutagenesis products)  # This variant is also reported to be a highly polymorphic SNP (rs2282057).",Non-OADS,/arxiv_data1/oa_pdf/46/cf/IJMR-141-175.PMC4418154.pdf
"Sequence  source: http://ncbi.nlm.nih.gov , Accession No.",OADS,/arxiv_data1/oa_pdf/46/cf/IJMR-141-175.PMC4418154.pdf
"Available from: http://www.who.int/mediacentre/ factsheets/ fs328/en/ , accessed on June 12, 2013.",Non-OADS,/arxiv_data1/oa_pdf/71/59/IJMR-141-213.PMC4418158.pdf
Available from: http://www.who.int/tb/publications/global_ report/2009/pdf/ind.pdf.,Non-OADS,/arxiv_data1/oa_pdf/15/78/IJMR-141-228.PMC4418160.pdf
"DNA fingerprinting was performed by  PFGE  in  CHEF-DRIII system (BioRad Laboratories, Hercules,  CA, USA), following standard PulseNet one-day  protocol ( http://www.cdc.gov/pulsenet/PDF/ecoli- shigella-salmonella-pfge-protocol-508c.pdf ) and using  Salmonella Braenderup H9812 as control.",OADS,/arxiv_data1/oa_pdf/e9/ff/IJMR-141-239.PMC4418162.pdf
sequences obtained were submitted to the  MLST database ( http://mlst.ucc.ie/mlst/dbs/Senterica )  to assign sequence type (ST) of each isolate based on  the set of allele types derived from all the seven loci.,OADS,/arxiv_data1/oa_pdf/e9/ff/IJMR-141-239.PMC4418162.pdf
The  current data have been entered in the MLST database  and are available at the website ( http://mlst.ucc.ie/mlst/ dbs/Senterica/GetTableInfo_html ).,OADS,/arxiv_data1/oa_pdf/e9/ff/IJMR-141-239.PMC4418162.pdf
"Available from http://www.who.int/ salmsurv/en/ , accessed on July 7, 2012.",OADS,/arxiv_data1/oa_pdf/e9/ff/IJMR-141-239.PMC4418162.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Glioblastoma and intracranial aneurysms: Case report and review  of literature Rushna Ali, Aqueel Pabaney, Adam Robin, Horia Marin1, Mark Rosenblum Departments of Neurological Surgery and 1Radiology, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, USA E‑mail: *Rushna Ali ‑ rali1@hfhs.org; Aqueel Pabaney ‑ apabane1@hfhs.org; Adam Robin ‑ arobin1@hfhs.org; Horia Marin ‑ marinh@rad.hfh.edu;   Mark Rosenblum ‑ mrosenb1@hfhs.org   *Corresponding author Received: 04 Decemberr 14  Accepted: 22 January 15  Published: 23 April 15 Abstract Background:  There is a paucity of data on the association of glioblastoma  multiforme (GBM) with intracranial aneurysms.",Non-OADS,/arxiv_data1/oa_pdf/93/e9/SNI-6-66.PMC4418170.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/66/155759,Non-OADS,/arxiv_data1/oa_pdf/93/e9/SNI-6-66.PMC4418170.pdf
"Surgical Neurology International 2015, 6:66  http://www.surgicalneurologyint.com/content/6/1/66efficacious and safe surgical resection combined with a  regimen of concurrent temozolomide and fractionated  radiotherapy followed by adjuvant temozolomide.",Non-OADS,/arxiv_data1/oa_pdf/93/e9/SNI-6-66.PMC4418170.pdf
"Surgical Neurology International 2015, 6:66  http://www.surgicalneurologyint.com/content/6/1/66 Table 1: Studies reporting patients with GBM and intracranial aneurysms Author and year Age  (years)*, sexPresentation Tumor location Tumor  histologyAneurysm location Aneurysm  typeTreatment Outcome Cheng et al.",OADS,/arxiv_data1/oa_pdf/93/e9/SNI-6-66.PMC4418170.pdf
"Surgical Neurology International 2015, 6:66  http://www.surgicalneurologyint.com/content/6/1/66 Table 1: Contd...",Non-OADS,/arxiv_data1/oa_pdf/93/e9/SNI-6-66.PMC4418170.pdf
"Surgical Neurology International 2015, 6:66  http://www.surgicalneurologyint.com/content/6/1/66DISCUSSION Glioblastoma development is most common in the sixth  through eighth decades of life.",Non-OADS,/arxiv_data1/oa_pdf/93/e9/SNI-6-66.PMC4418170.pdf
"Surgical Neurology International 2015, 6:66  http://www.surgicalneurologyint.com/content/6/1/66are false aneurysms that do not possess all three vessel  wall layers, lack a distinguishable neck and are formed by  either invasion of the vessel by the tumor cells or develop  after an iatrogenic injury during surgical resection of the  tumor.",Non-OADS,/arxiv_data1/oa_pdf/93/e9/SNI-6-66.PMC4418170.pdf
"Surgical Neurology International 2015, 6:66  http://www.surgicalneurologyint.com/content/6/1/66versus radiotherapy alone on survival in glioblastoma in a randomised  phase III study: 5‑year analysis of the EORTC‑NCIC trial.",Non-OADS,/arxiv_data1/oa_pdf/93/e9/SNI-6-66.PMC4418170.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/1c/6a/jjm-08-03-14813.PMC4418171.pdf
The  sequences of the pdhC  and glyRS  genes were entered into  a BLAST search (http://blast.ncbi.nlm.nih.gov/Blast.cgi).,OADS,/arxiv_data1/oa_pdf/1c/6a/jjm-08-03-14813.PMC4418171.pdf
"http://www.mentalhealth.org.uk/help- information/mental-health-a-z/r/recovery/) and  programs, both for people with mental illness and  for professionals involved in their care, which aim at  recovery and wellness.",Non-OADS,/arxiv_data1/oa_pdf/ea/c9/IJPsyM-37-117.PMC4418239.pdf
(See Mental  Health Providers Forum website- http://www.mhpf.,Non-OADS,/arxiv_data1/oa_pdf/ea/c9/IJPsyM-37-117.PMC4418239.pdf
"It represents the  views of service users from both dominant and  marginalized communities, (See Checklist of Good  Practice - http://www.mentalhealth.org.uk/content/ assets/PDF/publications/checklist-good-practice- approaches-recovery.pdf).CONCLUSION The current approaches to mental health and illness  with their exclusive focus on symptoms, the partial  response to treatment of many people with severe  mental illness and their inability to get back to their  pervious level of function and realize their full potential  mandates complementary approaches to the care and  management of people with mental health difficulties.",Non-OADS,/arxiv_data1/oa_pdf/ea/c9/IJPsyM-37-117.PMC4418239.pdf
Available from: http://www.isro.org/ pslv-c25/mission.aspx [Last accessed on 15 Oct 2014].,Non-OADS,/arxiv_data1/oa_pdf/69/b3/IJPsyM-37-120.PMC4418240.pdf
Available from: http://www.isro.,Non-OADS,/arxiv_data1/oa_pdf/69/b3/IJPsyM-37-120.PMC4418240.pdf
Available from:  http://www.svym.org/ [Last accessed on 2014 Oct 11].,Non-OADS,/arxiv_data1/oa_pdf/41/d4/IJPsyM-37-122.PMC4418241.pdf
Available from:  http://en.wikipedia.org/wiki/Swami_Vivekananda_Youth_ Movement [Last accessed on 2014 Oct 11].,Non-OADS,/arxiv_data1/oa_pdf/41/d4/IJPsyM-37-122.PMC4418241.pdf
Available from: http://www.psychiatry.org/ [Last  accessed on 2014 Oct 11].,Non-OADS,/arxiv_data1/oa_pdf/41/d4/IJPsyM-37-122.PMC4418241.pdf
Available from: http://pbhealth.gov.in/pdf/mental health.,Non-OADS,/arxiv_data1/oa_pdf/41/d4/IJPsyM-37-122.PMC4418241.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/98/c5/IJPsyM-37-131.PMC4418242.pdf
Available from: http://www.ndmindia.nic.in/DM- Booklet-080211.pdf.,Non-OADS,/arxiv_data1/oa_pdf/55/21/IJPsyM-37-138.PMC4418243.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/55/21/IJPsyM-37-138.PMC4418243.pdf
The ISAA  is now freely available through the National Trust of  India (http://www.thenationaltrust.co.in/nt/index.,Non-OADS,/arxiv_data1/oa_pdf/70/17/IJPsyM-37-169.PMC4418249.pdf
Available from: http://www.medscape.com/  viewarticle/493650 [Last accessed on 22nd June 2014].,Non-OADS,/arxiv_data1/oa_pdf/c9/61/IJPsyM-37-184.PMC4418252.pdf
"Available from: http://www.hetv.org/india/nfhs/nfhs3/ NFHS-3-Chapter-13-Morbidity-and-Health-Care.pdf [Last  accessed on November 13, 2013].",Non-OADS,/arxiv_data1/oa_pdf/09/59/IJPsyM-37-195.PMC4418253.pdf
Available from: https://www.unodc.org/.,OADS,/arxiv_data1/oa_pdf/09/59/IJPsyM-37-195.PMC4418253.pdf
Available  from: http://www.unodc.org/documents/southasia/reports/ UNODC_Book_Women_and _Drug_Use_in_India_2008.pdf.,Non-OADS,/arxiv_data1/oa_pdf/09/59/IJPsyM-37-195.PMC4418253.pdf
"Available  from: http://www.ncbi.nlm.nih.gov/books/NBK83252 [Last  accessed on May 27, 2012].",Non-OADS,/arxiv_data1/oa_pdf/09/59/IJPsyM-37-195.PMC4418253.pdf
Available from: http://www.un.org/ disabilities [Last accessed on 2015 Jan 05].,Non-OADS,/arxiv_data1/oa_pdf/57/26/IJPsyM-37-215.PMC4418257.pdf
Available from: http://www.medicines.,Non-OADS,/arxiv_data1/oa_pdf/6b/4a/IJPsyM-37-220.PMC4418258.pdf
Available from: http://www.nice.org.uk/nicemedia/pdf/ cg031fullguideline.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1e/43/IJPsyM-37-230.PMC4418261.pdf
Available  from: http://pubchem.ncbi.nlm.nih.gov/summary/summary.,OADS,/arxiv_data1/oa_pdf/5c/f1/IJPsyM-37-233.PMC4418262.pdf
Toluene Available  from: http://toxnet.nlm.nih.gov/cgi-bin/sis/search/ a?dbs+hsdb:@term+@ DOCNO+131 [Last cited on 2013  Jul 25].,OADS,/arxiv_data1/oa_pdf/5c/f1/IJPsyM-37-233.PMC4418262.pdf
Available from: http://www.cdc.gov/Lyme/ stats/.,OADS,/arxiv_data1/oa_pdf/0f/c2/IJPsyM-37-243.PMC4418265.pdf
"As another example, this time using the medical literature [http://www.ncbi.nlm.nih.gov/pubmed], between the 1970s and 2010, the time necessary to study all of the texts considered as well-established content (articles and reviews in medicine) increased from 20% of the time dedicated to a medical course, or 10,000 hours in six years, to sevenfold.",Non-OADS,/arxiv_data1/oa_pdf/86/ec/cln-70-04-229.PMC4418277.pdf
"Additionally, comple- mentary to the addition of new knowledge in the field of medicine, the theme of ‘‘social determinants of health ’’ [http://www.ssrn.com/en/] has become more frequent in the medical literature since the 1990s and has significantly highlighted the need for new generations of health profes- sionals to study and perform research.",Non-OADS,/arxiv_data1/oa_pdf/86/ec/cln-70-04-229.PMC4418277.pdf
"2010;3(5):484-8, http://dx.doi.org/10.1161/CIRCGENETICS.110.958363.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2012;93(4):633-44, http://dx.doi.org/10.1093/cvr/cvs007.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2014;103(2):258-67, http://dx.doi.org/10.1093/cvr/cvu126.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2011;469(7330):336-42, http://dx.doi.org/10.1038/nature09783.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2014;1165:71-80, http://dx.doi.org/10.1007/978-1-4939-0856-1.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"Cardiology.2011;118(4):217-26, http://dx.doi.org/10.1159/000328869.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2014;23(6):503-10, http://dx.doi.org/10.1016/j.hlc.2014.01.001.",OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2010;121(8):1022-32, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2010;107(5):677-84, http://dx.doi.org/10.1161/CIRCRESAHA.109.215566.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2014;35(31):2106-14, http://dx.doi.org/10.1093/eurheartj/ehu151.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2010;31(6):659-66, http://dx.doi.org/10.1093/eurheartj/ehq013.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2012;14(2):147-54, http://dx.doi.org/10.1093/eurjhf/hfr155.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2014;11(4):663-9,http://dx.doi.org/10.1016/j.hrthm.2014.01.018.",OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2013;50(4):346-54, http://dx.doi.org/10.1159/000351767.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2014;9(3):e90605, http://dx.doi.org/10.1371/ journal.pone.0090605.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2012;8(6):811-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2014;1(9):89, http://dx.doi.org/10.1186/1746-1596-9-89.25.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2010;106(6):1035-9, http://dx.doi.org/10.1161/CIRCRESAHA.110.218297.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"?e164, http://dx.doi.org/10.1016/j.jacc.2012.07.013.",OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"?1900, http://dx.doi.org/10.1161/01.CIR.0000037106.76139.53.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2004;148(1):7-15, http://dx.doi.org/ 10.1016/j.ahj.2003.11.027.",OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2013;227(2):201-8, http://dx.doi.org/10.1016/j.atherosclerosis.2012.11.025.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2014;232(1):171-9, http://dx.doi.org/10.1016/j.atherosclerosis.2013.11.029.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2013;23(7):693-8, http://dx.doi.org/10.1016/j.numecd.2012.02.009.",OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2013;33(2):420-30, http://dx.doi.org/10.1161/ATVBAHA.112.300251.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2014;443(1):246-51, http://dx.doi.org/ 10.1016/j.bbrc.2013.11.092.",OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2013;44(6):1706-13, http://dx.doi.org/10.1161/STROKEAHA.111.000504.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"2010;27(12):2147-56, http://dx.doi.org/10.1089/neu.2010.1481.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/cln-70-04-257.PMC4418278.pdf
"© Gu Xiao, Pao Kue, Rahul Bhosle, and Jill Bargonetti *Corresponding authors: Jill Bargonetti; Email: bargonetti@genectr.hunter.cuny.eduSubmitted: 10/02/2014; Revised: 12/08/2014; Accepted: 12/09/2014 http://dx.doi.org/10.1080/15384101.2014.997517 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"Bargonetti J, Champeil E, and Tomasz M. (2010) Dif- ferential toxicity of DNA adducts of mitomycin C, J Nucleic Acids 2010; PMID:20798760; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(1996) DNA adducts from chemotherapeutic agents, Mutat Res 355:13-40;PMID:8781575; http://dx.doi.org/10.1016/0027- 5107(96)00020-6 5.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2010) DNA adducts of decarbamoyl mitomycin C efﬁ- ciently kill cells without wild-type p53 resulting from pro-teasome-mediated degradation of checkpoint protein 1, Chem Res Toxicol 23:1151-62; PMID:20536192; http://dx.doi.org/10.1021/tx900420k 6.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2007) Mitomycin-DNA adducts induce p53-dependent and p53-inde- pendent cell death pathways, ACS Chem Biol 2:399-407; PMID:17530733; http://dx.doi.org/10.1021/ cb700060t 7.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2002) Differential acti- vation of p53 by the various adducts of mitomycin C, J Biol Chem 277:40513-9; PMID:12183457; http://dx.doi.org/10.1074/jbc.M205495200 8.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2012) Comprehensive molecular portraits of human breast tumours, Nature 490:61-70; PMID:23000897; http://dx.doi.org/10.1038/nature11412 10.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"Reaper PM, Grifﬁths MR, Long JM, Charrier JD, Maccormick S, Charlton PA, Golec JM, Pollard JR. (2011) Selective killing of ATM- or p53-deﬁcientcancer cells through inhibition of ATR, Nat Chem Biol 7:428-30; PMID:21490603; http://dx.doi.org/ 10.1038/nchembio.573 11.",OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2011) DNA interstrand crosslink repair and cancer, Nat Rev Cancer 11:467-80; PMID:21701511; http://dx.doi.org/10.1038/nrc3088 13.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2003) A splicing mutation affecting expression of ataxia-telangiectasia and rad3-related pro-tein (ATR) results in seckel syndrome, Nat Genet 33:497-501; PMID:12640452; http://dx.doi.org/ 10.1038/ng1129 14.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2000) Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress, Genes Dev 14:2989- 3002; PMID:11114888; http://dx.doi.org/10.1101/gad.851000 16.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2014) ATR suppresses endogenousDNA damage and allows completion of homologous recombination repair, PLoS One 9:e91222; PMID:24675793; http://dx.doi.org/10.1371/journal.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"pathway for survival after DNA damage, Cancer Cell 11:175-89; PMID:17292828; http://dx.doi.org/ 10.1016/j.ccr.2006.11.024 18.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2010) DNA damage activates a spa- tially distinct late cytoplasmic cell-cycle checkpoint net- work controlled by MK2-mediated RNA stabilization, Mol Cell 40:34-49; PMID:20932473; http://dx.doi.org/10.1016/j.molcel.2010.09.018 19.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2012) GADD45 proteins:central players in tumorigenesis, Curr Mol Med 12:634-51; PMID:22515981; http://dx.doi.org/ 10.2174/156652412800619978 20.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"Zhao H, Piwnica-Worms H. (2001) ATR-mediated checkpoint pathways regulate phosphorylation andactivation of human chk1, Mol Cell Biol 21:4129-39; PMID:11390642; http://dx.doi.org/10.1128/MCB.21.",OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2003) Sensing DNA damage through ATRIP recognition of RPA-ssDNA com- plexes, Science 300:1542-8; PMID:12791985; http://dx.doi.org/10.1126/science.1083430 22.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2011) hMSH2 recruits ATR to DNA damage sites for activation during DNA damage-induced apoptosis, J Biol Chem 286:10411-8; PMID:21285353; http://dx.doi.org/10.1074/jbc.M110.210989 23.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2013) ATR prohibits replication catastro- phe by preventing global exhaustion of RPA, Cell 155:1088-103; PMID:24267891; http://dx.doi.org/ 10.1016/j.cell.2013.10.043 24.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"Sirbu BM, Couch FB, Feigerle JT, Bhaskara S, Hiebert SW, Cortez D. (2011) Analysis of protein dynamics at active, stalled, and collapsed replication forks, Genes Dev 25:1320-7; PMID:21685366; http://dx.doi.org/10.1101/gad.2053211 25.",OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2011) Dynamics of DNA damage response proteins at DNA breaks: a focus on protein mod- iﬁcations, Genes Dev 25, 409-33; PMID:21363960; http://dx.doi.org/10.1101/gad.2021311 26.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"Stone HR, Morris JR. (2014) DNA damage emer- gency: cellular garbage disposal to the rescue?, Onco- gene 33:805-13; PMID:23503465; http://dx.doi.org/10.1038/onc.2013.6027.",OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2003) p53 has a direct apoptogenic role at the mitochondria, Mol Cell 11:577-90; PMID:12667443; http://dx.doi.org/10.1016/S1097-2765(03)00050-9 29.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2004) Recruitment of the cell cycle checkpoint kinase ATR tochromatin during S-phase, J Biol Chem 279:16433-40; PMID:14871897; http://dx.doi.org/10.1074/jbc.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2006) Recruitment of DNA dam- age checkpoint proteins to damage in transcribed andnontranscribed sequences, Mol Cell Biol 26:39-49; PMID:16354678; http://dx.doi.org/10.1128/MCB.26.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2011) A p53-independent role of mdm2 in estrogen-mediated activation of breast cancer cell pro-liferation, Breast Cancer Res 13:R3; PMID:21223569; http://dx.doi.org/10.1186/bcr2804 32.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2013) Drug-induced histoneeviction from open chromatin contributes to the che- motherapeutic effects of doxorubicin, Nat Commun 4:1908; PMID:23715267; http://dx.doi.org/10.1038/ncomms2921 33.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"Liu S, Shiotani B, Lahiri M, Marechal A, Tse A, Leung CC, Glover JN, Yang XH, Zou L. (2011) ATR auto- phosphorylation as a molecular switch for checkpoint activation, Mol Cell 43:192-202; PMID:21777809;http://dx.doi.org/10.1016/j.molcel.2011.06.019 34.",OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"Sorensen CS, Hansen LT, Dziegielewski J, Syljuasen RG, Lundin C, Bartek J, Helleday T. (2005) The cell-cycle checkpoint kinase chk1 is required for mamma- lian homologous recombination repair, Nat Cell Biol 7:195-201; PMID:15665856; http://dx.doi.org/ 10.1038/ncb1212 35.",OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2000) BRCA1 activation of the GADD45 promoter, Oncogene 19:4050-7; PMID:10962562; http://dx.doi.org/10.1038/sj.onc.1203759 37.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2011) Is post-transcriptional stabilization, splicing and translation of selective mRNAs a key to the DNA dam- age response?, Cell Cycle 10:23-7; PMID:21173571;http://dx.doi.org/10.4161/cc.10.1.14351 38.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2010) ATM-dependentchromatin changes silence transcription in cis to DNA double-strand breaks, Cell 141:970-81; PMID:20550933; http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"Helleday T. (2003) Pathways for mitotic homologous recombination in mammalian cells, Mutat Res 532:103-15; PMID:14643432; http://dx.doi.org/ 10.1016/j.mrfmmm.2003.08.013 40.",OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"Canaani D. (2013) Application of the concept synthetic lethality toward anticancer therapy: a promise fulﬁlled?, Cancer Lett 352(1):59-65; PMID:23962561; http://dx.doi.org/10.1016/j.canlet.2013.08.019 41.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"derivatives of decarba-moylmitosane and decarbamoylmitosene, J Med Chem 14:109-12; PMID:4993458; http://dx.doi.org/ 10.1021/jm00284a006 44.",Non-OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"(2000) Chromatin association of human origin recognition complex, cdc6, and mini- chromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis, Mol Cell Biol 20:8602-12; PMID:11046155;http://dx.doi.org/10.1128/MCB.20.22.8602- 8612.2000 754 Volume 14 Issue 5 Cell Cycle",OADS,/arxiv_data1/oa_pdf/fa/ec/kccy-14-744.PMC4418290.pdf
"The Cell Cycle: A Rapid Overview Mitosis represents a crucial event by which eukaryotic cells divide and equally segregate their genetic material into 2 daughter cells.1,2This process consists of 4 consecutive phases: prophase, when chromatin is condensed, nucleoli and nuclear membranedisappear, and the mitotic spindle is formed; metaphase, whenchromosomes are arranged at the equatorial plane of the cell; ana-phase, when chromatids separate toward the opposite sides of themitotic spindle; and telophase, in which chromosomes decondense © Jos /C19e M Frade and María C Ovejero-Benito *Correspondence to: Jos /C19e M Frade; Email: frade@cajal.csic.es Submitted: 11/19/2014; Revised: 12/23/2014; Accepted: 12/28/2014http://dx.doi.org/10.1080/15384101.2015.1004937 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Genes Cancer 2012; 3:731-8; PMID:23634260; http://dx.doi.org/ 10.1177/1947601912473308 2.,Non-OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Nat Rev Mol Cell Biol 2008; 9:910-6; PMID:18813291; http://dx.doi.org/10.1038/nrm2510 4.,OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Mol Biol Cell 2010; 21:3149-61; PMID:20660152; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Cell Cycle 2012; 11:2600-5; PMID:22732498; http://dx.doi.org/10.4161/cc.20758 10.,OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
PMID:21630153; http://dx.doi.org/10.1007/978-3-642-19065-0_16 11.,Non-OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Nat Rev Cancer 2009; 9:153-66; PMID:19238148; http://dx.doi.org/10.1038/nrc2602 13.,Non-OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Cell Cycle 2013; 12:1501-9; PMID:23598718; http://dx.doi.org/10.4161/cc.24637 16.,OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Dev Cell 2008;14:159-69; PMID:18267085; http://dx.doi.org/ 10.1016/j.devcel.2008.01.013 18.,OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Chromo-some Res 2011; 19:291-306; PMID:21194009; http://dx.doi.org/10.1007/s10577-010-9178-z 20.,Non-OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Genes Cancer 2010; 1:1124-31; PMID:21779436; http://dx.doi.org/10.1177/ 1947601910392989 21.,Non-OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Genes (Basel) 2014; 5:147-75;PMID:24705291; http://dx.doi.org/10.3390/genes 5010147 22.,Non-OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Prog Mol Biol Transl Sci 2012; 106:327-41; PMID:22340723; http://dx.doi.org/10.1016/B978-0-12-396456-4.00008-0 35.,OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Neurobiol Dis 2008; 31:230-41; PMID:18585919; http://dx.doi.org/ 10.1016/j.nbd.2008.04.010 36.,OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
J Neurochem 2014; 129:850-63; PMID:24460902; http://dx.doi.org/10.1111/jnc.12655 40.,Non-OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Neuron 2009;62:312-26; PMID:19447088; http://dx.doi.org/ 10.1016/j.neuron.2009.03.029 42.,OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Development 2013; 140:3079- 93; PMID:23861057; http://dx.doi.org/10.1242/ dev.091744 43.,OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Neurochem Int 2013; 62:719-30; PMID:23291249; http://dx.doi.org/ 10.1016/j.neuint.2012.12.015 51.,OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Science 2008; 319:1665-8; PMID:18356527; http://dx.doi.org/10.1126/science.1152337 59.,OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
J Biol Chem 2014; 289:18202-13; PMID:24828495 http://dx.doi.org/10.1074/jbc.M114.574145 60.,OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
PLoS One 2013; 8:e59133;PMID:23527113 http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Mol Biol Cell 2012; 23:4362- 72; PMID:23015754; http://dx.doi.org/10.1091/ mbc.E12-04-0293 72.,Non-OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Dev Dyn 2012; 241:1525-44; PMID:22837015; http://dx.doi.org/10.1002/dvdy.23840 73.,Non-OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Mol Cell Biol 2012; 32:2722- 37; PMID:22586272; http://dx.doi.org/10.1128/ MCB.00239-12 74.,Non-OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
J Neurosci 2013; 33:7488- 500; PMID:23616554; http://dx.doi.org/10.1523/ JNEUROSCI.3849-12.2013 78.,Non-OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Results Probl Cell Differ 2011;53:547-63; PMID:21630159; http://dx.doi.org/ 10.1007/978-3-642-19065-0_22 79.,Non-OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Prog Neurobiol 2009;89:1-17; PMID:19619927; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Am J Pathol 2010; 177:15-20; PMID:20472889;http://dx.doi.org/10.2353/ajpath.2010.090955 84.,Non-OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Mol Neurobiol 2012; 46:125-35; PMID:22528601; http://dx.doi.org/10.1007/ s12035-012-8262-0 88.,Non-OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
J Neurosci 2013;33:14645-59; PMID:24027266; http://dx.doi.org/ 10.1523/JNEUROSCI.1327-13.2013 96.,Non-OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
PLoS One 2013; 8:e64890; PMID:23741412;http://dx.doi.org/10.1371/journal.pone.0064890 111.,OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Cell Cycle 2014; 13:408-17; PMID:24247150; http://dx.doi.org/10.4161/cc.,OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Pharmacol Ther 2013;138:155-75; PMID:23348013; http://dx.doi.org/ 10.1016/j.pharmthera.2013.01.004 125.,Non-OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Nat Rev Neurol 2009; 5:311-22; PMID:19498435; http://dx.doi.org/ 10.1038/nrneurol.2009.54 126.,Non-OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
Nat Rev Mol Cell Biol 2013; 14:83-97; PMID:23325358 http://dx.doi.org/10.1038/nrm3507 130.,OADS,/arxiv_data1/oa_pdf/96/e6/kccy-14-712.PMC4418291.pdf
"2008;144(6):949-55, http://dx.doi.org/ 10.1016/j.surg.2008.08.030.",OADS,/arxiv_data1/oa_pdf/26/14/cln-70-04-247.PMC4418302.pdf
"2010;22(6):498-507, http://dx.doi.org/10.1016/j.clon.2010.04.007.",OADS,/arxiv_data1/oa_pdf/26/14/cln-70-04-247.PMC4418302.pdf
"2011;2:532-7, http://dx.doi.org/10.7150/jca.2.532.",Non-OADS,/arxiv_data1/oa_pdf/26/14/cln-70-04-247.PMC4418302.pdf
"2011;202(5):590-7, http://dx.doi.org/10.1016/j.amjsurg.2010.09.025.",OADS,/arxiv_data1/oa_pdf/26/14/cln-70-04-247.PMC4418302.pdf
"2005;89(3):136-42, http://dx.doi.org/10.1002/(ISSN)1096-9098.",Non-OADS,/arxiv_data1/oa_pdf/26/14/cln-70-04-247.PMC4418302.pdf
"2012;13(1):11-23, http://dx.doi.org/10.1007/s11864-011-0171-3.7.",Non-OADS,/arxiv_data1/oa_pdf/26/14/cln-70-04-247.PMC4418302.pdf
"2001;86(2):485-93, http://dx.doi.org/10.1210/jcem.86.2.7207.",Non-OADS,/arxiv_data1/oa_pdf/26/14/cln-70-04-247.PMC4418302.pdf
"1993;60(4):331-5, http://dx.doi.org/10.3949/ccjm.60.4.331.",Non-OADS,/arxiv_data1/oa_pdf/26/14/cln-70-04-247.PMC4418302.pdf
"2010;43(2):441-53, http://dx.doi.org/10.1016/ j.otc.2010.01.011.",OADS,/arxiv_data1/oa_pdf/26/14/cln-70-04-247.PMC4418302.pdf
"2010;136(7):969-74, http://dx.doi.org/10.1007/s00432-009-0740-z.",Non-OADS,/arxiv_data1/oa_pdf/26/14/cln-70-04-247.PMC4418302.pdf
"2009;3(2):140-9, http://dx.doi.org/10.1007/s12105-009-0115-4.",Non-OADS,/arxiv_data1/oa_pdf/26/14/cln-70-04-247.PMC4418302.pdf
"1999;86(3):538-44, http://dx.doi.org/10.1002/(ISSN)1097-0142.",Non-OADS,/arxiv_data1/oa_pdf/26/14/cln-70-04-247.PMC4418302.pdf
"2004;26(8):716-26, http://dx.doi.org/10.1002/(ISSN)1097-0347.",Non-OADS,/arxiv_data1/oa_pdf/26/14/cln-70-04-247.PMC4418302.pdf
"2010;34(11):2611-20, http://dx.doi.org/10.1007/s00268-010-0722-y.",Non-OADS,/arxiv_data1/oa_pdf/26/14/cln-70-04-247.PMC4418302.pdf
"2011;96(12):3679-86, http://dx.doi.org/10.1210/ jc.2011-1571.",Non-OADS,/arxiv_data1/oa_pdf/26/14/cln-70-04-247.PMC4418302.pdf
"2014;21(6):1891-7, http://dx.doi.org/10.1245/s10434-014-3530-z.Table 3 - Patient characteristics.",Non-OADS,/arxiv_data1/oa_pdf/26/14/cln-70-04-247.PMC4418302.pdf
"1998; 18(2):127-42, http://dx.doi.org/10.1016/S0272-7358(97)00085-8.",Non-OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
"2009;107(2):160 –1, http://dx.doi.org/10.1016/j.ijgo.2009.06.018.",OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
"2005;88(3):271-5, http://dx.doi.org/10.1016/j.ijgo.2004.12.001.",OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
"2005;27 (5):275-82, http://dx.doi.org/10.1590/S0100-72032005000500008.",Non-OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
"2011;113(3):187-91, http://dx.doi.org/10.1016/j.ijgo.",OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
"2008;12(8):961-9, http://dx.doi.org/10.1016/j.ejpain.2008.01.004.",OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
"2011;27(6):e293-300, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
"2010;89(6):794-800, http://dx.doi.org/10.3109/00016341003694978.",Non-OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
"2013;13:154, http://dx.doi.org/10.1186/1471-2393-13-154.",Non-OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
"2013;13:171, http://dx.doi.org/10.1186/1471-2393-13-171.",Non-OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
"1995;10(2): 104-9, http://dx.doi.org/10.1016/0268-0033(95)92047-P. 23.",Non-OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
"1996;21(6):702-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
"2006;17(3):219-3, http://dx.doi.org/10.1007/s00192-005- 1361-y.",Non-OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
"2007; 23(2):204-17, http://dx.doi.org/10.1016/j.midw.2006.06.006.",OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
"2014; 27(2):176-89, http://dx.doi.org/10.1080/10615806.2013.830107.",Non-OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
"2011;377(9780):1863-76, http://dx.doi.org/10.1016/S0140-6736(11)60138-4.",Non-OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
"2008;13(5):1521-34, http://dx.doi.org/ 10.1590/S1413-81232008000500017.",Non-OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
"2014;17(3):221-8, http://dx.doi.org/10.1007/s00737-013-0409-0.",Non-OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
"2014;23(1):9-16, http://dx.doi.org/ 10.1891/1058-1243.23.1.9.",Non-OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
"2009;374(9693):863-4, http://dx.doi.org/10.1016/S0140-6736(09)61610-X.",Non-OADS,/arxiv_data1/oa_pdf/46/b8/cln-70-04-231.PMC4418303.pdf
The expres-sion data and anatomical annotations together with sup-plemental information such as gene expression levels and chromosome location were compiled in a publicly available database named AGETAZ for Atlas of Gene Expression inthe Telencephalon of Adult Zebrafish that is accessible at http://cory.itg.kit.edu/agetaz/index.php.,OADS,/arxiv_data1/oa_pdf/ba/a1/cne0523-1202.PMC4418305.pdf
"The E-zone tool wasinstalled as a search option in the AGETAZ database (http://cory.itg.kit.edu/agetaz/index.php) for detection of genes coexpressed in a particular region, allowing further rapid evaluation of coexpression of these 640genes with those classified in specific patterns.",OADS,/arxiv_data1/oa_pdf/ba/a1/cne0523-1202.PMC4418305.pdf
"For further details on the TR genes expressed in particular ventricular regions, consult the AGETAZ data- base (http://cory.itg.kit.edu/agetaz/index.php) usingthe search options to group coexpressed genes.",OADS,/arxiv_data1/oa_pdf/ba/a1/cne0523-1202.PMC4418305.pdf
"We report here the expression pattern of 1,202 TR genes in the telencephalon of the adult zebra- fish, summarized in the searchable expression databaseAGETAZ (http://cory.itg.kit.edu/agetaz/index.php).",OADS,/arxiv_data1/oa_pdf/ba/a1/cne0523-1202.PMC4418305.pdf
"It was conducted in accordance with Good Clinical Practice 19and the Declaration of Helsinki,20and followed the accepted rules for interaction studies according to the US Food and Drug Administra- tion (FDA) Guidance for Industry21and the European Medicines Agency (EMA) guidelines.22The study was registered at http://ClinicalTrials.gov with the identi ﬁer NCT01324505.",Non-OADS,/arxiv_data1/oa_pdf/22/14/jcph0055-0497.PMC4418331.pdf
http://www.ich.org/ ﬁleadmin/Public_Web_Site/ICH_Prod- ucts/Guidelines/Ef ﬁcacy/E6_R1/Step4/E6_R1__Guideline.pdf.,Non-OADS,/arxiv_data1/oa_pdf/22/14/jcph0055-0497.PMC4418331.pdf
http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/22/14/jcph0055-0497.PMC4418331.pdf
Availablefrom URL: http://www.tbfacts.org/tb-statistics-india.html.,Non-OADS,/arxiv_data1/oa_pdf/ee/89/resp0020-0474.PMC4418345.pdf
"Classical clinical features of 3-M syndrome include a triangular face with a pointed chin, a long Open AccessA Deeb and others Novel mutation in 3-M syndrome phenotypeID: 15-0012; May 2015 DOI: 10.1530/EDM-15-0012 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd",Non-OADS,/arxiv_data1/oa_pdf/9f/bf/edmcr-2015-150012.PMC4418346.pdf
A Deeb and others Novel mutation in 3-M syndrome phenotypeID: 15-0012; May 2015 DOI: 10.1530/EDM-15-0012 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/9f/bf/edmcr-2015-150012.PMC4418346.pdf
A Deeb and others Novel mutation in 3-M syndrome phenotypeID: 15-0012; May 2015 DOI: 10.1530/EDM-15-0012 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/9f/bf/edmcr-2015-150012.PMC4418346.pdf
(doi:10.1016/j.beem.2010.08.015 ) Received in ﬁnal form 11 March 2015 Accepted 1 April 2015 A Deeb and others Novel mutation in 3-M syndrome phenotypeID: 15-0012; May 2015 DOI: 10.1530/EDM-15-0012 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/9f/bf/edmcr-2015-150012.PMC4418346.pdf
21CFR58: Good Laboratory Practice for Nonclinical Laboratory Studies 2013: http://www.accessdata.fda.gov/scri pts/cdrh/cfdocs/cfcfr/ CFRSearch.cfm?CFRPart ¼ 58&showFR ¼1.,Non-OADS,/arxiv_data1/oa_pdf/b9/9a/jcph0055-0525.PMC4418347.pdf
Guidance for Industry: Bioanalytical Method Validation 2001: http://www.fda.gov/downloads/Drugs/Guidances/ucm070107.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b9/9a/jcph0055-0525.PMC4418347.pdf
"2012;308(17):1775-84, http://dx.doi.org/ 10.1001/jama.2012.14517.",Non-OADS,/arxiv_data1/oa_pdf/3d/81/cln-70-04-242.PMC4418353.pdf
"2013; 267(3):718-26, http://dx.doi.org/10.1148/radiol.13121669.",Non-OADS,/arxiv_data1/oa_pdf/3d/81/cln-70-04-242.PMC4418353.pdf
"2014;174(1):64-72, http://dx.doi.org/10.1016/j.ijcard.2014.03.163.",OADS,/arxiv_data1/oa_pdf/3d/81/cln-70-04-242.PMC4418353.pdf
"2013;24(2):135-41, http://dx.doi.org/10.1097/MCA.0b013e32835be39a.",Non-OADS,/arxiv_data1/oa_pdf/3d/81/cln-70-04-242.PMC4418353.pdf
"2009; 3(2):122-36, http://dx.doi.org/10.1016/j.jcct.2009.01.001.",OADS,/arxiv_data1/oa_pdf/3d/81/cln-70-04-242.PMC4418353.pdf
"2011;12(4):416-23, http://dx.doi.org/10.3348/kjr.2011.12.4.416.",Non-OADS,/arxiv_data1/oa_pdf/3d/81/cln-70-04-242.PMC4418353.pdf
"2013;166(1):90-5, http://dx.doi.org/10.1016/j.ijcard.2011.10.003.",OADS,/arxiv_data1/oa_pdf/3d/81/cln-70-04-242.PMC4418353.pdf
"2012;41(1): 27-33, http://dx.doi.org/10.1024/0301-1526/a000160.",Non-OADS,/arxiv_data1/oa_pdf/3d/81/cln-70-04-242.PMC4418353.pdf
"2008;94(11):1386-93, http://dx.doi.org/10.1136/hrt.2008.145292.",Non-OADS,/arxiv_data1/oa_pdf/3d/81/cln-70-04-242.PMC4418353.pdf
"2001;10(2):146-52, http://dx.doi.org/10.1046/j.1440- 6047.2001.00224.x.Table 4 - Atherosclerotic plaques between the two groups.",Non-OADS,/arxiv_data1/oa_pdf/3d/81/cln-70-04-242.PMC4418353.pdf
"2009;19(8):548-54, http://dx.doi.org/10.1016/j.numecd.2008.10.006.",OADS,/arxiv_data1/oa_pdf/3d/81/cln-70-04-242.PMC4418353.pdf
"2013;22(1):16-8, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/3d/81/cln-70-04-242.PMC4418353.pdf
"2008;359(22):2324-36, http://dx.doi.org/10.1056/NEJMoa0806576.",Non-OADS,/arxiv_data1/oa_pdf/3d/81/cln-70-04-242.PMC4418353.pdf
"2012; 76(5):1182-9, http://dx.doi.org/10.1253/circj.CJ-11-1078.",Non-OADS,/arxiv_data1/oa_pdf/3d/81/cln-70-04-242.PMC4418353.pdf
"2014;234(2):426-35, http://dx.doi.org/ 10.1016/j.atherosclerosis.2014.02.011.",Non-OADS,/arxiv_data1/oa_pdf/3d/81/cln-70-04-242.PMC4418353.pdf
"2013;178(1):12-21, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/3d/81/cln-70-04-242.PMC4418353.pdf
Available from: http://www.inca.gov.br/estimativa/ 2012/.,Non-OADS,/arxiv_data1/oa_pdf/92/ef/cln-70-04-289.PMC4418354.pdf
"2011;45(6):1009-8, http://dx.doi.org/10.1590/S0034-89102011005000076.",Non-OADS,/arxiv_data1/oa_pdf/92/ef/cln-70-04-289.PMC4418354.pdf
"2008;5(6):e132, http://dx.doi.org/10.1371/journal.pmed.0050132.",Non-OADS,/arxiv_data1/oa_pdf/92/ef/cln-70-04-289.PMC4418354.pdf
"2013; 8(1):22, http://dx.doi.org/10.1186/1750-9378-8-22.8.",Non-OADS,/arxiv_data1/oa_pdf/92/ef/cln-70-04-289.PMC4418354.pdf
"2007;25(33):6257-70, http://dx.doi.org/10.1016/j.vaccine.2007.05.058.",Non-OADS,/arxiv_data1/oa_pdf/92/ef/cln-70-04-289.PMC4418354.pdf
"2009;27(40):5519-29, http://dx.doi.org/10.1016/j.vaccine.2009.06.097.",Non-OADS,/arxiv_data1/oa_pdf/92/ef/cln-70-04-289.PMC4418354.pdf
"2008;11(1):135-50, http://dx.doi.org/10.3111/13696990801961611.",Non-OADS,/arxiv_data1/oa_pdf/92/ef/cln-70-04-289.PMC4418354.pdf
"2011;29(32):5245-9, http://dx.doi.org/ 10.1016/j.vaccine.2011.05.018.",Non-OADS,/arxiv_data1/oa_pdf/92/ef/cln-70-04-289.PMC4418354.pdf
"2012;30(42):6016-9, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/92/ef/cln-70-04-289.PMC4418354.pdf
"2007;105(2):335-40, http://dx.doi.org/10.1016/j.ygyno.2006.12.010.",Non-OADS,/arxiv_data1/oa_pdf/92/ef/cln-70-04-289.PMC4418354.pdf
"2008;18(3):253-60, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/92/ef/cln-70-04-289.PMC4418354.pdf
"2012;26(1):63-78, http://dx.doi.org/10.1016/j.hoc.2011.10.008.",OADS,/arxiv_data1/oa_pdf/92/ef/cln-70-04-289.PMC4418354.pdf
"2011; 121(3):431-3, http://dx.doi.org/10.1016/j.ygyno.2011.04.010.",OADS,/arxiv_data1/oa_pdf/92/ef/cln-70-04-289.PMC4418354.pdf
"First published online February 24, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(4): 286-291, http://dx.doi.org/10.1590/1414-431X20144222 ISSN 1414-431X Review Braz J Med Biol Res 48(4) 2015 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/4a/33/1414-431X-bjmbr-48-04-00286.PMC4418357.pdf
"First published online February 24, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(4): 292-298, http://dx.doi.org/10.1590/1414-431X20144310 ISSN 1414-431X Review Braz J Med Biol Res 48(4) 2015 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/3e/9a/1414-431X-bjmbr-48-04-00292.PMC4418358.pdf
"First published online February 13, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(4): 299-307, http://dx.doi.org/10.1590/1414-431X20144226 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 48(4) 2015",Non-OADS,/arxiv_data1/oa_pdf/bc/a6/1414-431X-bjmbr-48-04-00299.PMC4418359.pdf
"First published online February 13, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(4): 308-315, http://dx.doi.org/10.1590/1414-431X20144127 ISSN 1414-431X Braz J Med Biol Res 48(4) 2015 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/a4/7a/1414-431X-bjmbr-48-04-00308.PMC4418360.pdf
"First published online February 13, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(4): 316-320, http://dx.doi.org/10.1590/1414-431X20144336 ISSN 1414-431X Braz J Med Biol Res 48(4) 2015 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/a4/6f/1414-431X-bjmbr-48-04-00316.PMC4418361.pdf
"First published online February 13, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(4): 321-331, http://dx.doi.org/10.1590/1414-431X20144187 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 48(4) 2015",Non-OADS,/arxiv_data1/oa_pdf/e7/2d/1414-431X-bjmbr-48-04-00321.PMC4418362.pdf
"First published online February 13, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(4): 332-338, http://dx.doi.org/10.1590/1414-431X20144217 ISSN 1414-431X Braz J Med Biol Res 48(4) 2015 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/7a/74/1414-431X-bjmbr-48-04-00332.PMC4418363.pdf
"First published online February 13, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(4): 339-343, http://dx.doi.org/10.1590/1414-431X20143969 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 48(4) 2015",Non-OADS,/arxiv_data1/oa_pdf/30/46/1414-431X-bjmbr-48-04-00339.PMC4418364.pdf
"First published online February 24, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(4): 344-348, http://dx.doi.org/10.1590/1414-431X20144211 ISSN 1414-431X Braz J Med Biol Res 48(4) 2015 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/1d/5d/1414-431X-bjmbr-48-04-00344.PMC4418365.pdf
"First published online February 24, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(4): 349-353, http://dx.doi.org/10.1590/1414-431X20144235 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 48(4) 2015",Non-OADS,/arxiv_data1/oa_pdf/e5/96/1414-431X-bjmbr-48-04-00349.PMC4418366.pdf
"First published online February 24, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(4): 354-362, http://dx.doi.org/10.1590/1414-431X20143467 ISSN 1414-431X Braz J Med Biol Res 48(4) 2015 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/4d/ba/1414-431X-bjmbr-48-04-00354.PMC4418367.pdf
"First published online February 24, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(4): 363-369, http://dx.doi.org/10.1590/1414-431X20143619 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 48(4) 2015",Non-OADS,/arxiv_data1/oa_pdf/6c/74/1414-431X-bjmbr-48-04-00363.PMC4418368.pdf
"First published online February 24, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(4): 370-376, http://dx.doi.org/10.1590/1414-431X20144294 ISSN 1414-431X Braz J Med Biol Res 48(4) 2015 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/be/0b/1414-431X-bjmbr-48-04-00370.PMC4418369.pdf
"2010;62(5):600-10, http://dx.doi.org/10.1002/ acr.20140.",Non-OADS,/arxiv_data1/oa_pdf/4a/0a/cln-70-04-296.PMC4418374.pdf
"2011;66(6):973-8, http://dx.doi.org/ 10.1590/S1807-59322011000600009.3.",Non-OADS,/arxiv_data1/oa_pdf/4a/0a/cln-70-04-296.PMC4418374.pdf
"2013;68(2):135-40, http://dx.doi.org/10.6061/clinics.",Non-OADS,/arxiv_data1/oa_pdf/4a/0a/cln-70-04-296.PMC4418374.pdf
"1988;77(3):187-91, http://dx.doi.org/10.1111/ane.1988.77.issue-3.",Non-OADS,/arxiv_data1/oa_pdf/4a/0a/cln-70-04-296.PMC4418374.pdf
"1999;353(9162):1390-6, http://dx.doi.org/10.1016/S0140-6736(98)08428-1.",Non-OADS,/arxiv_data1/oa_pdf/4a/0a/cln-70-04-296.PMC4418374.pdf
"1990;33(2):160-72, http://dx.doi.org/10.1002/ (ISSN)1529-0131.",Non-OADS,/arxiv_data1/oa_pdf/4a/0a/cln-70-04-296.PMC4418374.pdf
"2002;6(3):256-61, http://dx.doi.org/10.1023/A:1016333109829.",Non-OADS,/arxiv_data1/oa_pdf/4a/0a/cln-70-04-296.PMC4418374.pdf
"2000;29(4):197-9, http://dx.doi.org/10.1016/S0049-0172 (00)80008-6.",OADS,/arxiv_data1/oa_pdf/4a/0a/cln-70-04-296.PMC4418374.pdf
"1992;48(3):371-5,http://dx.doi.org/10.1016/0304-3959(92)90086-Q.",OADS,/arxiv_data1/oa_pdf/4a/0a/cln-70-04-296.PMC4418374.pdf
"1998;41(11):1966-71, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4a/0a/cln-70-04-296.PMC4418374.pdf
"2000;5(1):57-71, http://dx.doi.org/10.1023/ A:1009898107964.",Non-OADS,/arxiv_data1/oa_pdf/4a/0a/cln-70-04-296.PMC4418374.pdf
"2002;13(5):427-31, http://dx.doi.org/10.1046/j.1540-8167.2002.00427.x.",Non-OADS,/arxiv_data1/oa_pdf/4a/0a/cln-70-04-296.PMC4418374.pdf
"2001;22(16):1374-450, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4a/0a/cln-70-04-296.PMC4418374.pdf
"2004;1(6):732-8, http://dx.doi.org/10.1016/j.hrthm.2004.09.003.",OADS,/arxiv_data1/oa_pdf/4a/0a/cln-70-04-296.PMC4418374.pdf
"1989;14(6):1511- 8, http://dx.doi.org/10.1016/0735-1097(89)90390-2.",Non-OADS,/arxiv_data1/oa_pdf/4a/0a/cln-70-04-296.PMC4418374.pdf
"PM R. 2014;6(9):802-7, http://dx.doi.org/ 10.1016/j.pmrj.2014.02.007.29.",OADS,/arxiv_data1/oa_pdf/4a/0a/cln-70-04-296.PMC4418374.pdf
"2010;62(5):611-7, http://dx.doi.org/10.1002/acr.20118.",Non-OADS,/arxiv_data1/oa_pdf/4a/0a/cln-70-04-296.PMC4418374.pdf
"2010;49(3):195-203, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
http://www.who.int/whr/1996/en/whr96_en.pdf?ua = 1 (1996 acessed 10 feb 2013).,OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"2005;28(2):171-4, http://dx.doi.org/10.1097/00004356- 200506000-00012.",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"2003;12(2):59-65, http://dx.doi.org/ 10.1044/1059-0889(2003/011).",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"2007;13(5):501-8, http://dx.doi.org/10.1089/tmj.",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"Online Referencing, http://www.asha.org/policy/ GL1997-00199.htm (1997 acessed 10 feb 2013).",OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"1970;92(4):311-24, http://dx.doi.org/10.1001/archotol.1970.04310040005002.",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"2010;16(5):557-63, http://dx.doi.org/ 10.1089/tmj.2009.0143.",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"2010;16(5):248-52, http://dx.doi.org/10.1258/jtt.2010.090906.",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"2012;18(8):485-9, http://dx.doi.org/10.1258/jtt.2012.",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"2013;42:21, http://dx.doi.org/10.1186/1916-0216-42-21.",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"2006;33(3):259-63, http://dx.doi.org/10.1016/j.anl.2005.11.013.",OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"2010;36(3):323-31, http://dx.doi.org/10.1111/cch.2010.36.issue-3.",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"2011;32 (5):799-804, http://dx.doi.org/10.1097/MAO.0b013e31821b0d07.",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"2001;40(3):141-7, http://dx.doi.org/10.3109/00206090109073109.",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"2009; 163(2):158-63, http://dx.doi.org/10.1001/archpediatrics.2008.526.",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"1984;5(4):205-10, http://dx.doi.org/10.1097/ 00003446-198407000-00005.",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"2003;9(4):375-8, http://dx.doi.org/ 10.1089/153056203772744707.",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"2013;13(1):6, http://dx.doi.org/10.1186/1472-6815-13-6.",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"2012;19(1):1-7, http://dx.doi.org/10.1258/jms.2012.011051.",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"2009; 15(7):678-81, http://dx.doi.org/10.1089/tmj.2009.0013.",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
"2010;16(2):181-200, http://dx.doi.org/ 10.1089/tmj.2009.0111.",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/cln-70-04-283.PMC4418376.pdf
Correspondence to : Bogdan Banecki (Telephone: +48-58-5236324; Fax: +48- 58-5236427; E-mail: banecki@biotech.ug.edu.pl) This article contains supplementary material available from the authors upon request or via the Internet at http://onlinelibrary.wiley.com/.,Non-OADS,/arxiv_data1/oa_pdf/aa/76/jps0104-1275.PMC4418381.pdf
"The DOI: 10.6061/clinics/2015(04)10Copyright &2015 CLINICS – This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/6d/cln-70-04-278.PMC4418383.pdf
"2005;31(1): 5-19, http://dx.doi.org/10.1093/schbul/sbi020.",Non-OADS,/arxiv_data1/oa_pdf/5e/6d/cln-70-04-278.PMC4418383.pdf
"2011;125(2 –3):161-8, http://dx.doi.org/10.1016/j.schres.2010.09.015.",OADS,/arxiv_data1/oa_pdf/5e/6d/cln-70-04-278.PMC4418383.pdf
"2004;68(2 –3):283-97, http://dx.doi.org/10.1016/j.schres.2003.09.011.",OADS,/arxiv_data1/oa_pdf/5e/6d/cln-70-04-278.PMC4418383.pdf
"2004;71(2 –3):273-83, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5e/6d/cln-70-04-278.PMC4418383.pdf
"2011;6(5):e20469, http://dx.doi.org/10.1371/journal.pone.0020469.",Non-OADS,/arxiv_data1/oa_pdf/5e/6d/cln-70-04-278.PMC4418383.pdf
"2007;22(6):365-70, http://dx.doi.org/10.1016/j.eurpsy.2007.02.001.",OADS,/arxiv_data1/oa_pdf/5e/6d/cln-70-04-278.PMC4418383.pdf
"2007;61(6):602-9, http://dx.doi.org/ 10.1111/pcn.2007.61.issue-6.",Non-OADS,/arxiv_data1/oa_pdf/5e/6d/cln-70-04-278.PMC4418383.pdf
"2011;26(2):74-7, http://dx.doi.org/10.1016/j.eurpsy.2009.10.006.",Non-OADS,/arxiv_data1/oa_pdf/5e/6d/cln-70-04-278.PMC4418383.pdf
"2011;26(2):69-73, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/5e/6d/cln-70-04-278.PMC4418383.pdf
"2008;29(2):85-92, http://dx.doi.org/10.1007/ s10072-008-0866-9.",Non-OADS,/arxiv_data1/oa_pdf/5e/6d/cln-70-04-278.PMC4418383.pdf
"2014;68(2):160-6, http://dx.doi.org/10.1111/pcn.2014.68.issue-2.",Non-OADS,/arxiv_data1/oa_pdf/5e/6d/cln-70-04-278.PMC4418383.pdf
"2000;22(3):106-5, http://dx.doi.org/10.1590/S1516-44462000000300003.14.",Non-OADS,/arxiv_data1/oa_pdf/5e/6d/cln-70-04-278.PMC4418383.pdf
"1987;13(2):261-76, http://dx.doi.org/10.1093/schbul/13.2.261.",Non-OADS,/arxiv_data1/oa_pdf/5e/6d/cln-70-04-278.PMC4418383.pdf
"2012; ISBN 3-900051-07-0, URL http://www.R-project.org/ 19.",Non-OADS,/arxiv_data1/oa_pdf/5e/6d/cln-70-04-278.PMC4418383.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on The Journal of Antibiotics website (http://www.nature.com/ja)Two new amides isolated from Myrothecium sp.",Non-OADS,/arxiv_data1/oa_pdf/d6/1f/ja2014136a.PMC4418385.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ef/f2/jbm-6-131.PMC4418388.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Blood Medicine 2015:6 131–141Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  131Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S5463 2Profile of efraloctocog alfa and its potential   in the treatment of hemophilia A Lindsey A George1,2 Rodney M Camire1–3 1Division of Hematology, The  Children’s Hospital of Philadelphia,  Philadelphia, PA, USA;  2Center for  Cellular and Molecular Therapeutics,  The Children’s Hospital of  Philadelphia, Philadelphia, PA, USA;   3Department of Pediatrics, Perelman  School of Medicine, University of  Pennsylvania, Philadelphia, PA, USA Correspondence: Rodney M Camire   University of Pennsylvania Perelman  School of Medicine, The Children’s  Hospital of Philadelphia, The Colket  Translational Research Building,  Room 5018, Philadelphia, PA 19104, USA   email rcamire@mail.med.upenn.ed uAbstract:  Hemophilia care has improved dramatically over the past  50 years, evolving from  plasma concentrates, to purified plasma proteins, to recombinant clotting factors.",Non-OADS,/arxiv_data1/oa_pdf/ef/f2/jbm-6-131.PMC4418388.pdf
"Available from: http://www.nature.com/nri/journal/v7/n9/full/nri2155.htm l. Abbreviation:  Fc, dimeric constant region.",OADS,/arxiv_data1/oa_pdf/ef/f2/jbm-6-131.PMC4418388.pdf
Available from: http://www1.wfh.org/publication/files/pdf-1472.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ef/f2/jbm-6-131.PMC4418388.pdf
Available from: https://ash.confex.com/ ash/2014/webprogram/Paper70146.html.,Non-OADS,/arxiv_data1/oa_pdf/ef/f2/jbm-6-131.PMC4418388.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/ef/f2/jbm-6-131.PMC4418388.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/f2/jbm-6-131.PMC4418388.pdf
Available from: https://ash.confex.com/ash/2014/webprogram/ Paper67797.html.,Non-OADS,/arxiv_data1/oa_pdf/ef/f2/jbm-6-131.PMC4418388.pdf
Available from: https://ash.confex.com/ash/2014/webprogram/ Paper75077.html .,Non-OADS,/arxiv_data1/oa_pdf/ef/f2/jbm-6-131.PMC4418388.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1d/32/ijwh-7-449.PMC4418389.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 449–458International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  449RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S5555 2Benefits, risks, and safety of external beam  radiation therapy for breast cancer Lindsay C Brown1 Robert W Mutter1 Michele Y Halyard2 1Department of Radiation Oncology,   Mayo Clinic, Rochester, MN,   2Department of Radiation Oncology,   Mayo Clinic, Scottsdale, AZ, USAAbstract:  Breast cancer is a common and complex disease often necessitating multimo - dality care.",Non-OADS,/arxiv_data1/oa_pdf/1d/32/ijwh-7-449.PMC4418389.pdf
"Although oncologically effective, the procedure was morbid and disfiguring Correspondence: Michele Y Halyard Department of Radiation Oncology,  13400 East Shea Boulevard, Scottsdale,  AZ 85259, USA Tel +1 480 301 8000 Fax +1 480 301 7687 email mhalyard@mayo.ed u Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2015 Volume: 7 Running head verso: Brown et al Running head recto: Breast radiotherapy review DOI: http://dx.doi.org/10.2147/IJWH.S55552",Non-OADS,/arxiv_data1/oa_pdf/1d/32/ijwh-7-449.PMC4418389.pdf
"Available from: http://globocan.iarc.f r. Accessed July 24, 2014.",Non-OADS,/arxiv_data1/oa_pdf/1d/32/ijwh-7-449.PMC4418389.pdf
Available from: http://www.choosingwisely.,Non-OADS,/arxiv_data1/oa_pdf/1d/32/ijwh-7-449.PMC4418389.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/1d/32/ijwh-7-449.PMC4418389.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1d/32/ijwh-7-449.PMC4418389.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/a1/copd-10-823.PMC4418390.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 823–830International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  823OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7895 2Do females behave differently in COPD  exacerbation?,Non-OADS,/arxiv_data1/oa_pdf/56/a1/copd-10-823.PMC4418390.pdf
"Methods subjects Six hundred eighteen patients with COPD were evaluated  retrospectively from January  2000 to January 2010 at the Department of Pulmonary Medicine, Gazi University Correspondence: nurdan Kokturk Department of Pulmonary Medicine,  school of Medicine, gazi University  school of Medicine, 06500  Besevler,  ankara, Turkey Tel +90 312 202 6121 Fax +90 312 212 9019 email kokturk.nurdan@gmail.co mJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Kilic et al Running head recto: Female phenotype and COPD exacerbation DOI: http://dx.doi.org/10.2147/COPD.S78952",Non-OADS,/arxiv_data1/oa_pdf/56/a1/copd-10-823.PMC4418390.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/56/a1/copd-10-823.PMC4418390.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/a1/copd-10-823.PMC4418390.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a7/42/rmhp-8-073.PMC4418391.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pRisk Management and Healthcare Policy 2015:8 73–80Risk Management and Healthcare Policy Dove press submit your manuscript | www.dovepress.co m Dove press  73ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/RMHP .S7817 9Prescription of potentially inappropriate  medication in older persons in switzerland:   does the dispensing channel make a difference?,Non-OADS,/arxiv_data1/oa_pdf/a7/42/rmhp-8-073.PMC4418391.pdf
Available from: https://ideas.repec.org/p/ube/ dpvwib/dp1303.html /.,Non-OADS,/arxiv_data1/oa_pdf/a7/42/rmhp-8-073.PMC4418391.pdf
"Available from: http://www.raonline.ch/pages/ag/pdf/AG-LU- Portrait2010.pd f. Accessed January 6, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a7/42/rmhp-8-073.PMC4418391.pdf
Available from: http://www.whocc.no/atc_ddd_index /.,OADS,/arxiv_data1/oa_pdf/a7/42/rmhp-8-073.PMC4418391.pdf
"Avail - able from: http://www.bfs.admin.ch/bfs/portal/de/index/themen/01/02/ blank/dos/mittlere/01.html  Accessed February 11, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a7/42/rmhp-8-073.PMC4418391.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/a7/42/rmhp-8-073.PMC4418391.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/42/rmhp-8-073.PMC4418391.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/86/copd-10-831.PMC4418394.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2015:10 831–841International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  831OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8161 1Inter-alpha-trypsin inhibitor heavy chain 4: a  novel biomarker for environmental exposure  to particulate air pollution in patients with  chronic obstructive pulmonary disease Kang-Yun lee1–3 Po-hao Feng1,2 shu-Chuan ho4 Kai-Jen Chuang5,6 Tzu-Tao Chen2,3 Chien-ling su2,4 Wen-T e liu2,4 hsiao-Chi Chuang2,4 1Department of Internal Medicine,   school of Medicine, College of  Medicine, Taipei Medical University,   2Division of Pulmonary Medicine,   Department of Internal Medicine,   shuang ho hospital, Taipei Medical  University, 3graduate Institute  of Clinical Medicine, College of  Medicine, Taipei Medical University,   4school of respiratory Therapy,   College of Medicine, Taipei Medical  University, 5Department of Public  health, school of Medicine, College  of Medicine, Taipei Medical University,   6school of Public health, College of  Public health and nutrition, Taipei  Medical University, Taipei, TaiwanAbstract:  Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease  that is correlated with environmental stress.",Non-OADS,/arxiv_data1/oa_pdf/71/86/copd-10-831.PMC4418394.pdf
"However, the effects of PM10 on protein  expression in COPD are not well understood.Correspondence: hsiao-Chi Chuang Taiwan CardioPulmonary research  group, school of respiratory Therapy,  College of Medicine, Taipei Medical  University, 250 Wuxing street,  Taipei City 110, Taipei, Taiwan Tel +886 2 2736 1661 ext 3515 Fax +886 2 2739 1143 email r92841005@ntu.edu.t w Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Lee et al Running head recto: Inter-alpha-trypsin inhibitor heavy chain 4 DOI: http://dx.doi.org/10.2147/COPD.S81611",Non-OADS,/arxiv_data1/oa_pdf/71/86/copd-10-831.PMC4418394.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/71/86/copd-10-831.PMC4418394.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/86/copd-10-831.PMC4418394.pdf
"2013;31(4):432-7, http://dx.doi.org/10.1016/j.clindermatol.2013.01.010.",OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"2012;26(1): 13-24, http://dx.doi.org/10.1016/j.berh.2012.01.011.",OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"Autoimmun Rev.2011;10(1):241-3, http://dx.doi.org/10.1016/j.autrev.2010.09.008.",OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"2009;4(6):e5903, http://dx.doi.org/ 10.1371/journal.pone.0005903.",Non-OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"2012;188(8):3573-83, http://dx.doi.org/10.4049/jimmunol.1100591.",Non-OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"2014;16(1):R4, http://dx.doi.org/10.1186/ ar4430.",Non-OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"2008;151(2):79-87, http://dx.doi.org/10.1016/j.trsl.2007.11.005.",OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"2012;30(4):843-52, http://dx.doi.org/ 10.1159/000341462.",Non-OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"2013;8(2):e56774, http://dx.doi.org/10.1371/journal.pone.0056774.",Non-OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"J Ethnopharma- col. 2010;129(2):273-9, http://dx.doi.org/10.1016/j.jep.2010.03.021.",Non-OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"2014;9(4):e94957, http://dx.doi.org/10.1371/ journal.pone.0094957.",Non-OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"2009;125(3):436-43, http://dx.doi.org/10.1016/j.jep.2009.07.020.",OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"2001; 60(6):592-8, http://dx.doi.org/10.1136/ard.60.6.592.",Non-OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"2007;568(1-3):213-21, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"2008;83(11-12):394-403, http://dx.doi.org/10.1016/j.lfs.2008.07.011.",OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"2012;23(2):212-9, http://dx.doi.org/10.1097/CAD.0b013e32834e5592.",Non-OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"2010;33(11):1828-34, http://dx.doi.org/10.1248/bpb.33.1828.",Non-OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"2010;31(12):1569-75, http://dx.doi.org/ 10.1038/aps.2010.176.",Non-OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"2011;39(2):381-94, http://dx.doi.org/10.1142/ S0192415X11008890.",Non-OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"1999;31(4):174-8,http://dx.doi.org/10.1038/emm.1999.28.",Non-OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
"2014; 34(2):266-76, http://dx.doi.org/10.1159/000362997.",Non-OADS,/arxiv_data1/oa_pdf/e7/73/cln-70-04-250.PMC4418395.pdf
Data accessibility The data are available at the Utah State University research data reposi-tory: http://digitalcommons.usu.edu/all_datasets/6/.,OADS,/arxiv_data1/oa_pdf/fd/22/JPE-52-467.PMC4418398.pdf
Tel: +44 (0) 115 8231090; fax: +44 (0) 115 8231409; e-mail: robin.spiller@nottingham.ac.uk View the podcast on this paper at the following sites: Youtube: https://www.youtube.com/watch?v=UiW_cJp6nGA iTunes: https://itunes.apple.com/gb/podcast/ neurogastroenterology-motility/id976042116 Received : 20 November 2014 Accepted for publication : 23 January 2015 ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/c4/nmo0027-0542.PMC4418402.pdf
"To view a copy ofthis license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/CTRC Variants and Chronic Pancreatitis LaRusch et al.",Non-OADS,/arxiv_data1/oa_pdf/f3/d8/ctg201413a.PMC4418406.pdf
"FD patients overestimated their median (IQR) lifetime risk of developing any cancer at 50% (50 –73%), in contrast to reported lifetime estimates of developing cancerfrom the American Cancer Society of 45% in men and 38% in women (http://www.cancer.org/cancer/cancerbasics/lifetime- probability-of-developing-or-dying-from-cancer).",Non-OADS,/arxiv_data1/oa_pdf/28/d4/ctg201418a.PMC4418407.pdf
"To view a copy ofthis license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Medication Risk-Taking Behavior in FD Patients Lacy et al.",Non-OADS,/arxiv_data1/oa_pdf/28/d4/ctg201418a.PMC4418407.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Response threshold for NASHA/Dx Sanchez et al.",Non-OADS,/arxiv_data1/oa_pdf/f0/67/ctg201420a.PMC4418408.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Clinical and Trans lational Gastroenterology website ( http://www.nat ure.com/ctg)Exclusive Enteral Nutrition and Crohn ’s Disease Kaakoush et al.",Non-OADS,/arxiv_data1/oa_pdf/49/56/ctg201421a.PMC4418409.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Pancreatic Juice PGE2 in Chronic Pancreatitis Abu Dayyeh et al.",Non-OADS,/arxiv_data1/oa_pdf/a8/cc/ctg201423a.PMC4418410.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/TP-IAT Kesseli et al.",Non-OADS,/arxiv_data1/oa_pdf/b0/17/ctg20152a.PMC4418411.pdf
"http://e-cnr.org104 This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.© 2015 The Korean Society of Clinical Nutrition Clin Nutr Res 2015;4:104-109 http://dx.doi.org/10.7762/cnr.2015.4.2.104 pISSN 2287-3732 ∙ eISSN 2287-3740Original Article *Corresponding author  Li Li Address  Department of Nutrition and Food Hygiene, School of Pub - lic Health, Anhui Medical University, 81 Meishan Road, Hefei, Anhui  230032, PR China Tel +86-551-63869176   Fax +86-551-63869179 E-mail  li1964li@163.com †These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/f3/d7/cnr-4-104.PMC4418414.pdf
"Risk Factors in Relation to Fetal Macrosomia105 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.104triglyceride (TG), gestational weight gain and other blood pa - rameters [10-14].",Non-OADS,/arxiv_data1/oa_pdf/f3/d7/cnr-4-104.PMC4418414.pdf
http://e-cnr.org106        http://dx.doi.org/10.7762/cnr.2015.4.2.104Table 1.,Non-OADS,/arxiv_data1/oa_pdf/f3/d7/cnr-4-104.PMC4418414.pdf
"Risk Factors in Relation to Fetal Macrosomia107 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.1041.09]), and pre-pregnancy BMI (OR = 1.53, 95% CI [1.05-2.23]),  respectively.",Non-OADS,/arxiv_data1/oa_pdf/f3/d7/cnr-4-104.PMC4418414.pdf
http://e-cnr.org108        http://dx.doi.org/10.7762/cnr.2015.4.2.104factors.,Non-OADS,/arxiv_data1/oa_pdf/f3/d7/cnr-4-104.PMC4418414.pdf
Risk Factors in Relation to Fetal Macrosomia109 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.104tational weight gain and pregnancy outcomes.,Non-OADS,/arxiv_data1/oa_pdf/f3/d7/cnr-4-104.PMC4418414.pdf
"http://e-cnr.org110 Clin Nutr Res 2015;4:110-123 http://dx.doi.org/10.7762/cnr.2015.4.2.110pISSN 2287-3732 ∙ eISSN 2287-3740Original Article © 2015 The Korean Society of Clinical Nutrition  This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/17/cnr-4-110.PMC4418415.pdf
"Dietary Intakes and Colorectal Cancer111 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.1 10Introduction Cancer has been the leading cause of death which accounts  for approximately 28% of the total number of deaths in Korea  [1], and colorectal cancer is the third most common cancer  and the fourth most common cause of cancer-related death.",Non-OADS,/arxiv_data1/oa_pdf/6a/17/cnr-4-110.PMC4418415.pdf
"http://e-cnr.org112        http://dx.doi.org/10.7762/cnr.2015.4.2.1 10each item was classified as ‘less than standard’, ‘standard’, and  ‘more than standard’ and the food figures were presented for  standard intake.",Non-OADS,/arxiv_data1/oa_pdf/6a/17/cnr-4-110.PMC4418415.pdf
Dietary Intakes and Colorectal Cancer113 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.1 10Table 1.,Non-OADS,/arxiv_data1/oa_pdf/6a/17/cnr-4-110.PMC4418415.pdf
http://e-cnr.org114        http://dx.doi.org/10.7762/cnr.2015.4.2.1 10Table 2.,Non-OADS,/arxiv_data1/oa_pdf/6a/17/cnr-4-110.PMC4418415.pdf
"Dietary Intakes and Colorectal Cancer115 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.1 10group than the lowest tertile intake group (ORT3 vs T1 = 0.31,  95% CI: 0.17-0.58, p for trend = 0.010) but this difference also  disappeared after adjustment for covariates.",Non-OADS,/arxiv_data1/oa_pdf/6a/17/cnr-4-110.PMC4418415.pdf
http://e-cnr.org116        http://dx.doi.org/10.7762/cnr.2015.4.2.1 10Table 3.,Non-OADS,/arxiv_data1/oa_pdf/6a/17/cnr-4-110.PMC4418415.pdf
Dietary Intakes and Colorectal Cancer117 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.1 10cancer risk in a case-control study among Korean adults.,Non-OADS,/arxiv_data1/oa_pdf/6a/17/cnr-4-110.PMC4418415.pdf
"http://e-cnr.org118        http://dx.doi.org/10.7762/cnr.2015.4.2.1 10also showed a significantly lower risk of colorectal cancer in  the group with high dietary fiber intake compared to those  with low dietary fiber intake [16], and the risk of colorectal  cancer decreased as whole grain intake increased in males  [17].",Non-OADS,/arxiv_data1/oa_pdf/6a/17/cnr-4-110.PMC4418415.pdf
Dietary Intakes and Colorectal Cancer119 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.1 10toxins.,Non-OADS,/arxiv_data1/oa_pdf/6a/17/cnr-4-110.PMC4418415.pdf
"http://e-cnr.org120        http://dx.doi.org/10.7762/cnr.2015.4.2.1 10intake increased odds for colorectal cancer incidence, which  is consistent with previous studies.",Non-OADS,/arxiv_data1/oa_pdf/6a/17/cnr-4-110.PMC4418415.pdf
Dietary Intakes and Colorectal Cancer121 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.1 10Table 7.,Non-OADS,/arxiv_data1/oa_pdf/6a/17/cnr-4-110.PMC4418415.pdf
http://e-cnr.org122        http://dx.doi.org/10.7762/cnr.2015.4.2.1 10of rice cakes or breads is a marker of a certain dietary pattern  rather than it is an independent factor for colorectal cancer.,Non-OADS,/arxiv_data1/oa_pdf/6a/17/cnr-4-110.PMC4418415.pdf
Available from http://ncc.re.kr/manage/man - age03_033_list.jsp [cited 2015 April 1].,OADS,/arxiv_data1/oa_pdf/6a/17/cnr-4-110.PMC4418415.pdf
Available from https://knhanes.cdc.go.kr/knhanes/in - dex.do [cited 2014 April 20].,OADS,/arxiv_data1/oa_pdf/6a/17/cnr-4-110.PMC4418415.pdf
Available  from https://knhanes.cdc.go.kr/knhanes/index.do [cited 2014 April 20].,OADS,/arxiv_data1/oa_pdf/6a/17/cnr-4-110.PMC4418415.pdf
Dietary Intakes and Colorectal Cancer123 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.1 10diaries.,Non-OADS,/arxiv_data1/oa_pdf/6a/17/cnr-4-110.PMC4418415.pdf
"http://e-cnr.org124 This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.© 2015 The Korean Society of Clinical Nutrition Clin Nutr Res 2015;4:124-131 http://dx.doi.org/10.7762/cnr.2015.4.2.124 pISSN 2287-3732 ∙ eISSN 2287-3740Original Article *Corresponding author  Beom Joon Kim Address  Department of Dermatology, Chung-Ang University College  of Medicine, 84 Heukseok-ro, Dongjak-gu, Seoul, 156-755, Korea  Tel +82-2-6299-1525   Fax +82-2-823-1049 E-mail  beomjoon@unitel.co.krReceived March 2, 2015 Revised March 23, 2015 Accepted March 30, 2015Efficacy of Cistanche Tubulosa  and Laminaria Japonica   Extracts (MK-R7) Supplement in Preventing Patterned  Hair Loss and Promoting Scalp Health Joon Seok1, Tae Su Kim2, Hyun Jung Kwon1, Sung Pyo Lee2, Myung Hwa Kang3,   Beom Joon Kim1*, Myeung Nam Kim1 1Department of Dermatology, Chung-Ang University College of Medicine, Seoul 156-755, Korea   2 Misuba RTech Co., Ltd., Asan 336-795, Korea   3Department of Food and Nutrition, Hoseo University, Asan 336-795, Korea Cistanche tubulosa  and Laminaria japonica  have been reported to have anti-oxidative, anticoagulant, anti-cancer and anti- inflammatory properties.",Non-OADS,/arxiv_data1/oa_pdf/0e/45/cnr-4-124.PMC4418416.pdf
"Hair Loss Prevention of Cistanche Tubulosa  and Laminaria Japonica  Extract (MK-R7)125 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.124Introduction Recently, the occurrence of patterned hair loss has been  significantly increased among the middle-aged adults but also  among young adults, and has made several hindrances in their  social life.",Non-OADS,/arxiv_data1/oa_pdf/0e/45/cnr-4-124.PMC4418416.pdf
http://e-cnr.org126        http://dx.doi.org/10.7762/cnr.2015.4.2.124ing women were also excluded from this study.,Non-OADS,/arxiv_data1/oa_pdf/0e/45/cnr-4-124.PMC4418416.pdf
"Hair Loss Prevention of Cistanche Tubulosa  and Laminaria Japonica  Extract (MK-R7)127 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.1248 weeks of consumption, and 182.84  ± 32.98 (n/cm2) at 16 weeks  of product consumption.",Non-OADS,/arxiv_data1/oa_pdf/0e/45/cnr-4-124.PMC4418416.pdf
"http://e-cnr.org128        http://dx.doi.org/10.7762/cnr.2015.4.2.124Changes in hair diameter The mean hair diameter of the test group was 0.063 ± 0.014  (mm) prior to product consumption, 0.079 ± 0.045 (mm) after  8 weeks of consumption, and 0.086 ± 0.018 (mm) after 16  weeks of consumption.",Non-OADS,/arxiv_data1/oa_pdf/0e/45/cnr-4-124.PMC4418416.pdf
Hair Loss Prevention of Cistanche Tubulosa  and Laminaria Japonica  Extract (MK-R7)129 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.124but the difference between the groups was not statistically  significant (p > 0.05) (Figure 5A).,Non-OADS,/arxiv_data1/oa_pdf/0e/45/cnr-4-124.PMC4418416.pdf
http://e-cnr.org130        http://dx.doi.org/10.7762/cnr.2015.4.2.124the control group did show a difference (p = 0.042) (Figure  6B).,OADS,/arxiv_data1/oa_pdf/0e/45/cnr-4-124.PMC4418416.pdf
Hair Loss Prevention of Cistanche Tubulosa  and Laminaria Japonica  Extract (MK-R7)131 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.124sessed considerable antioxidant activities.,Non-OADS,/arxiv_data1/oa_pdf/0e/45/cnr-4-124.PMC4418416.pdf
"http://e-cnr.org132 This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.© 2015 The Korean Society of Clinical Nutrition Clin Nutr Res 2015;4:132-136 http://dx.doi.org/10.7762/cnr.2015.4.2.132 pISSN 2287-3732 ∙ eISSN 2287-3740Case Report Introduction Mitochondrial neurogastrointestinal encephalopathy (MNGIE)  is caused by mutations in the nuclear gene TYMP.",Non-OADS,/arxiv_data1/oa_pdf/ab/31/cnr-4-132.PMC4418417.pdf
"Nutrition Therapy for Mitochondrial Neurogastrointestinal Encephalopathy133 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.13235 years, and approximately 33% of the patients were born  to consanguineous parents.",Non-OADS,/arxiv_data1/oa_pdf/ab/31/cnr-4-132.PMC4418417.pdf
"http://e-cnr.org134 http://dx.doi.org/10.7762/cnr.2015.4.2.132Discussion In the present case, according to the clinical features and  homozygous mutation of the TYMP gene (c.217G > A), the  patient was diagnosed with MNGIE [1].",Non-OADS,/arxiv_data1/oa_pdf/ab/31/cnr-4-132.PMC4418417.pdf
"Nutrition Therapy for Mitochondrial Neurogastrointestinal Encephalopathy135 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.132liver biopsy samples presented varying severity of pathological  changes, ranging from portal area inflammatory infiltration to  necrosis, even though they had normal liver function.",Non-OADS,/arxiv_data1/oa_pdf/ab/31/cnr-4-132.PMC4418417.pdf
http://e-cnr.org136 http://dx.doi.org/10.7762/cnr.2015.4.2.132on Parenteral Nutrition: intensive care.,Non-OADS,/arxiv_data1/oa_pdf/ab/31/cnr-4-132.PMC4418417.pdf
"http://e-cnr.org69 Clin Nutr Res 2015;4:69-75 http://dx.doi.org/10.7762/cnr.2015.4.2.69pISSN 2287-3732 ∙ eISSN 2287-3740Review Article © 2015 The Korean Society of Clinical Nutrition  This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/1c/cnr-4-69.PMC4418418.pdf
"http://e-cnr.org70 http://dx.doi.org/10.7762/cnr.2015.4.2.69Carbohydrate restriction is largely driven by the notion of   sugar ‘toxicity’, or the deleterious effects of carbohydrate- induced hyperglycemia.",Non-OADS,/arxiv_data1/oa_pdf/b8/1c/cnr-4-69.PMC4418418.pdf
"Effects of Carbohydrates on Endothelial Function  71 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.69that, in an acute setting, a high carbohydrate load will ad - versely affect postprandial endothelial events.",Non-OADS,/arxiv_data1/oa_pdf/b8/1c/cnr-4-69.PMC4418418.pdf
http://e-cnr.org72 http://dx.doi.org/10.7762/cnr.2015.4.2.69carbohydrate restriction from the effects due to alterations in  other macronutrients.,Non-OADS,/arxiv_data1/oa_pdf/b8/1c/cnr-4-69.PMC4418418.pdf
Effects of Carbohydrates on Endothelial Function  73 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.69tions were corroborated by the two randomized controlled tri - als undertaken in this field.,OADS,/arxiv_data1/oa_pdf/b8/1c/cnr-4-69.PMC4418418.pdf
"http://e-cnr.org74 http://dx.doi.org/10.7762/cnr.2015.4.2.69dissected through a series of meta-analyses [51-54], but the  effects on FMD per se have yet to be reviewed.",OADS,/arxiv_data1/oa_pdf/b8/1c/cnr-4-69.PMC4418418.pdf
Effects of Carbohydrates on Endothelial Function  75 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.69changes in adipocyte biology.,Non-OADS,/arxiv_data1/oa_pdf/b8/1c/cnr-4-69.PMC4418418.pdf
Avail - able from https://clinicaltrials.gov/ct2/show/study/NCT02245399 [cited  2015 Mar 5].,Non-OADS,/arxiv_data1/oa_pdf/b8/1c/cnr-4-69.PMC4418418.pdf
"http://e-cnr.org76 Clin Nutr Res 2015;4:76-89 http://dx.doi.org/10.7762/cnr.2015.4.2.76 pISSN 2287-3732 ∙ eISSN 2287-3740Original Article This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.© 2015 The Korean Society of Clinical Nutrition *Corresponding author  Cheong-Min Sohn Address  Department of Food and Nutrition, Wonkwang University,  460 Iksan-daero, Iksan 570-749, Korea Tel +82-63-850-6656, Fax +82-63-850-5363 E-mail  ccha@wku.ac.kr Received April 7, 2015 Revised April 15, 2015 Accepted  April 15, 2015Introduction Prevalence of chronic illnesses is increasing due to rapid  economic development, undesirable lifestyle and diet, and the  increase of elderly population [1,2].",Non-OADS,/arxiv_data1/oa_pdf/12/04/cnr-4-76.PMC4418419.pdf
"Job Standards of Clinical Nutrition Therapy for Dyslipidemia77 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.76the development of dyslipidemia [7] and, especially, a diet is  the most influencing factor to dyslipidemia [8].",Non-OADS,/arxiv_data1/oa_pdf/12/04/cnr-4-76.PMC4418419.pdf
"http://e-cnr.org78        http://dx.doi.org/10.7762/cnr.2015.4.2.76Field application evaluation  For field application evaluation, 10 medical institutions  among those with most trainings on dyslipidemia were se - lected based on the size and region of institution.",Non-OADS,/arxiv_data1/oa_pdf/12/04/cnr-4-76.PMC4418419.pdf
Job Standards of Clinical Nutrition Therapy for Dyslipidemia79 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.76Table 3 shows the current status of dyslipidemia nutrition  education.,Non-OADS,/arxiv_data1/oa_pdf/12/04/cnr-4-76.PMC4418419.pdf
"http://e-cnr.org80        http://dx.doi.org/10.7762/cnr.2015.4.2.76The job of clinical dietitians for dyslipidemia patients was  analyzed based on the DACUM method, and the job specifica - tion included duties, tasks, and task elements.",OADS,/arxiv_data1/oa_pdf/12/04/cnr-4-76.PMC4418419.pdf
"Job Standards of Clinical Nutrition Therapy for Dyslipidemia81 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.76Field application evaluation General information on the subjects and nutrition  practice in medical institutions  Field application evaluation was performed by working  clinical dietitians at 10 medium and large hospitals, and Table  4 shows general information on patients with dyslipidemia  to whom the study was applied.",Non-OADS,/arxiv_data1/oa_pdf/12/04/cnr-4-76.PMC4418419.pdf
http://e-cnr.org82        http://dx.doi.org/10.7762/cnr.2015.4.2.76Table 8.,Non-OADS,/arxiv_data1/oa_pdf/12/04/cnr-4-76.PMC4418419.pdf
Job Standards of Clinical Nutrition Therapy for Dyslipidemia83 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.76Table 8.,Non-OADS,/arxiv_data1/oa_pdf/12/04/cnr-4-76.PMC4418419.pdf
http://e-cnr.org84        http://dx.doi.org/10.7762/cnr.2015.4.2.76Table 8.,Non-OADS,/arxiv_data1/oa_pdf/12/04/cnr-4-76.PMC4418419.pdf
Job Standards of Clinical Nutrition Therapy for Dyslipidemia85 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.76Table 8.,Non-OADS,/arxiv_data1/oa_pdf/12/04/cnr-4-76.PMC4418419.pdf
http://e-cnr.org86 http://dx.doi.org/10.7762/cnr.2015.4.2.76Table 8.,Non-OADS,/arxiv_data1/oa_pdf/12/04/cnr-4-76.PMC4418419.pdf
"Job Standards of Clinical Nutrition Therapy for Dyslipidemia87 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.76Final version of job standards of clinical nutrition  service for dyslipidemia The draft job standards were shown to relevant institutions  for advice and review, and, after field application evaluation  and discussions, experts mainly suggested that the criteria for  ‘basic’ and ‘recommended’ tasks need to be more specified;  there are too many task elements and items in job description  evaluation; and job standards for other diseases were needed  as well.",Non-OADS,/arxiv_data1/oa_pdf/12/04/cnr-4-76.PMC4418419.pdf
http://e-cnr.org88 http://dx.doi.org/10.7762/cnr.2015.4.2.76tion and management of patients.,Non-OADS,/arxiv_data1/oa_pdf/12/04/cnr-4-76.PMC4418419.pdf
Available  from http://www.kostat.go.kr [cited 2015 March 15].,Non-OADS,/arxiv_data1/oa_pdf/12/04/cnr-4-76.PMC4418419.pdf
Available from http://www.kidee2011.or.kr/ [cited 2015  March 15].,Non-OADS,/arxiv_data1/oa_pdf/12/04/cnr-4-76.PMC4418419.pdf
Job Standards of Clinical Nutrition Therapy for Dyslipidemia89 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.76foodservice: centering around Kyoungsang buk-do.,Non-OADS,/arxiv_data1/oa_pdf/12/04/cnr-4-76.PMC4418419.pdf
"http://e-cnr.org90 This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.© 2015 The Korean Society of Clinical Nutrition Clin Nutr Res 2015;4:90-96 http://dx.doi.org/10.7762/cnr.2015.4.2.90 pISSN 2287-3732 ∙ eISSN 2287-3740Original Article *Corresponding author  Mi-Hyun Kim  Address  Department of Food and Nutrition, Korea National Univer - sity of Transportation, 61 Daehak-ro, Jeungpyeong-gun 368-701,  Korea Tel +82-43-820-5335  Fax +82-43-820-5335 E-mail  mhkim1129@ut.ac.kr Received April 5, 2015 Revised April 9, 2015 Accepted April 10, 2015Introduction Digestive diseases commonly occur in Koreans and account  for 1/3 of internal diseases [1].",Non-OADS,/arxiv_data1/oa_pdf/f8/14/cnr-4-90.PMC4418420.pdf
 Dietary and Biochemical Characteristics of Patients with Chronic Gastritis91 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.90and seems to be a cause of the incidence of gastric cancer  [4].,Non-OADS,/arxiv_data1/oa_pdf/f8/14/cnr-4-90.PMC4418420.pdf
"http://e-cnr.org92               http://dx.doi.org/10.7762/cnr.2015.4.2.90Analysis of biochemical indices Serum glucose and lipids were analyzed using an auto - analyzer (ADVIA 1650, Bayer, Massachusetts, USA) based on  enzymatic principle.",OADS,/arxiv_data1/oa_pdf/f8/14/cnr-4-90.PMC4418420.pdf
 Dietary and Biochemical Characteristics of Patients with Chronic Gastritis93 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.90starchy foods  than control subjects.,Non-OADS,/arxiv_data1/oa_pdf/f8/14/cnr-4-90.PMC4418420.pdf
http://e-cnr.org94               http://dx.doi.org/10.7762/cnr.2015.4.2.90Table 3.,Non-OADS,/arxiv_data1/oa_pdf/f8/14/cnr-4-90.PMC4418420.pdf
 Dietary and Biochemical Characteristics of Patients with Chronic Gastritis95 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.90significantly higher serum triglyceride level than normal con - trol group (99.2 mg/dL).,Non-OADS,/arxiv_data1/oa_pdf/f8/14/cnr-4-90.PMC4418420.pdf
http://e-cnr.org96               http://dx.doi.org/10.7762/cnr.2015.4.2.90take and risk of gastric cancer: a meta-analysis of prospective studies.,Non-OADS,/arxiv_data1/oa_pdf/f8/14/cnr-4-90.PMC4418420.pdf
"http://e-cnr.org97 Clin Nutr Res 2015;4:97-103 http://dx.doi.org/10.7762/cnr.2015.4.2.97pISSN 2287-3732 ∙ eISSN 2287-3740Original Article This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.© 2015 The Korean Society of Clinical Nutrition *Corresponding author  Oh Yoen Kim Address  Department of Food Science and Nutrition, Dong-A Univer - sity, 840 Hadan-dong, Saha-gu, Busan 604-714, Korea Tel +82-51-200-7326  Fax +82-51-200-7535 E-mail  oykim@dau.ac.kr Received April 5, 2015 Revised April 9, 2015 Accepted April 10, 2015Introduction Diabetes mellitus (DM) is not only an important and depen - dent risk factor, but also a predictor of adverse outcomes for  cardio-cerebrovascular diseases (i.e.",Non-OADS,/arxiv_data1/oa_pdf/58/ca/cnr-4-97.PMC4418421.pdf
"http://e-cnr.org98        http://dx.doi.org/10.7762/cnr.2015.4.2.97associated with a marked excess in cardiovascular disease  (CVD) risk independent of classical CVD risk factors [6,7].",Non-OADS,/arxiv_data1/oa_pdf/58/ca/cnr-4-97.PMC4418421.pdf
Glycated Hemoglobin and Cardiometabolic Risk in Non-diabetes99 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.97respectively).,Non-OADS,/arxiv_data1/oa_pdf/58/ca/cnr-4-97.PMC4418421.pdf
"http://e-cnr.org100 http://dx.doi.org/10.7762/cnr.2015.4.2.974.0               4.2                 4.4                4.6                 4.8                5.0100 80 60 40 4                                   5                                   6                               7100 80 60 40Diastolic BP (mmHg) r0 =   0.206, p = 0.050 r1 = -0.013, p = 0.690r0 = 0.225, p = 0.032 r1 = 0.190, p = 0.049 4.0               4.2                 4.4                4.6                 4.8                5.080 60 4020 0 4                                   5                                   6                               780 6040 20 0AST (U/L)r0 = 0.237, p = 0.024 r1 = 0.142, p = 0.207r0 = 0.368, p <  0.0001 r1 = 0.262, p = 0.018 4.0               4.2                 4.4                4.6                 4.8                5.080 604020 0 4.0                                5.0                              6.0                             7.080 604020 0ALT (U/L) Glucose (mg/dL)øHgbAIC (%)r0 = 0.296, p = 0.004 r1 = 0.106, p = 0.345r0 = 0.356, p = 0.001r1 = 0.277, p = 0.012 Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/58/ca/cnr-4-97.PMC4418421.pdf
"Glycated Hemoglobin and Cardiometabolic Risk in Non-diabetes101 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.97of DBP, AST, ALT, and HDL-cholesterol with HgbA1C were still  maintained, but those with fasting glucose disappeared.",Non-OADS,/arxiv_data1/oa_pdf/58/ca/cnr-4-97.PMC4418421.pdf
http://e-cnr.org102 http://dx.doi.org/10.7762/cnr.2015.4.2.97dysfunction (i.e.,Non-OADS,/arxiv_data1/oa_pdf/58/ca/cnr-4-97.PMC4418421.pdf
Glycated Hemoglobin and Cardiometabolic Risk in Non-diabetes103 http://e-cnr.org http://dx.doi.org/10.7762/cnr.2015.4.2.9717.,Non-OADS,/arxiv_data1/oa_pdf/58/ca/cnr-4-97.PMC4418421.pdf
"To view a copy ofthis license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Clinical and Trans lational Gastroenterology website ( http://www.nat ure.com/ctg)Association of elevated CA19-9 with increased mortality Hsu et al.",Non-OADS,/arxiv_data1/oa_pdf/c7/26/ctg201422a.PMC4418494.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Gut Instincts: My Perspective 2 Clinical and Translational Gastroenterology",Non-OADS,/arxiv_data1/oa_pdf/16/c0/ctg20153a.PMC4418495.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/bb/main.PMC4418767.pdf
http://dx.doi.org/10.1016/j.bbacli.2014.06.001 2214-6474/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/bb/main.PMC4418767.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/bb/main.PMC4418767.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/2b/bb/main.PMC4418767.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/Telomere length and cortisol reactivity in children IH Gotlib et al 620 Molecular Psychiatry (2015), 615 –620 © 2015 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/05/5d/mp2014119a.PMC4419149.pdf
The exact cause Open AccessA Ozderya and others A case of Madelung’s disease ID: 14-0119; April 2015 DOI: 10.1530/EDM-14-0119 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd,Non-OADS,/arxiv_data1/oa_pdf/1d/9c/edmcr-2015-140119.PMC4419150.pdf
A Ozderya and others A case of Madelung’s disease ID: 14-0119; April 2015 DOI: 10.1530/EDM-14-0119 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/1d/9c/edmcr-2015-140119.PMC4419150.pdf
A Ozderya and others A case of Madelung’s disease ID: 14-0119; April 2015 DOI: 10.1530/EDM-14-0119 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/1d/9c/edmcr-2015-140119.PMC4419150.pdf
A Ozderya and others A case of Madelung’s disease ID: 14-0119; April 2015 DOI: 10.1530/EDM-14-0119 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/1d/9c/edmcr-2015-140119.PMC4419150.pdf
108.007005 ) Received in ﬁnal form 27 January 2015 Accepted 1 April 2015 A Ozderya and others A case of Madelung’s disease ID: 14-0119; April 2015 DOI: 10.1530/EDM-14-0119 http://www.edmcasereports.com 5,Non-OADS,/arxiv_data1/oa_pdf/1d/9c/edmcr-2015-140119.PMC4419150.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Role of Foxp1 in cognition and behaviour C Bacon et al 639 © 2015 Macmillan Publishers Limited Molecular Psychiatry (2015), 632 –639",Non-OADS,/arxiv_data1/oa_pdf/e7/ad/mp2014116a.PMC4419151.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/40265_2015_Article_386.PMC4419154.pdf
http://www.nccn.org/ .,Non-OADS,/arxiv_data1/oa_pdf/22/6a/40265_2015_Article_386.PMC4419154.pdf
http://www.nccn.org/ .,Non-OADS,/arxiv_data1/oa_pdf/22/6a/40265_2015_Article_386.PMC4419154.pdf
2013. http://www.ema.europa.eu/ docs/en_GB/document_library/Summary_of_opinion/human/ 000741/WC500144827.pdf .,Non-OADS,/arxiv_data1/oa_pdf/22/6a/40265_2015_Article_386.PMC4419154.pdf
2013. http://www.ema.europa.eu/docs/en_ GB/document_library/EPAR_-_Product_Information/human/000741/WC500047710.pdf .,Non-OADS,/arxiv_data1/oa_pdf/22/6a/40265_2015_Article_386.PMC4419154.pdf
2013. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000558/WC500029119.pdf .,Non-OADS,/arxiv_data1/oa_pdf/22/6a/40265_2015_Article_386.PMC4419154.pdf
European Society of Pathology: colon external quality assessment scheme 2014. http://kras.eqascheme.org/ .,Non-OADS,/arxiv_data1/oa_pdf/22/6a/40265_2015_Article_386.PMC4419154.pdf
2011. http://www.bbc.co.uk/news/health-15032862 .,Non-OADS,/arxiv_data1/oa_pdf/22/6a/40265_2015_Article_386.PMC4419154.pdf
"http://www.accessdata.fda.gov/ drugsatfda_docs/label/2009/019090s053,019593s042lbl.pdf.",Non-OADS,/arxiv_data1/oa_pdf/b4/12/JPP-6-100.PMC4419240.pdf
Available from: http://www.office.microsoft.com/en.us/excel.,Non-OADS,/arxiv_data1/oa_pdf/e9/7f/JPP-6-116.PMC4419246.pdf
Available  from: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm  409950.htm.,Non-OADS,/arxiv_data1/oa_pdf/e8/ed/JPP-6-118.PMC4419247.pdf
Available from: http://www.fda.gov/downloads/Advisory  Committees/CommitteesMeetingMaterials/Drugs/Peripheraland Central  Nervous System Drugs Advisory Committee/UCM352970.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e8/ed/JPP-6-118.PMC4419247.pdf
Available  from: http://www.bloomberg.com/news/2011‑01‑28/actelion‑glaxo‑stop  ‑development‑of‑insomnia‑medicine‑on‑safety‑concern.html.,Non-OADS,/arxiv_data1/oa_pdf/e8/ed/JPP-6-118.PMC4419247.pdf
Available from: http://www.youthkiawaaz.com/2011/04/indian‑  education‑system‑analysis/.,Non-OADS,/arxiv_data1/oa_pdf/8d/9c/JPP-6-61.PMC4419249.pdf
Available from: http://www.scholarlyoa.,Non-OADS,/arxiv_data1/oa_pdf/8d/9c/JPP-6-61.PMC4419249.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/c2/70/JPP-6-71.PMC4419251.pdf
Available from: http://www.mciindia.org/RulesandRegulations/Codeof  Medical Ethics Regulations 2002.aspx.,Non-OADS,/arxiv_data1/oa_pdf/c1/8a/JPP-6-83.PMC4419253.pdf
Accessed from: http://www.WHO‑UMC.org/graphics/24734.,Non-OADS,/arxiv_data1/oa_pdf/27/3b/JPP-6-91.PMC4419255.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/e7/93/JPP-6-94.PMC4419256.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/e7/93/JPP-6-94.PMC4419256.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.4049/jimmunol.179.5.317 1 Bartlett, N.W., L. Slater, N. Glanville, J.J. Haas, G. Caramori, P. Casolari,  D.L.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi   .org/10.1002/emmm.20120165 0 Behera, A.K., M. Kumar, R.F.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1074/jbc.M20021120 0 Bhoj, V.G., Q.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1007/s12016-013-8368- 9 Boyapalle, S., T. Wong, J. Garay, M. Teng, H. San Juan-Vergara, S.  Mohapatra, and S. Mohapatra.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1371/ journal.pone.002938 6 Conrady, C.D., M. Zheng, N.A.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi   .org/10.1038/mi.2012.4 6 Crane, M.J., K.L.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.4049/jimmunol.090020 5 Culley , F .J., J. Pollott, and P .J.M.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1084/jem.2002094 3 Culley, F.J., A.M.J.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1128/JVI.80.9.4521-4527.200 6 Davidson, S., S. Crotta, T.M.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"5:3864. http://dx.doi.org/10.1038/ncomms486 4 Demoor, T., B.C.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.4049/jimmunol.120176 3 Deshmane, S.L., S. Kremlev, S. Amini, and B.E.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1089/jir.2008.002 7 Durant, L.R., C. Pereira, A. Boakye, S. Makris, F. Kausar, M. Goritzka, and  C. Johansson.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"44:2340– 2348. http://dx.doi.org/10.1002/eji.20144445 4 El Saleeby, C.M., and J.P. Devincenzo.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1002/jmv.2203 9 Everitt, A.R., S. Clare, J.U.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1371/journal.pone.008072 3 Garofalo, R.P ., J. Patti, K.A.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1086/32278 8 Goritzka, M., L.R.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
Online supple - mental material is available at http://www.jem.org/cgi/content/full/jem   .20140825/DC1.,Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10   .1038/ni73 6 Awomoyi, A.A., P .",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.4049/jimmunol   .166.7.469 7 Majer, O., C. Bourgeois, F .",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi   .org/10.1371/journal.ppat.100281 1 Marr, N., S.E.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1016/   j.tim.2013.08.00 6 McNamara, P .S., B.F .",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1164/ajrccm   .152.4.755139 5 Messier, E.M., R.J. Mason, and B. Kosmider.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.3109/01902148.2012.71307 7 Miller, A.L., T.L.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1086/38295 8 Narasaraju, T., H.H.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1165/rcmb.2008-0423O C Perkins, S.M., D.L.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi   .org/10.1016/j.immuni.2012.10.01 6 Pribul, P.K., J. Harker, B. Wang, H. Wang, J.S.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi   .org/10.1128/JVI.02541-0 7 Ravi, L.I., L. Li, R. Sutejo, H. Chen, P.S.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"14:190. http://dx.doi.org/10.1186/1471-2164-14-19 0 Rutigliano, J.A., and B.S.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.4049/jimmunol.173.5.340 8 Samstein, M., H.A.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"201:311– 317. http://dx.doi.org/10.1007/s00430-012-0233- 6 Schijf, M.A., M.V .",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1016/j.immuni   .2013.05.00 7 Grainger, J.R., E.A.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1038/nm.318 9 Haeberle, H.A., W .A.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1128/JVI.75.2.878-890.200 1 Helft, J., B. Manicassamy, P .",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1172/JCI6065 9 Herold, S., M. Steinmueller, W. von Wulffen, L. Cakarova, R. Pinto, S.  Pleschka, M. Mack, W.A.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1084/jem.2008020 1 Hussell, T ., and T .J.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1038/nri360 0 Iijima, N., L.M.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1086/52088 6 Jewell, N.A., N. Vaghefi, S.E.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1128/JVI.00530-0 7 Kumagai, Y ., O. Takeuchi, H. Kato, H. Kumar, K. Matsui, E. Morii, K. Aozasa,  T. Kawai, and S. Akira.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1016/j.immuni.2007.07.01 3 Lee, D.C.P ., J.A.E.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi   .org/10.1128/JVI.00796-1 0 Lin, K.L., Y .",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.4049/jimmunol.180.4.256 2 Ling, Z., K.C.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1128/JVI.01740-0 6 Loebbermann, J., H. Thornton, L. Durant, T. Sparwasser, K.E.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1038/mi.2011.6 2 Loo, Y .-M., J. Fornek, N. Crochet, G. Bajwa, O. Perwitasari, L. Martinez- Sobrido, S. Akira, M.A.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1128/JVI.01080-0 7 Mack, M., J. Cihak, C. Simonis, B. Luckow, A.E.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1371/ journal.pone.008169 5 Schoggins, J.W ., D.A.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1038/   nature1286 2 Segura, E., M. Touzot, A. Bohineust, A. Cappuccio, G. Chiocchia, A.  Hosmalin, M. Dalod, V. Soumelis, and S. Amigorena.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.10.01 8 Seo, S.-U., H.-J.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1371/journal   .ppat.100130 4 Serbina, N.V ., and E.G.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1038/ni130 9 Serbina, N.V., T.P.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10   .1038/nri307 0 Siezen, C.L.E., L. Bont, H.M. Hodemaekers, M.J. Ermers, G. Doornbos,  R. Van’t Slot, C. Wijmenga, H.C. Houwelingen, J.L.L.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1097/INF.0b013e31818e2aa 9 Slater, L., N.W.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10   .1084/jem.2005235 9 Spann, K.M., K.C.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi   .org/10.1128/JVI.78.8.4363-4369.200 4 Stark, J.M., A.M. Khan, C.L.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1086/42724 1 Tal, G., A. Mandelberg, I. Dalal, K. Cesar, E. Somekh, A. Tal, A. Oron, S.  Itskovich, A. Ballin, S. Houri, et al.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1086/   42083 0 Tulic, M.K., R.J. Hurrelbrink, C.M.",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.4049/jimmunol.179.1.13 2 Welliver, R.C., R.P .",OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
"http://dx.doi.org/10.1097/00006454-200205000-   00033 Y oboua, F ., A. Martel, A. Duval, E. Mukawera, and N. Grandvaux.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
84:7267– 7277. http://dx.doi.org/10.1128/JVI.00142-1 0,Non-OADS,/arxiv_data1/oa_pdf/b0/16/JEM_20140825.PMC4419339.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1016/j.coi.2012   .04.01 1 Browne, S.K., and S.M.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"10:534– 541. http://dx.doi.org/10.1097/ACI.0b013e3283402b4 1 Casanova, J.L., and L. Abel.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"14:215– 243. http://dx.doi.org/10.1146/annurev-genom-091212-15344 8 Casanova, J.L., L. Abel, and L. Quintana-Murci.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1101/sqb.2013.78.01996 8 Casanova, J.L., M.E.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/   10.1084/jem.2014052 0 Chandesris, M.O., I. Melki, A. Natividad, A. Puel, C. Fieschi, L. Y un, C. Thumerelle,  E. Oksenhendler, D. Boutboul, C. Thomas, et al.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1097/MD.0b013e31825f95b 9 Curtis, M.M., and S.S. Way.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
126:177– 185. http://dx.doi.org/10.1111/j.1365-2567.2008.03017.,Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1002/eji.20124260 5 de Beaucoudrey , L., A. Puel, O. Filipe-Santos, A. Cobat, P .",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi   .org/10.1084/jem.2008032 1 de Beaucoudrey, L., A. Samarina, J. Bustamante, A. Cobat, S. Boisson- Dupuis, J. Feinberg, S. Al-Muhsen, L. Jannière, Y .",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/   10.1097/MD.0b013e3181fdd83 2 Ely, L.K., S. Fischer, and K.C.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1038/ni.181 3 Engelhardt, K.R., and B. Grimbacher.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1016/j.jaci.2011.12.96 6 Frans, G., L. Moens, H. Schaballie, L. Van Eyck, H. Borgers, M. Wuyts, D.  Dillaerts, E. Vermeulen, J. Dooley, B. Grimbacher, et al.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"134:1209– 1213. http://dx.doi.org/10.1016/j.jaci.2014.05.04 4 Gaffen, S.L.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1038/nri258 6 Glocker, E.O., A. Hennigs, M. Nabavi, A.A. Schäffer, C. Woellner, U. Salzer,  D. Pfeifer, H. Veelken, K. Warnatz, F .",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1056/   NEJMoa081071 9 Ho, A.W., and S.L.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1007/   s00281-009-0185- 0 Ho, A.W., F. Shen, H.R.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"185:1063– 1070. http://dx.doi.org/10.4049/jimmunol.090373 9 Hori, T., H. Ohnishi, T. Teramoto, K. Tsubouchi, T. Naiki, Y.  Hirose, O. Ohara, M. Seishima, H. Kaneko, T. Fukao, and N. Kondo.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1016/j.jpeds.2013.02.04 0 Aldave, J.C., E. Cachay, L. Núñez, A. Chunga, S. Murillo, S. Cypowyj, J.  Bustamante, A. Puel, J.L.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1016/j.smim   .2007.10.00 9 Boisson, B., C. W ang, V .",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
http://dx.doi.org/10.1016/j.immuni   .2013.09.00 2,OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1084/jem.20080218 McAllister, F., A. Henry, J.L.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.4049/jimmunol.175.1.40 4 Mekki, N., I. Ben-Mustapha, L. Liu, L. Boussofara, S. Okada, S. Cypowyj,  N. Ghariani, W. Saidi, M. Denguezli, J.L.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1038/jid.2013.48 0 Milner, J.D., J.M.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10   .1038/nature0676 4 Mizoguchi, Y ., M. Tsumura, S. Okada, O. Hirata, S. Minegishi, K. Imai, N.  Hyakuna, H. Muramatsu, S. Kojima, Y .",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10   .1189/jlb.051325 0 Moseley, T.A., D.R.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1016/S1359-6101(03)00002- 9 Ouederni, M., O. Sanal, A. Ikinciogullari, I. Tezcan, F. Dogu, I. Sologuren,  S. Pedraza-Sánchez, M. Keser, G. Tanir, C. Nieuwhof, et al.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi   .org/10.1093/cid/cit72 2 Prando, C., A. Samarina, J. Bustamante, S. Boisson-Dupuis, A. Cobat, C.  Picard, Z. AlSum, S. Al-Jumaah, S. Al-Hajjar, H. Frayha, et al.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"92:190)  http://dx.doi.org/10.1097/MD.0b013e31828a01f 9 Puel, A., R. Döffinger, A. Natividad, M. Chrabieh, G. Barcenas-Morales,  C. Picard, A. Cobat, M. Ouachée-Chardin, A. Toulon, J. Bustamante,  et al.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi   .org/10.1084/jem.2009198 3 Puel, A., C. Picard, S. Cypowyj, D. Lilic, L. Abel, and J.L.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1016/j.coi.2010.06.00 9 Puel, A., S. Cypowyj, J. Bustamante, J.F.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1126/science.120043 9 Puel, A., S. Cypowyj, L. Maródi, L. Abel, C. Picard, and J.L.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1097/ACI.0b013e328358cc0 b Purcell, S., B. Neale, K. Todd-Brown, L. Thomas, M.A.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10   .1086/51979 5 Renner, E.D., S. Rylaarsdam, S. Anover-Sombke, A.L.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"122:181–   187. http://dx.doi.org/10.1016/j.jaci.2008.04.03 7 Rickel, E.A., L.A. Siegel, B.R.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10   .1007/s10875-012-9744- 6 Hu, Y., N. Ota, I. Peng, C.J.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.4049/   jimmunol.090361 4 Hu, Y., F. Shen, N.K.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
http://dx.doi.org/10.1111/j.1749-6632.2010.05825.,Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"14:217. http://dx.doi.org/10.1186/ar389 3 Husebye, E.S., and M.S.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1016/j.immuni.2010.03.01 6 Ishigame, H., S. Kakuta, T. Nagai, M. Kadoki, A. Nambu, Y. Komiyama, N.  Fujikado, Y. Tanahashi, A. Akitsu, H. Kotaki, et al.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1073/   pnas.1218167110 Itan, Y ., M. Mazel, B. Mazel, A. Abhyankar, P .",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"15:256. http://dx.doi.org/10.1186/1471-2164-15-256 Kilic, S.S., A. Puel, and J.L.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1084/jem.2009166 9 Kisand, K., D. Lilic, J.L.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1002/eji.20104125 3 Kuestner, R.E., D.W .",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.4049/jimmunol.179   .8.546 2 Lanternier, F., S. Pathan, Q.B.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1056/NEJMoa120848 7 Lee, P.P., H. Mao, W. Yang, K.W.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1016/j.jaci.2013.08.05 1 Ling, Y., and A. Puel.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1016/S0001-7310(14)70016- X Lionakis, M.S.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1007/s12281-011-   0076- 4 Liu, L., S. Okada, X.F .",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/   10.1084/jem.2011095 8 Ma, C.S., G.Y.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"181:4299– 4310. http://dx.doi.org/10.4049/jimmunol.181.6.429 9 Romberg, N., H. Morbach, M.G.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1016/   j.jaci.2013.01.00 4 Sampaio, E.P ., A.P .",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1016/j.jaci   .2013.01.05 2 Sharfe, N., A. Nahum, A. Newell, H. Dadi, B. Ngan, S.L.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1016/j.jaci.2013.09.03 2 Smeekens, S.P., T.S.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1371/journal.pone.002924 8 Soltész, B., B. Tóth, N. Shabashova, A. Bondarenko, S. Okada, S. Cypowyj,  A. Abhyankar, G. Csorba, S. Taskó, A.K.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1136/jmedgenet-2013-10157 0 Takezaki, S., M. Yamada, M. Kato, M.J. Park, K. Maruyama, Y. Yamazaki,  N. Chida, O. Ohara, I. Kobayashi, and T. Ariga.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"379:2500. http://dx.doi.org/10   .1016/S0140-6736(12)60365- 1 Toy, D., D. Kugler, M. Wolfson, T. Vanden Bos, J. Gurgel, J. Derry, J. Tocker,  and J. Peschon.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi   .org/10.4049/jimmunol.177.1.3 6Trautwein-Weidner, K., A. Gladiator, S. Nur, P. Diethelm, and S.  LeibundGut-Landmann.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"8:221– 231. http://dx.doi.org/10.1038/mi.2014.5 7 Uzel, G., E.P .",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1016/j.jaci.2012.11   .054 van de Veerdonk, F.L., T.S.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1056/NEJMoa110010 2 Vidlak, D., and T. Kielian.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"9:128. http://dx.doi.org/   10.1186/1742-2094-9-12 8 Vinh, D.C. 2011.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1146/annurev   .immunol.25.022106.14155 7 Wildbaum, G., E. Shahar, R. Katz, N. Karin, A. Etzioni, and S. Pollack.",Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/10.1016/j.jaci   .2013.04.01 8 Wright, J.F ., F .",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
"http://dx.doi.org/   10.4049/jimmunol.181.4.279 9 Yamazaki, Y ., M. Yamada, T. Kawai, T. Morio, M. Onodera, M. Ueki, N.  Watanabe, H. Takada, S. Takezaki, N. Chida, et al.",OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
http://dx.doi.org/10.4049/jimmunol.140146 7,Non-OADS,/arxiv_data1/oa_pdf/ce/5e/JEM_20141065.PMC4419340.pdf
© 2015 Montine and Montine  This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"After six months   it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"Indeed, this approach is being widely  adopted in cancer care and in new mechanism-based therapies  for cystic fibrosis as highlighted by the Precision Medicine Ini - tiative put forth by the White House Office of Science and  Technology in early 2015 (http://www.whitehouse.gov/   blog/2015/01/30/precision-medicine-initiative-data-driven-   treatments-unique-your-own-body).",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"72:130– 136. http://dx.doi.org/10.1097/NEN.0b013e3182805c7 2 Beecham, G.W., K. Hamilton, A.C. Naj, E.R.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi   .org/10.1371/journal.pgen.100460 6 Beecham, G.W., D.W. Dickson, W.K.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1212/WNL.000000000000133 2 Clinton, L.K., M. Blurton-Jones, K. Myczek, J.Q.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"30:7281– 7289. http://dx.doi.org/10.1523/JNEUROSCI.0490-10.201 0 Corder, E.H., A.M. Saunders, W.J.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1007/s00401-010-0665- 2 Dorsey, E.R., R. Constantinescu, J.P. Thompson, K.M.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"68:384– 386. http://dx.doi.org/10.1212/01.wnl.0000247740.47667.0 3 Dugger, B.N., G.E.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.3233/JPD-2012-1107 3 Faulkner, M.A.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1517/14740338.2014.93136 9 Goldman, S.M.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1146/annurev-   pharmtox-011613-13593 7 Gomperts, S.N., D.M.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1212/01.wnl.0000326146.60732.d 6 Guerreiro, R., A. Wojtas, J. Bras, M. Carrasquillo, E. Rogaeva, E. Majounie,  C. Cruchaga, C. Sassi, J.S.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1056/NEJMoa121185 1 Guo, J.L., D.J.",OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1016/j.cell.2013.05.05 7 Hyman, B.T., C.H.",OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1016/j.jalz.2011.10.00 7 Irwin, D.J., M.T.",OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1002/ana.2365 9 Jonsson, T., H. Stefansson, S. Steinberg, I. Jonsdottir, P.V.",OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
http://dx.doi.org/10.1056/NEJMoa121110 3PD.,OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/   10.1001/archneur.60.3.38 7 Albert, M.S., S.T.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1016/j.jalz   .2011.03.00 8 Alcalay, R.N., E. Caccappolo, H. Mejia-Santana, M. Tang, L. Rosado, M.  Orbe Reilly, D. Ruiz, B. Ross, M. Verbitsky, S. Kisselev, et al.",OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
http://dx.doi.org/   10.1212/WNL.0b013e318253d54 b Alzheimer’s Association and Centers for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"Available at: http://www.alz.org/publichealth/downloads/   2013-RoadMap.pdf (accessed April 15, 2015).",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1126/science.276.5321.204 5 Postuma, R.B., D. Aarsland, P. Barone, D.J.",OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"27:617– 626. http://dx.doi.org/10.1002/mds.2499 6 Reiman, E.M., J.B. Langbaum, A.S. Fleisher, R.J. Caselli, K. Chen, N.  Ayutyanont, Y.T.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1212/WNL.0b013e3182918ca 6 Schellenberg, G.D., and T.J. Montine.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1056/NEJMoa090128 1 Sieber, B.A., S. Landis, W. Koroshetz, R. Bateman, A. Siderowf, W.R. Galpern,  J. Dunlop, S. Finkbeiner, M. Sutherland, H. Wang, et al.",OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1002/ana.2426 1 Sperling, R.A., P.S.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1016/j.jalz.2011.03.00 3 Sperling, R.A., D.M.",OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1126/   scitranslmed.300794 1 Srivatsal, S., B. Cholerton, J.B. Leverenz, Z.K.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1002/mds.2616 1 Strauss, I., S.K.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1016/S1353-8020(13)70044- 0 Strittmatter, W.J., A.M. Saunders, D. Schmechel, M. Pericak-Vance, J.  Enghild, G.S.",OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1001/jamaneurol.2013.60 0 Verstraeten, A., J. Theuns, and C. Van Broeckhoven.",OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1016/j.tig.2015.01.00 4 Zemek, F., L. Drtinova, E. Nepovimova, V. Sepsova, J. Korabecny, J.  Klimes, and K. Kuca.",OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1517/14740338.2014.91416 8Lambert, J.C., C.A.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"381:628)  http://dx.doi.org/10.1016/S0140-6736(12)61766- 8 Litvan, I., D. Aarsland, C.H.",OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1146/annurev.genom.1.1.50 7 Mata, I.F., J.B. Leverenz, D. Weintraub, J.Q.",OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10   .1001/jamaneurol.2014.145 5 McKhann, G.M., D.S.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1016/j.jalz.2011.03.00 5 Montine, T.J., W.J.",OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1212/   WNL.000000000000073 3 Moulder, K.L., B.J.",OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"5:48. http://dx.doi.org/10.1186/alzrt21 3 Murray, C.J., C. Atkinson, K. Bhalla, G. Birbeck, R. Burstein, D. Chou,  R. Dellavalle, G. Danaei, M. Ezzati, A. Fahimi, et al.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
http://dx.doi.org/10.1038/ng.304 3 National Research Council of the National Academies.,Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1002/mds.2583 8 Paisán-Ruíz, C., S. Jain, E.W.",Non-OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
"http://dx.doi.org/10.1016/   j.neuron.2004.10.02 3 Plassman, B.L., and J. Grafman.",OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
http://dx.doi.org/10.1016/   B978-0-444-63521-1.00044- 3,OADS,/arxiv_data1/oa_pdf/53/f0/JEM_20150656.PMC4419342.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi.org/10.1084/jem.2006193 1 Beier, U.H., L. Wang, T.R.",OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi.org/10.1128/MCB.01206-1 0 Davalos, D., J.K. Ryu, M. Merlini, K.M.",Non-OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"3:1227. http://dx.doi.org/10.1038/ncomms223 0 Gao, B., Q. Kong, K. Kemp, Y .S.",OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi   .org/10.1073/pnas.111846210 9 Gerber, P.R., and K. Müller.",OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi.org/10.1007/BF0012445 6 He, Y.W., M.L.",Non-OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi.org/10.1016/   j.cell.2006.07.03 5 Kebir, H., K. Kreymborg, I. Ifergan, A. Dodelet-Devillers, R. Cayrol, M.  Bernard, F. Giuliani, N. Arbour, B. Becher, and A. Prat.",Non-OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi   .org/10.1038/nm165 1 Kwon, H.S., M.M.",OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"3:158– 167. http://dx.doi.org/10.1016/j.chom.2008.02.00 2 Kwon, H.S., H.W.",OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"188:2712– 2721. http://dx.doi.org/10.4049/jimmunol.110090 3 Labute, P .",Non-OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
Online sup - plemental material is available at http://www.jem.org/cgi/content/full/jem   .20132378/DC1.,Non-OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi.org/10.1016/j.immuni.2007.02.00 9 Littman, D.R., Z.",OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi.org/10   .1101/sqb.1999.64.37 3 MacLean, B., D.M.",OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi   .org/10.1093/bioinformatics/btq05 4 Onufriev, A., D. Bashford, and D.A.",OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi.org/10.1021/jp994072 s Perkins, D.N., D.J.",Non-OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi.org/ 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>   3.0.CO;2- 2 Quintana, F .J., H. Jin, E.J.",OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi.org/10.1038/ni.236 3 Rastinejad, F ., T. Perlmann, R.M.",OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi.org/10.1038/375203a 0 Schilling, B., M.J. Rardin, B.X.",Non-OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi.org/10.1074/mcp.M112.01770 7 Sharma, V ., J. Eckels, G.K. Taylor, N.J. Shulman, A.B.",Non-OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi.org/10.1021/pr500663 6 Shilov, I.V ., S.L.",OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi.org/10.1074/   mcp.T600050-MCP20 0 Shirakawa, K., A. Takaori-Kondo, M. Y okoyama, T. Izumi, M. Matsui, K. Io,   T .",OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi.org/10.1038/nsmb.149 7 van Loosdregt, J., Y. Vercoulen, T. Guichelaar, Y.Y.",OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi.org/10   .1182/blood-2009-02-20711 8 Yamane, H., and W.E.",OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi.org/10.1038/ni.243 1 Zhang, F., G. Meng, and W. Strober.",OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi.org/10.1038/ni.166 3 Zhang, J., S.M.",OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
"http://dx.doi.org/10.1172/JCI3890 2 Zhao, Q., S.A. Chasse, S. Devarakonda, M.L.",OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
296:509– 520. http://dx.doi.org/10.1006/jmbi.1999.345 7,Non-OADS,/arxiv_data1/oa_pdf/6a/1f/JEM_20132378.PMC4419343.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
Online supplemental material is available at http://www.jem   .org/cgi/content/full/jem.20131675/DC1.,Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10   .1038/nprot.2009.9 7 Flacher, V ., M. Bouschbacher, E. Verronèse, C. Massacrier, V .",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.4049/   jimmunol.177.11.795 9 Fujimoto, K., T. Karuppuchamy, N. Takemura, M. Shimohigoshi, T.  Machida, Y. Haseda, T. Aoshi, K.J.",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.4049/   jimmunol.100403 6 Gautier, E.L., T. Shay, J. Miller, M. Greter, C. Jakubzick, S. Ivanov, J. Helft,   A. Chow, K.G.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1038/ ni.241 9 Ginhoux, F., F. Tacke, V. Angeli, M. Bogunovic, M. Loubeau, X.M.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/   10.1038/ni130 7 Gomez de Agüero, M., M. Vocanson, F. Hacini-Rachinel, M. Taillardet, T.  Sparwasser, A. Kissenpfennig, B. Malissen, D. Kaiserlian, and B. Dubois.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1172/JCI5972 5 Han, J.D., N. Bertin, T. Hao, D.S.",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10   .1038/nature0255 5 Han, P., O.D.",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.4049/jimmunol.172.10.593 1 Haniffa, M., A. Shin, V. Bigley, N. McGovern, P. Teo, P. See, P.S.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.04.01 2 Hildner, K., B.T.",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1126/science.116420 6 Igyarto, B.Z., M.C.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.4049/jimmunol.090188 4 Igyártó, B.Z., K. Haley, D. Ortner, A. Bobr, M. Gerami-Nejad, B.T.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"35:260– 272. http://dx.doi.org/10.1016/j.immuni.2011.06.00 5 Jeong, H., S.P.",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10   .1038/3507513 8 Jongbloed, S.L., A.J.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1084/jem.2009214 0 Kautz-Neu, K., M. Noordegraaf, S. Dinges, C.L.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"207:1273– 1281. http://dx.doi.org/10.1084/jem.2010034 8 Banchereau, J., and R.M.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1038/3258 8 Banchereau, J., L. Thompson-Snipes, S. Zurawski, J.P. Blanck, Y. Cao, S.  Clayton, J.P. Gorvel, G. Zurawski, and E. Klechevsky.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1073/   pnas.120578510 9 Berry, M.P ., C.M.",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1038/   nature0924 7 Buonaguro, L., and B. Pulendran.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
http://dx.doi.org/10   .1111/j.1600-065X.2010.00971.,Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1016/j.immuni.2008   .05.01 2 Chu, C.C., N. Ali, P. Karagiannis, P. Di Meglio, A. Skowera, L. Napolitano,  G. Barinaga, K. Grys, E. Sharif-Paghaleh, S.N.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1084/jem.2011258 3 Cohn, L., B. Chatterjee, F. Esselborn, A. Smed-Sörensen, N. Nakamura,  C. Chalouni, B.C.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1084/jem.2012125 1 Crozat, K., R. Guiton, V. Contreras, V. Feuillet, C.A.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1084/jem.2010022 3 Crozat, K., R. Guiton, M. Guilliams, S. Henri, T. Baranek, I. Schwartz- Cornil, B. Malissen, and M. Dalod.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
http://dx.doi.org/10.1111/   j.0105-2896.2009.00868.,Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.08.02 1 Dresch, C., M. Ackermann, B. Vogt, B. de Andrade Pereira, K. Shortman,  and C. Fraefel.",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1002/eji.20104137 4 Durinck, S., Y. Moreau, A. Kasprzyk, S. Davis, B.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1093/bioinformatics/bti52 5 Durinck, S., P.T.",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1038/jid   .2012.2 6 Poulin, L.F ., M. Salio, E. Griessinger, F .",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
http://dx.doi.org/10.1111/j.0105-2896.2009.00886.,Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi   .org/10.1084/jem.2012003 0 Segura, E., and J.A.",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1016/   j.coi.2009.03.01 1 Segura, E., M. Durand, and S. Amigorena.",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"210:1035– 1047. http://dx.doi.org/10.1084/jem.2012110 3 Seneschal, J., R.A. Clark, A. Gehad, C.M.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"36:873– 884. http://dx.doi.org/10.1016/j.immuni.2012.03.01 8 Seré, K., J.H.",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.07.01 9 Silberberg, I., R.L.",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1111/   1523-1747.ep1248213 9 Sparber, F., C.H.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1016/j.imbio.2010.05.01 4 Subramanian, A., P .",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10   .1038/ ni.236 0Klechevsky, E. 2013.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1002/eji.20134379 0 Klechevsky, E., R. Morita, M. Liu, Y .",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1016/j   .immuni.2008.07.01 3 Klechevsky, E., M. Liu, R. Morita, R. Banchereau, L. Thompson-Snipes, A.K.",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"9:559. http://dx.doi   .org/10.1186/1471-2105-9-55 9 Lenz, A., M. Heine, G. Schuler, and N. Romani.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"92:2587– 2596. http://dx.doi.org/10.1172/JCI11687 3 Liard, C., S. Munier, A. Joulin-Giet, O. Bonduelle, S. Hadam, D. Duffy, A.  Vogt, B. Verrier, and B. Combadière.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10   .1038/jid.2011.34 6 Matthews, L., G. Gopinath, M. Gillespie, M. Caudy, D. Croft, B. de Bono,  P .",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1093/nar/gkn86 3 Meredith, M.M., K. Liu, G. Darrasse-Jeze, A.O.",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1084/jem.2011267 5 Miller, J.C., B.D.",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1038/ni.237 0 Nagao, K., F. Ginhoux, W.W. Leitner, S. Motegi, C.L.",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"106:3312-3317. http://dx.doi   .org/10.1073/pnas.080712610 6 Nestle, F.O., X.G.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.01.01 4 Novershtern, N., A. Subramanian, L.N.",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
"http://dx.doi.org/10.1016/j   .cell.2011.01.00 4 Polak, M.E., L. Newell, V .Y .",OADS,/arxiv_data1/oa_pdf/7f/ad/JEM_20131675.PMC4419344.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first  six months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
http://dx.doi.org/10.4049/jimmunol.173.1.55 9from BD for 20 min at room temperature in the dark.,Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1136/thx.42.4.24 1 Hugel, B., M.C.",OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1152/physiol.00029.200 4 Hussell, T., and T.J. Bell.",OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1038/   nri360 0 Hyde, D.M., N.K.",Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1002/ar.a.2001 2 Jo, D., D. Liu, S. Yao, R.D.",OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1038/nm126 9 John, G., K. Kohse, J. Orasche, A. Reda, J. Schnelle-Kreis, R. Zimmermann,  O. Schmid, O. Eickelberg, and A.O.",Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10   .1042/CS2013011 7 Jose, P ., M.G.",Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1080/   0190214080238972 7 Kelley, J.L., M.M.",Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1016/   0014-4800(87)90049- 9 MacKenzie, A., H.L.",OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1016/   S1074-7613(01)00229- 1 Mallat, Z., H. Benamer, B. Hugel, J. Benessiano, P.G.",OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1161/CIRCRESAHA.110.22645 6 Nicholson, S.E., T.A.",Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1093/emboj/18.2.37 5 Nickel, W., and C. Rabouille.",OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"279:41679– 41685. http://dx.doi.org/10.1074/jbc.M40641320 0 Raposo, G., and W .",Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1083/   jcb.20121113 8 Rubartelli, A., F. Cozzolino, M. Talio, and R. Sitia.",Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1016/j.cytogfr.2010.09.00 2 Sadallah, S., C. Eken, and J.A.",OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"84:1316– 1325. http://dx.doi.org/10.1189/jlb.010801 3Balter, M.S., G.B.",Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1093/protein/   gzh03 7 Bendtsen, J.D., H. Nielsen, G. von Heijne, and S. Brunak.",OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1016/j.jmb.2004.05.02 8 Bernard, M.A., H. Zhao, S.C. Y ue, A. Anandaiah, H. Koziel, and S.D.",OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1189/jlb.121159 0 Brandes, M.E., and J.N.",OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1165/ajrcmb/1.2.10 1 Brock, T.G., E. Maydanski, R.W.",OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1074/   jbc.M10567620 0 Brogan, P .A., V .",Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1002/art.2019 9 Canetti, C., D.M.",Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"79:1234– 1241. http://dx.doi.org/10.1189/jlb.070537 4 Chauncey, J.B., M. Peters-Golden, and R.H. Simon.",Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1002/pmic.20120032 9 Chuquimia, O.D., D.H. Petursdottir, M.J. Rahman, K. Hartl, M. Singh, and  C. Fernández.",OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/   10.1371/journal.pone.003212 5 Cosio, M.G., M. Saetta, and A. Agusti.",Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1016/j.taap.2009.02.02 1 Duval, D., B. Reinhardt, C. Kedinger, and H. Boeuf.",OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1096/fj.14.11.157 7 Gasser, O., C. Hess, S. Miot, C. Deon, J.C. Sanchez, and J.A.",OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1016/j.ghir.2003.12.01 1 Guth, A.M., W.J.",OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1152/ajplung.90625.200 8 Hasday, J.D., R. Bascom, J.J. Costa, T. Fitzgerald, and W. Dubin.",Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
http://dx.doi.org/10.1378/chest.115.3.82 9,Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1074/jbc.M110.20866 0 Standiford, T .J., S.L.",OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1172/JCI11492 8 Starr, R., T.A.",OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1038/4320 6 Takanashi, S., Y. Hasegawa, Y. Kanehira, K. Yamamoto, K. Fujimoto,   K. Satoh, and K. Okamura.",OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1161/   ATVBAHA.110.20746 4 Thepen, T., G. Kraal, and P.G.",Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
http://dx.doi.org/10.1111/j.1749-6632.1994.tb39802.,Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1007/s12471-013-0462- 3 Westphalen, K., G.A.",Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1038/nature1290 2 White, G.E., A. Cotterill, M.R.",Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
"http://dx.doi.org/10.1007/s10735-011-9317- 7 Yoshimura, A., T. Ohkubo, T. Kiguchi, N.A.",OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
287:9923– 9930. http://dx.doi.org/10.1074/jbc.M111.28037 0,Non-OADS,/arxiv_data1/oa_pdf/a5/d7/JEM_20141675.PMC4419346.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six  months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1016/j.immuni.2011.03.02 2 Elias, D., H. Akuffo, and S. Britton.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1016/j.trstmh.2004.08.00 6 Fletcher, H.A.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.2174/15665240778059852 0 Fortin, A., L. Abel, J.L.",Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10   .1084/jem.2008035 3 Gallegos, A.M., J.W .",Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1371/journal.ppat.100205 2 Hale, J.S., B. Y oungblood, D.R.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1016/   j.immuni.2013.11.01 7 Johnston, R.J., A.C. Poholek, D. DiT oro, I. Y usuf, D. Eto, B. Barnett, A.L.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1126/science.117587 0 Kahnert, A., U.E.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/   10.1086/50889 4 Khader, S.A., J. Rangel-Moreno, J.J. Fountain, C.A.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.4049/jimmunol   .090193 7 Lázár-Molnár, E., B. Chen, K.A.",Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10   .1073/pnas.100739410 7 Leal, I.S., B. Smedegård, P. Andersen, and R. Appelberg.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
http://dx.doi.org/10.1046/j.1365-2567.2001.01305.,Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/   10.4049/jimmunol.130024 8 Marshall, H.D., A. Chandele, Y .W .",Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
35:633– 646. http://dx.doi.org/10.1016/j.immuni.2011.08.01 6Data acquisition and analysis.,OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10   .1016/j.it.2014.04.00 6 Anderson, K.G., K. Mayer-Barber, H. Sung, L. Beura, B.R.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1038/nprot.2014.00 5 Barber, D.L., E.J.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi   .org/10.1038/nature0444 4 Barber, D.L., K.D.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
http://dx.doi.org/10.1046/ j.1440-1711.1998.00709.,Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1038/ni.204 1 Bold, T.D., N. Banaei, A.J.",Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1371/journal   .ppat.100206 3 Choi, Y .S., R. Kageyama, D. Eto, T .C.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1016/j.immuni.2011   .03.02 3 Cooper, A.M. 2009.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1146/annurev.immunol   .021908.13270 3 Crotty , S. 2011.",Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"29:621– 663. http://dx.doi.org/10.1146/annurev-immunol-031210-10140 0 Day , C.L., D.E.",Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1038/nature0511 5 Deffur, A., N.J. Mulder, and R.J. Wilkinson.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1111/2049-632X.1206 0 Dent, A.L., A.L.",Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
http://dx.doi.org/10.1126/science.276   .5312.58 9,Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1016/   j.immuni.2010.10.00 8 Schreiber, S.L., and G.R.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi   .org/10.1016/0167-5699(92)90111- J Scriba, T.J., M. Tameris, N. Mansoor, E. Smit, L. van der Merwe, K. Mauff, E.J.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1093/infdis/jir19 5 Shafiani, S., G. T ucker-Heard, A. Kariyone, K. Takatsu, and K.B.",Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1016/j.immuni.2013.06.00 3 Slight, S.R., J. Rangel-Moreno, R. Gopal, Y. Lin, B.A.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/   10.1172/JCI6572 8 Srivastava, S., and J.D.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1016/j.chom.2014.05.00 7 Tameris, M.D., M. Hatherill, B.S.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1016/S0140-6736(13)60177- 4 Urdahl, K.B.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1016/j.smim.2014.10.00 3 Urdahl, K.B., D. Liggitt, and M.J. Bevan.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.4049/jimmunol.130028 3 Yu, D., S. Rao, L.M.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.07.00 2Mittrücker, H.W., U. Steinhoff, A. Köhler, M. Krause, D. Lazar, P. Mex,  D. Miekley, and S.H.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1073/   pnas.070351010 4 Mollo, S.B., A.J.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.4049/jimmunol.130203 3 Moon, J.J., H.H.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1016/j.immuni.2007.07.00 7 Moon, J.J., H.H.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
http://dx.doi.org/10.1038/nprot.2009.,Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1016/j.immuni.2011.11.01 2 Nurieva, R.I., Y .",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10   .1126/science.117667 6 Oestreich, K.J., A.C. Huang, and A.S. Weinmann.",Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1084/jem   .2010214 4 Oestreich, K.J., S.E.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"13:405– 411. http://dx.doi.org/10.1038/ni.224 2 Pepper, M., A.J.",Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1016/j.immuni.2011.09.00 9 Ravn, P ., A. Demissie, T. Eguale, H. Wondwosson, D. Lein, H.A.",OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
"http://dx.doi.org/10.1086/   31464 0 Reiley, W.W., S. Shafiani, S.T.",Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
229:114– 125. http://dx.doi.org/10.1111/j.1600-065X.2009.00767.,Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
http://dx.doi.org/10.1111/j.1365-2567.2006.02355.,Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
http://dx.doi.org/10   .4049/jimmunol.140001 9,Non-OADS,/arxiv_data1/oa_pdf/9b/88/JEM_20141518.PMC4419347.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1182/blood-   2012-12-47280 3 Benedito, R., S.F .",Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1038/   nature1090 8 Buch, T., F.L.",OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1038/nmeth76 2 Ding, L., and S.J.",OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"495:231– 235. http://dx.doi.org/10.1038/nature1188 5 Greenbaum, A., Y.M.",Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
http://dx.doi.org/10.1084/jem.163.1.,Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1093/intimm/dxf03 0 Harman, B.C., W .E.",OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1182/blood-2004-   12-488 1 Holmes, R., and J.C. Zúñiga-Pflücker.",Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/   10.1101/pdb.prot515 6 Hozumi, K., C. Mailhos, N. Negishi, K. Hirano, T. Yahata, K. Ando, S.  Zuklys, G.A.",OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1084/jem.2008013 4 Inlay, M.A., D. Bhattacharya, D. Sahoo, T. Serwold, J. Seita, H. Karsunky, S.K.",Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/   10.1101/gad.183600 9 Karsunky, H., M.A.",OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1242/dev.0192 2 Krueger, A., and H. von Boehmer.",Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
http://dx.doi.org/10.1182/blood-2009-07-23572 1DLL4 rescue experiment.,Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
http://dx.doi.org/10.1038/nature0494 0,Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1038/nri298 9 Luche, H., T. Nageswara Rao, S. Kumar, A. Tasdogan, F .",Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1126/science.114088 1 Mansson, R., S. Zandi, E. Welinder, P .",OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1182/blood-2009-08-23639 8 Mirandola, L., M. Chiriva-Internati, D. Montagna, F .",Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1002/path.301 5 Mohtashami, M., D.K.",Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.4049/jimmunol   .100078 2 Moya, I.M., L. Umans, E. Maas, P .N.",Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1016/   j.devcel.2012.01.00 7 Parfitt, A.M., M.K.",OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1002/jbmr.565002061 7 Park, D., J.A.",OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi   .org/10.1242/dev.0248 0 Rothenberg, E.V., J. Zhang, and L. Li.",Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
http://dx.doi.org/10   .1111/j.1600-065X.2010.00964.,Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1038/ni121 6 Sato, M., N. Asada, Y. Kawano, K. Wakahashi, K. Minagawa, H. Kawano,  A. Sada, K. Ikeda, T. Matsui, and Y. Katayama.",OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"18:749– 758. http://dx.doi.org/10.1016/j.cmet.2013.09.01 4 Scimone, M.L., I. Aifantis, I. Apostolou, H. von Boehmer, and U.H.",OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1038/ni121 7 Tsapogas, P ., S. Zandi, J. Åhsberg, J. Zetterblad, E. Welinder, J.I.",OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1182/blood-2011-01-33218 9 Uhmann, A., J. van den Brandt, K. Dittmann, I. Hess, R. Dressel, C. Binder, F .",Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.4049/jimmunol   .100193 9 Visan, I., J.S.",OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1111/j.0105- 2896.2006.00360. x Visnjic, D., Z. Kalajzic, D.W. Rowe, V. Katavic, J. Lorenzo, and H.L.",OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1182/   blood-2003-11-401 1 W elinder, E., R. Mansson, E.M. Mercer, D. Bryder, M. Sigvardsson, and C. Murre.",Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1073/   pnas.080289810 5 Yao, D., Y. Huang, X. Huang, W. Wang, Q. Yan, L. Wei, W. Xin, S. Gerson,  P. Stanley, J.B. Lowe, and L. Zhou.",Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1182/blood-2010-12-32607 4 Zakrzewski, J.L., A.A. Kochman, S.X.",Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"12:1039– 1047. http://dx.doi.org/10.1038/nm146 3 Zhang, M., S. Xuan, M.L.",OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
"http://dx.doi.org/10.1182/blood-2006-08-04138 4 Zlotoff, D.A., S.L.",Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
http://dx.doi.org/10.1182/blood-2010-12-32495 4,Non-OADS,/arxiv_data1/oa_pdf/df/31/JEM_20141843.PMC4419348.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi   .org/10.1038/sj.cdd.440213 2 Funakoshi, H., T.O.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"114:2240– 2250. http://dx.doi.org/10.1161/CIRCULATIONAHA.106.62021 1 Glaser, T., A.R.",Non-OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1038/nrd263 8 Hermouet, S., I. Corre, and E. Lippert.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1006/bbrc.1994.131 4 Kaimakis, P., M. Crisan, and E. Dzierzak.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"1830:2395– 2403. http://dx.doi.org/10.1016/j.bbagen.2012.10.00 4 Kim, I., T.L.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1016/j.cell.2007   .06.01 1 Kim, P.G., C.E.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"212. http://dx.doi.org/10.1084/   jem.2014151 4 Kissa, K., and P. Herbomel.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1038/nature0876 1 Koupenova, M., H. Johnston-Cox, and K. Ravid.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1007/   s11883-012-0263- y Lancrin, C., P. Sroczynska, C. Stephenson, T. Allen, V. Kouskoff, and  G. Lacaud.",Non-OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/   10.1007/s11302-012-9290- y Medvinsky, A., and E. Dzierzak.",Non-OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi   .org/10.1016/S0092-8674(00)80165- 8flk1:GFP+ cells initiate EHT, and the process ends with an explosion.",Non-OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
On - line supplemental material is available at http://www.jem.org/cgi/content/   full/jem.20141528/DC1.,Non-OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1152/ajpregu.00840.200 4 Andersson, O., B.A.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1016/j.cmet.2012.04.01 8 Baggiolini, M., and I. Clark-Lewis.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10   .1016/0014-5793(92)80909- Z Bertrand, J.Y., N.C. Chi, B. Santoso, S. Teng, D.Y.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1038/   nature0873 8 Boehmler, W., J. Petko, M. Woll, C. Frey, B. Thisse, C. Thisse, V.A.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1016/j.gep.2008.11.00 6 Boisset, J.C., W. van Cappellen, C. Andrieu-Soler, N. Galjart, E. Dzierzak,  and C. Robin.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi   .org/10.1093/nar/gkr21 8 Chen, A.T., and L.I.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1002/jcb.2225 1 Chen, M.J., T .",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1038/nature0761 9 Dahlem, T.J., K. Hoshijima, M.J. Jurynec, D. Gunther, C.G.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1016/   B978-0-12-385526-8.00005- 9 Feoktistov, I., A.E.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/   10.1161/01.RES.0000012203.21416.1 4 Fernandez, E.J., and E. Lolis.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
http://dx.doi.org/   10.1146/annurev.pharmtox.42.091901.11583 8,Non-OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1016/j.cell.2011.11.04 1 Nostro, M.C., X. Cheng, G.M.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1016/j.stem.2007.10.01 1 Okuda, T., J. van Deursen, S.W.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80986- 1 Orkin, S.H., and L.I.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1016/   j.cell.2008.01.02 5 Porcher, C., W. Swat, K. Rockwell, Y. Fujiwara, F.W.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi   .org/10.1016/S0092-8674(00)80076- 8 Pospísil, M., M. Hofer, A. Vacek, J. Netíková, I. Pipalová, and S. Viklická.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/   10.1016/S0301-472X(01)00622- 1 Robu, M.E., J.D.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1371/journal.pgen.003007 8 Rossi, L., V. Salvestrini, D. Ferrari, F. Di Virgilio, and R.M.",Non-OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1182/   blood-2012-04-42237 8 Stoll, S.J., S. Bartsch, H.G.",Non-OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"108:1367– 1377. http://dx.doi.org/10.1161/CIRCRESAHA.111.24409 5Swiers, G., C. Baumann, J. O’Rourke, E. Giannoulatou, S. Taylor, A.  Joshi, V. Moignard, C. Pina, T. Bee, K.D.",Non-OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"4:2924. http://dx.doi.org/10.1038/   ncomms392 4 Tamplin, O.J., E.M. Durand, L.A. Carr, S.J.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1016/j.cell.2014.12.03 2 Thisse, C., and B. Thisse.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/   10.1038/nprot.2007.51 4 Tsai, F.Y., G. Keller, F.C.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"87:697– 708. http://dx.doi.org/10.1016/S0092-8674(00)81389- 6 Wen, J., A. Grenz, Y. Zhang, Y. Dai, R.E.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1096/fj.11-18105 7 Yegutkin, G., P. Bodin, and G. Burnstock.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1038/sj.bjp.070313 6 Yoshimoto, M., and M.C.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1038/   457801 a Yue, R., H. Li, H. Liu, Y. Li, B. Wei, G. Gao, Y. Jin, T. Liu, L. Wei,  J.",Non-OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
"http://dx.doi.org/10.1016/j.devcel.2012.01.02 5 Zhen, F., Y. Lan, B. Yan, W. Zhang, and Z. Wen.",OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
http://dx.doi.org/   10.1242/dev.09707 1,Non-OADS,/arxiv_data1/oa_pdf/6a/8d/JEM_20141528.PMC4419349.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1182/   blood-2009-11-25220 5 Alvarez, J.D., D.H. Y asui, H. Niida, T .",Non-OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi   .org/10.1038/nprot.2007.24 3 Han, H.J., J. Russo, Y. Kohwi, and T. Kohwi-Shigematsu.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1038/nature0678 1 Hao, B., and M.S.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.4049/jimmunol.110046 8 Hawwari, A., C. Bock, and M.S.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1038/ni118 9 Hsu, L.Y., J. Lauring, H.E.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.4049/jimmunol.175.8.518 6 Jackson, A., H.D.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1038/ni115 7 Jhunjhunwala, S., M.C.",Non-OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"138:435– 448. http://dx.doi.org/10.1016/j.cell.2009.07.01 6 Kim, T.K., M. Hemberg, J.M.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1038/nature0903 3 Koch, F., R. Fenouil, M. Gut, P. Cauchy, T.K.",Non-OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1038/nsmb.208 5 Kohwi-Shigematsu, T., K. Poterlowicz, E. Ordinario, H.J.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/   10.1016/j.semcancer.2012.06.00 9 Krangel, M.S.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1016/j.coi.2009.03.00 9 Kumar, P .P ., P .K.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1016/j.molcel.2006.03.01 0 Kumar, P .P ., O. Bischof, P .K.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1038/   ncb151 6 Kuo, T.C., and M.S.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1016/j.coi.2009.03.00 8 Li, W., D. Notani, Q. Ma, B. Tanasa, E. Nunez, A.Y.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1038/nature1221 0 Lund, R., H. Ahlfors, E. Kainonen, A.M. Lahesmaa, C. Dixon, and R.  Lahesmaa.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1002/eji.20052607 9 McMurry, M.T., C. Hernandez-Munain, P. Lauzurica, and M.S.",Non-OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1016/j.cell.2013.02.02 9 Monroe, R.J., F. Chen, R. Ferrini, L. Davidson, and F.W.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1128/   MCB.05917-1 1 Bert, A.G., J. Burrows, C.S.",Non-OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10   .1006/plas.2000.147 4 Beyer, M., Y .",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1038/ni.208 4 Bulger, M., and M. Groudine.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10   .1016/j.cell.2011.01.02 4 Cai, S., H.J.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1038/ng114 6 Cai, S., C.C.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1038/   ng191 3 Calo, E., and J. Wysocka.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1016/j.molcel   .2013.01.03 8 Cisse, I.I., I. Izeddin, S.Z.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1126/science.123905 3 Cook, P.R.",Non-OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1126/science.284.5421.179 0 de Boer, J., A. Williams, G. Skavdis, N. Harker, M. Coles, M. Tolaini, T. Norton,  K. Williams, K. Roderick, A.J.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1002/immu.20031000 5 Dekker, J., K. Rippe, M. Dekker, and N. Kleckner.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1126/   science.106779 9 Dickinson, L.A., T. Joh, Y. Kohwi, and T. Kohwi-Shigematsu.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1016/0092-   8674(92)90432- C Domen, J., K.L.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1083/jcb.20110114 8 Ghamari, A., M.P.",Non-OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10   .1101/gad.216200.11 3 Gibcus, J.H., and J. Dekker.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1016/j.molcel.2013.02.01 1 Giresi, P.G., J. Kim, R.M.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1101/gr.553350 6 Guo, J., A. Hawwari, H. Li, Z.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
http://dx.doi.org/10.1038/ni79 1,Non-OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi   .org/10.1073/pnas.96.22.1271 3 Natoli, G., and J.C. Andrau.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1146/annurev-genet-110711-15545 9 Notani, D., K.P.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10   .1371/journal.pbio.100029 6 Rosenbloom, K.R., C.A.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1093/nar/gks117 2 Satoh, Y ., T. Y okota, T. Sudo, M. Kondo, A. Lai, P .W .",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1016/j.immuni.2013.05.01 4 Savarese, F., A. Davila, R. Nechanitzky, I. De-La Rosa-Velazquez, C.F.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1101/gad.181570 9 Schatz, D.G., and P.C.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1146/   annurev-genet-110410-13255 2 Seitan, V.C., B. Hao, K. Tachibana-Konwalski, T. Lavagnolli, H. Mira- Bontenbal, K.E.",Non-OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1038/   nature1031 2 Shih, H.Y., and M.S.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10   .4049/jimmunol.130021 8Skowronska-Krawczyk, D., Q. Ma, M. Schwartz, K. Scully, W .",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1038/   nature1357 3 Stamatoyannopoulos, J.A., M. Snyder, R. Hardison, B. Ren, T. Gingeras,  D.M.",Non-OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"13:418. http://dx.doi.org/   10.1186/gb-2012-13-8-41 8 Will, B., T.O.",Non-OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1038/ni.257 2 Yannoutsos, N., P. Wilson, W. Yu, H.T.",Non-OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1084/jem.194.4.47 1 Yannoutsos, N., V. Barreto, Z. Misulovin, A. Gazumyan, W. Yu, N.  Rajewsky, B.R.",Non-OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1038/ni105 3 Yasui, D., M. Miyano, S. Cai, P. Varga-Weisz, and T. Kohwi-Shigematsu.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1038/nature0108 4 Yu, W., Z. Misulovin, H. Suh, R.R.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
"http://dx.doi.org/10.1126/science.285.5430.108 0 Zhang, W., C.L.",OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
10:323– 332. http://dx.doi.org/10.1016/S1074-7613(00)80032- 1,OADS,/arxiv_data1/oa_pdf/02/45/JEM_20142207.PMC4419350.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1128/MCB.24.14.6501-6513.200 4 Kim, P.J., S.Y.",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.4049/jimmunol   .177.10.665 0 Kovalovsky, D., O.U.",Non-OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1038/ni.164 1 Kovalovsky , D., Y .",Non-OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.4049/jimmuno l  .090136 9 Lee, Y.J., K.L.",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1038/ni.273 1 Lim, S.K., and F.M.",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1016/j.immuni.2013   .01.01 0 Michel, M.L., D. Mendes-da-Cruz, A.C. Keller, M. Lochner, E. Schneider,  M. Dy, G. Eberl, and M.C.",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1084/   jem.2011030 8 Morrow, M.A., G. Lee, S. Gillis, G.D. Yancopoulos, and F.W.",Non-OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1101/   gad.6.1.6 1 Mycko, M.P., I. Ferrero, A. Wilson, W. Jiang, T. Bianchi, A. Trumpp, and  H.R.",Non-OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.4049/jimmunol.080339 4 Nakashima, K., S. Arai, A. Suzuki, Y. Nariai, T. Urano, M. Nakayama, O.  Ohara, K. Yamamura, K. Yamamoto, and T. Miyazaki.",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"4:1836. http://dx.doi.org/10.1038/   ncomms286 2 Okamura, R.M., M. Sigvardsson, J. Galceran, S. Verbeek, H. Clevers, and  R. Grosschedl.",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)   80454- 9 Pellicci, D.G., K.J.",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1084/   jem.2001154 4 Reya, T., M. O’Riordan, R. Okamura, E. Devaney, K. Willert, R. Nusse,  and R. Grosschedl.",Non-OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
http://dx.doi.org/10.1016/S1074-7613(00)00004- 2M.,OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1084/jem.2005045 6 Brennan, P.J., M. Brigl, and M.B.",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1038/nri336 9 Chen, Q.Y., T. Zhang, S.H.",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.4049/jimmunol.090191 2 Cohen, N.R., P.J.",Non-OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1038/ni.249 0 Coquet, J.M., S. Chakravarti, K. Kyparissoudis, F.W.",Non-OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.4049/   jimmunol.130290 4 Dose, M., B.P.",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1016/j.immuni   .2005.03.01 1 Enders, A., S. Stankovic, C. Teh, A.P.",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/   10.1182/blood-2012-01-40628 0 Gapin, L., J.L.",Non-OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1038/ni71 0 Griewank, K., C. Borowski, S. Rietdijk, N. Wang, A. Julien, D.G.",Non-OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1016/j   .immuni.2007.08.02 0 Grumolato, L., G. Liu, T. Haremaki, S.K.",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
http://dx.doi.org/10.1371/journal.pgen.100360 3,Non-OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1016/j.immuni.2008.07.01 1 Seiler, M.P ., R. Mathew, M.K.",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"14:413) http://dx.doi   .org/10.1038/ni.223 0 Sharma, A., Q. Chen, T. Nguyen, Q. Y u, and J.M.",Non-OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.4049/jimmunol   .110372 9 Steinke, F.C., S. Yu, X. Zhou, B.",Non-OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi   .org/10.1038/ni.289 7 Tani-ichi, S., A. Shimba, K. W agatsuma, H. Miyachi, S. Kitano, K. Imai, T .",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1016/j.it.2012.08.00 9 Verykokakis, M., M.D.",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"33:203– 215. http://dx.doi.org/10.1016/j.immuni.2010.07.01 3 V erykokakis, M., V .",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.4049/jimmunol.130152 1 Verykokakis, M., E.C.",Non-OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10   .1111/imr.1220 3 Wang, L., T. Carr, Y. Xiong, K.F.",Non-OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1002/   eji.20104053 4 Wang, Y., I. Misumi, A.D. Gu, T.A.",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1038/ni.262 3 Watarai, H., E. Sekine-Kondo, T. Shigeura, Y. Motomura, T. Yasuda,  R. Satoh, H. Yoshida, M. Kubo, H. Kawamoto, H. Koseki, and M.  Taniguchi.",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1371/journal.pbio.100125 5 Weinreich, M.A., O.A.",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.12.00 3 Yip-Schneider, M.T., M. Horie, and H.E.",OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
"http://dx.doi   .org/10.1038/ni.176 2 Yu, S., X. Zhou, F.C.",Non-OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
http://dx.doi.org/10.4049/jimmunol.120115 0,Non-OADS,/arxiv_data1/oa_pdf/f5/8b/JEM_20141849.PMC4419352.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"Of the 1,263 DLBCL  samples for which comparative genomic hybridization data  are available from a publicly accessible database of DNA copy  number alterations (http://www.progenetix.org; Baudis and  Cleary, 2001), 6.4% exhibited losses in the DUSP4  genomic  locus, of which a few were highly focal (Fig.",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
(2012) data were analyzed using the R2 microarray analysis and visualization platform (http://r2.amc.nl).,OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"2:4. http://dx.doi.org/10   .1186/2162-3619-2- 4 Cagnol, S., and N. Rivard.",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1038/onc.2012.8 8 Ceribelli, M., P .N.",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1158/2159-8290.CD-13-011 7 Craig, V .J., S.B.",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1182/blood-2010-10-31223 1 Craig, V .J., S.B.",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-10-390 7 Cultrera, J.L., and S.M.",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1038/nature0863 8 De, S., R. Shaknovich, M. Riester, O. Elemento, H. Geng, M. Kormaksson, Y .",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1371/   journal.pgen.100313 7 Dhanak, D., and P .",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi   .org/10.1016/j.bbrc.2014.07.00 6 Esteller, M., G. Gaidano, S.N.",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1093/jnci/94.1.2 6 Fey, D., D.R.",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"3:355. http://dx.doi.org/10.3389/fphys.2012.0035 5 Fraga, M.F ., M. Berdasco, E. Ballestar, S. Ropero, P .",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/   10.1158/0008-5472.CAN-08-008 5 Frommer, M., L.E.",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10   .1073/pnas.89.5.182 7 Guan, H., L. Xie, F .",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
http://dx.doi.org/10.1182/blood-2009-12-25644 6(Leica) using the Application Suite 3.3.0 software (Leica).,OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"23:3940– 3947. http://dx.doi.org/10.1200/JCO.2005.11.65 0 Alizadeh, A.A., M.B.",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1038/3500050 1 Anders, S., D.J.",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1038/nprot.2013.09 9 Asmar, F ., V .",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.3324/haematol.2013.08874 0 Balko, J.M., R.S.",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1038/nm.279 5 Balko, J.M., L.J.",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1158/   0008-5472.CAN-13-138 5 Baudis, M., and M.L.",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
http://dx.doi.org/10.1371/journal   .pone.010424 9,Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1016/S0898-   6568(00)00121- 2 Roschewski, M., L.M.",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1038/nrclinonc.2013.19 7 Rosenwald, A., G. Wright, K. Leroy, X. Y u, P .",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1084/jem.2003107 4 Schmitz, R., R.M.",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1038/nature1137 8 Schneider, C., L. Pasqualucci, and R. Dalla-Favera.",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"28:167– 177. http://dx.doi.org/10.1053/j.semdp.2011.04.00 1 Shaffer, A.L.",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi   .org/10.1146/annurev-immunol-020711-07502 7 Shaknovich, R., H. Geng, N.A.",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1182/blood-2010-05-28532 0 Shen, Y .H., J. Godlewski, J. Zhu, P .",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi   .org/10.1074/jbc.M30326420 0 T eixeira, C., S.L.",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/ 10.1182/blood-   2002-11-362 1 Visco, C., Y .",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1038/leu.2012.8 3 Volk, A., J. Li, J. Xin, D. Y ou, J. Zhang, X. Liu, Y .",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi   .org/10.1084/jem.2013099 0 W aha, A., J. Felsberg, W .",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-09-321 8 W ang, M., C. Atayar, S. Rosati, A. Bosga-Bouwer, P .",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1002/path.252 1Gupta, S., T. Barrett, A.J.",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1038/nrc140 9 Jemaà, M., I. Vitale, O. Kepp, F .",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1002/emmm.20120022 8 Kim, D., G. Pertea, C. Trapnell, H. Pimentel, R. Kelley, and S.L.",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/   10.1093/nar/gkn29 4 Lawrence, M., W .",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10   .1371/journal.pcbi.100311 8 Lenz, G., I. Nagel, R. Siebert, A.V .",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi   .org/10.1084/jem.2006204 1 Lenz, G., G. Wright, S.S. Dave, W .",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1056/NEJMoa080288 5 Leventaki, V ., E. Drakos, M. Karanikou, K. Psatha, P .",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1016/j.humpath.2013.10.02 4 Li, Y ., H. Nagai, T. Ohno, M. Y uge, S. Hatano, E. Ito, N. Mori, H. Saito, and  T. Kinoshita.",OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1182/blood-2001-11-002 6 Martinez-Delgado, B., J. Fernandez-Piqueras, M.J. Garcia, E. Arranz, J. Gallego,   C. Rivas, M. Robledo, and J. Benitez.",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1038/sj.leu.240057 9 Mathews Griner, L.A., R. Guha, P .",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"Rep.  2:516.  http://dx.doi.org/10.1038/srep0051 6 Meyer, P .N., K. Fu, T.C.",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"29:200– 207. http://dx.doi.org/10.1200/JCO.2010.30.036 8 Muenst, S., S. Hoeller, N. Willi, S. Dirnhofera, and A. Tzankov.",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
"http://dx.doi.org/10.1155/2010/40406 9 Pasqualucci, L., and R. Dalla-Favera.",Non-OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
http://dx.doi.org/10.1016/j.ccr.2013.12.01 2,OADS,/arxiv_data1/oa_pdf/82/fc/JEM_20141957.PMC4419353.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
Online supplemental material is available  at http://www.jem.org/cgi/content/full/jem.20142235/DC1.,Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1038/nature0807 3 Ajubi, N.E., J. Klein-Nulend, M.J. Alblas, E.H. Burger, and P.J.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1006/bbrc.1996.110 4 Chen, A.E., D.D.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1038/nature0312 6 Cheng, Y., M. Wang, Y. Yu, J. Lawson, C.D.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1016/j.stem.2011.07.01 7 Lux, C.T., M. Yoshimoto, K. McGrath, S.J.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1182/blood-2007-08-10708 6 McKinney-Freeman, S., P. Cahan, H. Li, S.A. Lacadie, H.T.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1016/j.stem.2012.07.01 8 Merico, D., R. Isserlin, O. Stueker, A. Emili, and G.D. Bader.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1371/ journal.pone.001398 4 Mootha, V.K., C.M.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"34:267– 273. http://dx.doi.org/10.1038/ng118 0 Nemeth, M.J., L. Topol, S.M.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/   10.1016/j.devcel.2014.01.00 6 North, T.E., W. Goessling, C.R.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1038/nature0588 3 North, T.E., W. Goessling, M. Peeters, P. Li, C. Ceol, A.M. Lord, G.J.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1016/j.cell.2009.04.02 3 Ogasawara, A., T. Arakawa, T. Kaneda, T. Takuma, T. Sato, H. Kaneko,  M. Kumegawa, and Y .",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1074/jbc.M00807020 0 Ogawa, H., E. Kozhemyakina, H.H.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/   10.1101/gad.231969.11 3 Ponik, S.M., and F.M.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1002/stem.128 6 Rangaswami, H., R. Schwappacher, T. Tran, G.C.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10   .1074/jbc.M112.34724 5 Seta, F., A.D. Chung, P.V.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1152/ajpregu.90985.200 8 Shaywitz, A.J., and M.E.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
http://dx.doi.org/10.1146/annurev   .biochem.68.1.82 1cardiovascular function.,OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi   .org/10.1172/JCI2754 0 Cumano, A., J.C. Ferraz, M. Klaine, J.P. Di Santo, and I. Godin.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1016/S1074-7613(01)00190- X Cutler, C., P .",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1182/blood-2013-05-50317 7 Dzierzak, E., and N.A.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1038/ni156 0 Eilken, H.M., S. Nishikawa, and T. Schroeder.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1038/nature0776 0 Frangos, J.A., S.G. Eskin, L.V.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1126/science.388348 8 Godin, I.E., J.A.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi   .org/10.1038/364067a 0 Goessling, W., T.E.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1016/j.cell.2009.01.01 5 Goessling, W ., R.S.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1016/j.stem .2011.02   .003 Gordon-Keylock, S., M. Sobiesiak, S. Rybtsov, K. Moore, and A.  Medvinsky.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1182/blood-2012-12-47097 1 Hardy, R.R., and K. Hayakawa.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi   .org/10.1073/pnas.88.24.1155 0 Hoggatt, J., P. Singh, J. Sampath, and L.M.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1182/blood-2009-01-20133 5 Hoggatt, J., K.S.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1038/nature1192 9 Hoggatt, J., K.S.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi   .org/10.1182/blood-2013-07-51528 8 Hoggatt, J., P. Singh, K.N.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1016/j.bcmd.2012.11.00 6 Iida, A., K. Sakaguchi, K. Sato, H. Sakurai, D. Nishimura, A. Iwaki, M. Takeuchi,  M. Kobayashi, K. Misaki, S. Y onemura, et al.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"20:1110– 1116. http://dx.doi.org/10.1016/j.cub.2010.04.05 2 Johnson, D.L., T.N.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10   .1016/j.ceca.2005.06.02 2 Li, N., M.F .",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
http://dx.doi/10.1007/7651_2014_9 5,Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1016/j.cell.2012.05.04 1 Swiers, G., C. Baumann, J. O’Rourke, E. Giannoulatou, S. Taylor, A.  Joshi, V. Moignard, C. Pina, T. Bee, K.D.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"4:2924. http://dx.doi.org/10.1038/   ncomms392 4 Topper, J.N., J. Cai, D. Falb, and M.A.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"105:471– 480. http://dx.doi.org/10.1161/CIRCRESAHA.109.19365 6 Tsatsanis, C., A. Androulidaki, M. Venihaki, and A.N.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1016/j.biocel.2006.03   .021 Uematsu, S., M. Matsumoto, K. Takeda, and S. Akira.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.4049/jimmunol.168.11.581 1 Wang, L., P. Zhang, Y. Wei, Y. Gao, R. Patient, and F. Liu.",OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
"http://dx.doi.org/10.1182/blood-2011-05-35323 5 Wang, X.L., A. Fu, S. Raghavakaimal, and H.C. Lee.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/JEM_20142235.PMC4419354.pdf
